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Abstract 
Literature methods for the synthesis of benzyl 6-oxo-
penicillanate have been studied, it was apparent that some 
of these reports contained conflicting information with 
regard to reaction conditions and yields. The same 
methodology was also used to synthesise the cephalosporin 
analogue t.butyl 7-oxocephalosporanate. The reactions of 
these compounds with various trimethylsilyl amides and 
with the Wittig reagent 5' triphenylphosphoranylidenecyclo-
hexanespiro-2'-(l' ,3'dioxolan)-4'-one have been 
investigated. 
The potential for attaching penicillin and 
cephalosporin nuclei to polymer supports, and thereby 
utilising the well developed methodology of solid phase 
peptide synthesis in the field of the discovery of novel 
i3-lactam compounds, has been investigated. Difficulties 
were encountered when attempting to remove the/3-lactams 
from the resin, however both penicillin and cephalosporin 
compounds were recovered, in low yield, having had the 
63- (70-) amino protecting group changed whilst attached 
to the resin. 
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1.1 	Historical development of /3-Lactam Antibiotics 
13-Lactam antibiotics have been marketed as 
antibacterial agents for over 40 years. Today they account 
for nearly half of all prescribed antibiotics and are used 
to treat many common infections. 
The biological activity 	of /3-lactams was 	first 
discovered by Fleming 1 in 1929; he noticed the partial 
lysis of colonies of staphylococci on a plate that had 
been contaminated by Penicillium notatum. This led others 
to the isolation and characterisation of the first 
clinically useful antibiotic, benzyl penicillin 
(penicillin G) (1) by 1945. 
Problems were soon encountered; some bacteria were able 
to produce enzymes that could destroy the biological 
activity of the antibiotic before it had chance to act. 
These enzymes were initially called penicillinases, though 
later the more general term ' 0-lactamase' became common 
when a similar problem was found to exist with 
cephalosporins. Much work has been carried out over the 
years attempting to synthesise /3-lactamase resistant 
compounds. 
The chemical and biological properties of penicillins 
were found to be dependent on the acylarnino side chain at 
the 6i3 -position. New compounds were made by the addition 
of an alternative acyl side chain precursor to the 
- 1 - 
fermentation broth. This resulted in the discovery of the 
acid stable compound penicillin V (2) which has a 
phenoxymethyl group instead of the benzyl group of 
penicillin C. Penicillin V was found to be stable under 





 R = C6H5CH2CO- 
 R = C6H5OCH2 CO- 
 R = H 
 R = C6H5CH(NH2)CQ- 
 R = C6H5CH(CO2F1)CO- 
 R = H2NCH2(CH 2 ) 3C0- 
CO 2H 
(7) R = HO--CH(NH2 )CO- 
The initial attempts to chemically modify the side 
chain were hindered because of a shortage of the required 
intermediate 6-aminopenicillanic acid (6-APA) (3). 
6-APA was formed by the enzymatic removal of the side 
chain of penicillin G 2 , but the high demand for the latter 
by clinicians left little for researchers. Workers at 
Beecharn3 then discovered that 6-APA could be isolated from 
a precursor starved fermentation of Penicillium 
chrysogenum. Once a ready supply of 6-APA was available, 
many new semisynthetic penicillins were made, with a wide 
- 2 - 
variety of acylamino side chains 4 . Two important compounds 
resulting from this work were ampicillin (4) and 
carbenicillin (5). Compared to penicillin G these were 
found to have improved activity against Gram-negative and 
penicillinase producing bacteria, but poorer activity 
against non lactamase producing staphylococcal strains. 
Another major development was the discovery of the 
cephalosporins. In 1945 Brotzu noticed that culture 
filtrates from a mould, found near a sewage outlet in 
Sardinia, exhibited some activity against both Gram-
negative and Gram-positive bacteria 5 . Isolation of the 
active ingredient was beyond his means and a sample of the 
mould was sent to Oxford. There it was identified as 
Cephalosporium acremonium and two antibiotics were 
isolated. The first was called cephalosporin N 6 ; studies 
showed that this consisted of a penicillin nucleus with a 
D-c-aminoadipic side chain, and it was correspondingly 
renamed penicillin N (6). The second, cephalosporin C 
was discovered during work on penicillin N and was 
later isolated by the same researchers 8 . It did not show 
several of the characteristic properties of penicillins; 
penicilloic acid was not a product of its hydrolysis 
(Scheme 1.1) 9 and it was resistant to attack by 
penicillinase. Even though it was not a very potent 
antibacterial agent, it was active against both Gram-
negative and Gram-positive organisms. 










Scheme 1.1 	Hydrolysis of penicillins to penicillinoic 
acid 
The structure of cephalosporin C was reported by 
Abraham in 1961 g . It was found to be related to 
penicillin, with a dihydrothiazine ring fused to the 0 - 
lactam instead of a thiazolidine ring. This was confirmed 
by X-ray crystallography 10 . 
(8) R = H2NCH(CH2)3C0-, R' = OAc 
CO2H 
H 
RN 	 S 
COOH 
R = H, 
•R = OS-CH2CO-, 
R' = OAc 
R' = OAc 
R = )_CH2C0_, R' 
Following on from work with the penicillins, attempts 
were made to modify the acylamino side chain at the 7/3-
position of cephalosporins. 7-Aminocephalosporanic acid 
(7-ACA) (9) could not be made using methodology already 
developed for the synthesis of 6-APA, and was eventually 
- 4 - 
obtained by chemically removing the side chain of 
cephalosporin C using nitrosyl chloride" (scheme 1.2). 
HI 	 H  
:OEN 
HO 2 C NH2 	
COOH 	 H0 2C N 0 
	
COOH 
-.-- ()=N 	S 
-0 
HO 2 C 
COOH COOH 
Scheme 1.2 The synthesis of 7-ACA 
This led to other 7-acylamino side chains being 
investigated 12 and resulted in the first commercially 
available cephalosporins: cephalothin (10) and 
cephaloridine (11). They were found to be active against 
penicillinase producing bacteria and could be used to 
treat patients who were allergic to penicilliris. They are 
also more acid stable and have a broader spectrum of 
activity than penicillins. 
- 5 - 
Further 	developments 	in 	the 	field 	of f3-Iactam 
antibiotics resulted from the discovery of the naturally 
occuring 7a -methoxy cephalosporins (cephamycins) (12) 13 . 
It was initially thought that the addition of a 6 a-methyl 
group to penicillins would increase the similarity to N-
acyl-D-ala-D-ala (see section 1.3.1), but compounds of 
this type were found to be inactive14 . However, it was 
discovered that cephamycins were highly active and 
resistant to 0 -lactamase. The 6a-methoxy penicillin 
analogues (13) were synthesised and temocillin (14), the 
first penicillin with a broad spectrum of activity coupled 
with a high level of /3-lactamase resistance, was 
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Workers at Beecham later synthesised approximately 60 
different 6a -(7a -)substituted penicillins and cephalo-
sporins in a search for improved antibacterial activity 
and f3-lactamase stability 90 . This work resulted in the 
chance discovery of the 6a -(7a -) formamido analogues 16 . 
The 6cx -formamido penicillin (15) was found to -be more 
active than the 6a-methoxy compounds whilst retaining the 











Annual reviews covering research in the field of 3-
lactam antibiotics are published by the Royal Society of 
Chemistry in a series of specialist periodical reports 
entitled "Amino Acids and Peptides". 
- 7 - 
1.2 Some biological aspects of f3-lactam antibiotics 
1.2.1 Mode of action 
Unlike eukaryotic cells, both Gram-positive and Gram-
negative bacterial cells have a complex cell wall 
surrounding the cytoplasm. As well as maintaining the 
shape of the bacterium, the cell wall also acts as an 
osmotic barrier allowing the retention of nutrients and 
the exclusion of other unwanted compounds. The rigid 
structure of the cell wall in both types of bacteria is 
due to the crosslinking of linear polysaccharide chains by 
short peptide chains. 
It is generally accepted that 0 -Lactam antibiotics 
a cL. e e w ;+- ',  a 	_  a 1 cell- . 	wall  synthesis, 	i - the . aI & 
reason for the low levels of toxicity towards mammalian 
cells. However this has been subject to some debate, and - 
at least one report indicating that this may not be the 
case has been published 17 . 
3 -lactams only act against growing bacterial cells. 
Within a short time of adding penicillin to a bacterial 
culture, bulges begin to form in the bacteria. These 
increase in size until the bacterium bursts open. During 
this process the penicillin becomes covalently bonded to 
proteins, called penicillin binding proteins (PBP's) 18 . 
These proteins are located on an inner membrane and a 
series of barriers may have to be overcome before they can 
be reached by the antibiotic. 
The cell wall is made up of peptidoglycan which 
consists of polysaccharide or 'glycan' chains that are 
cross-linked by branched peptide chains. The length and 
nature of the crosslinks vary with bacteria, but the 
structure of the glycan is universal, consisting of 
alternating N-acetyl-D-glucosamine (NAG) and N- 
acetylmuramic acid (NAM). During the cell wall 
biosynthesis all peptidoglycans have a pentapeptide which 
commonly has the sequence: L-ala-D-glu-'Y-L-X-D-ala-D-ala, 
in which X is usually an amino acid with a free amino 
group such as L-lysine. Crosslinking occurs by a 
transpeptidation reaction, this involves displacing the 
terminal D-alanine residue with the free amine group (x) 
of an adjacent pentapeptide (Scheme 13). This reaction is 
highly penicillin sensitive. The extent of crosslinking 










Scheme 1.3 General structure of peptidoglycans 
The D-ala-0-ala residues of the uncrosslinked sections 
are removed by carboxypeptidases. The transpeptidase and 
carboxypeptidase reactions are similar in that both 
involve a reaction of the carbonyl of the penultimate D-
alanine with a nucleophile. When the nucleophile is water 
then hydrolysis results, whereas if it is the amino group 
of another peptide, a peptide bond will be formed (Scheme 
1.4). 
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Scheme 1.4 
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A historical model describing the selectivity and 
action of /3-lactam antibiotics was proposed by Tipper and 
Strominger over 25 years ago 19 . They suggested that 
penicillin may be a structural analogue of D-alanine-D-
alanine. It should however be noted that the configuration 
at C-6 in penicillins is opposite to what would be 
















Scheme 1.5 	Comparison of the configuration of N- 
acylated 	D-alanine-D--alanine 	(a) 	with 	a 	3S 2 5R,6R- 
penicillin (b). 
It was suggested that 	transpeptidation was a two step 
process involving an acyl-enzyme intermediate, formed by 
a serine hydroxyl on the enzyme displacing the terminal D-
alanine. Because of the reactivity of the /3-lactam ring, 
it was thought that penicillin was capable of irreversibly 
acylating bacterial transpeptidases thereby preventing the 
formation of crosslinks. This would lead to a weakening of 
the peptidoglycan and the eventual death of the cell. 
- 11 - 
This theory provided a simple model which helped to 
explain the observations, but when one considers the 
activity of compounds such as the norcardicins (16) or 
the monobactams (17), its limitations become apparent. 
H 
RN 








1.2.2 	Action of f3-1-actamases on penicillins and 
cephalosporins. 
The biological activity and microbial resistance of 
penicillins and cephalosporins are linked to the 
reactivity of the /3-lactam ring which is strained and 
susceptible to various cleavage reactions. The ring 
opening reactions of penicillins and cephalosporins are 
totally different. The hydrolysis of penicillins has been 
illustrated in scheme 1.1; this reaction will occur in the 
presence of dilute alkali, penicillinase or amino groups. 
The resulting penicilloates can be isolated and are well 
characterised. Cephalosporins however are more complicated 
because the corresponding cephalosporoate (18) is unstable 
(scheme 1.6). Newton et a1 20 reported extensive 
fragmentation and the production of free acetate when 
- 12 - 
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Hamilton-Millar and co workers 2 ' carried out a detailed 
study on the aminolysis and enzymatic hydrolysis of 
cephalosporins which led to some understanding of the 
chemistry involved. 
Excellent reviews are available regarding the types 
of 0-lactamases and their modes of action 22 . 
1.2.3 	3 -lactamase inhibitors. 
A 0-lactamase inhibitor is a /3-lactam compound that 
will irreversibly react with 0-lactames thereby 
preventing these enzymes from attacking the antibiotic. 
/3-Lactamase inhibitors will often have only poor 
antibiotic activity, and are used in conjunction with more 
active compounds. 
- 13 - 
V 
Clavulanic 	acid (19) 23, was the first 0-lactamase 
inhibitor discovered by workers at Beecham, and has been 
marketed as a drug called augmentin, in which it is 
combined with amoxycillin (7). When (19) is used in 
excess, the enzyme becomes irreversibly acylated. The 
reaction initially involves the formation of an acyl-
enzyme intermediate (20), after which it can follow one of 
three competing pathways (Scheme 1.7), two of which 
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Other common 0-lactamase inhibitors include 60-bromo 
penicillanic 	acid (21) 	and penicillanic acid 	suiphone 
(23). 	The 	former is believed to produce a thiazolidinone- 
enzyme adduct (22) (scheme 1.8), whereas the sulphone is 























CO 2 H 
(23) 
- 15 - 
1.3 	The synthesis and selected chemistry of 6-oxo- 
penicillins and 7-oxocephalosporins 
Compounds with a carbonyl group at the 6(7) position 
of a penicillin or cephalosporin nucleus were first 
synthesised by Y. S. Lo and J. C. Sheehan in 197224. The 
potential for the synthesis of novel compounds from these 
intermediates was soon realised. 
The first compound of this type synthesised by these 
researchers was benzyl 6-oxopenicillanate (24), which was 
obtained by the oxidation of benzyl 6a-hydroxy-
penicillanate (25). The oxidation of (25) was carried 
using diisopropyl carbodiimide in the presence of 
dimethyl suiphoxide, oxidation methodology that is 
commonly referred to as the Moffat oxidation 25 . Benzyl 
6 a -hydroxypenicillanate (25) was prepared by the method 
of Hauser and Sigg 26 . This involved the reaction of 6-APA 
(3) with sodium nitrite to produce 6a-hydroxypenicillanic 
acid (26), from which the benzyl ester (25) was obtained 
following treatment with phenyldiazomethane (Scheme 1.9). 
Difficulty was experienced in removing the byproduct 
resulting from the diisopropylcarbodiimide from the 
oxidation product, and the reaction was unsuccessful when 
water soluble carbodiimides were used in an attempt to 
overcome this problem. The final product was eventually 
















H 	 Me 









Scheme 1.9 Synthesis of benzyl 6-oxopenicillanate 
Sheehan and Lo then reduced (24) using potassium 
borohydride. This resulted in only the 0-hydroxy isomer 
which was acylated with phenoxyacetylchloride to benzyl 
60 -(phenoxyacetoxy)penicillanate (27). 
PhOCH 2CO 	 Me 
11 
01: N 	Me 
CO 2 Bz 
(27) 
No indication of yields were given in the initial 
report of this work, however in a later publication a 
yield of 22% was quoted for the conversion of 6-APA to 
benzyl 6-oxopenicillanate (24) 27 . 
- 17 - 
Due to the absence of amide stabilisation, the carbonyl 
group at the 6 position of (24) was significantly more 
reactive than the adjacent 0-lactam carbonyl group, and 
Wittig reactions were found to be highly regioselective 
towards it. Using this reaction, 60-phenoxyacetylmethyl 
penicillanic acid (28), a carbon analogue of penicillin V, 
was synthesised 28  (Scheme 1.10). 
(24) 
Me 




















Pd/C 	 0 	NMe 
CO2 Bz 
Scheme 1.10 
It should be noted that Wittig reactions with 13-lactarn 
carbonyl groups have since been successful. Workers at 
Beecham 29 initially reported the reaction of CH3CO2CHPPH3 
with derivatives of clavulanic acid (19) and penicillin V 
(2). Mixtures of the E and Z-isomers were obtained in high 
yield when the reactions were carried out in refluxing 
toluene. A more comprehensive study was later published in 
which reactions involving a wider range of 0-lactam 
compounds and Wittig reagents were reported 30 . 
The synthesis of 6a-substituted penicillins from 6-oxo-
penicillins was investigated soon after the discovery of 
the 7a-methoxycephalosporins (cephamycins) (12). These are 
naturally occurring compounds which were found to have a 
	
high degree of 	stability to /3-lactamase. Benzyl 6- 
oxopenicillanate 	was treated with the nitrogen Wittig 
reagent, N-phenoxyacetyliminotriphenylphosphorane (29) 7 
which gave an N-acylimine intermediate (30). This was then 
converted to the 6a-methoxy or cyano compound by treatment 
with methanol or HCN respectively, with the addition in 
both cases occurring from the least hindered side of the 
double bond 3 ' (scheme 1.11). 
0 	
S Me 	 Me 
N 	Me > NM 
PhOCH2C(0)NPPh3  
(24) CO 2CH 2 Ph 	(29) 	 (30) CO 2CH 2 1Ph 
I HX 
orCN 
Ix 	 HX\/ 





CO 2 H 	 CO 2CH2 Ph 
Scheme 1.11 Synthesis of 6a-methoxypenicillanic acid. 
- 19 - 
Unrelated work, by T. Jen et a1 32 , on 6cr (7a)-methoxy 
penicillins and cephalosporins led to an alternative 
method for the synthesis of 6-oxopenicillins. They 
synthesised both 6cr (7cr ) -methoxy penicillins and 
cephalosporjns by the addition of methanol in the presence 
of mercuric chloride to the respective 6cr (7cr )-methylthio 
compound. The methylthio intermediate (31) was synthesised 
from the Schiff base (32) by treatment with methyl 
methanethiolsulphonate (Scheme 1.12). It was found that 
the 6cr -me thy lthiopenicillin derivative (31) would yield 
benzyl 6-oxopenicillanate (24) on treatment with mercuric 
chloride in the presence of DMF and water. 







H 2 N OXX MeSO2 SMe 
(31) 	CO 2CH2 Ph 
Scheme 1.12 
During a study of the isomerisation of benzyl 6cr - and 
60 -phenoxyacetoxypenicillanates H. Vanderhaege et a1 33 
attempted the oxidation of benzyl 6cr-hydroxy—penicillanate 
(25) to benzyl 6-oxopenicillanate (24). These workers 
reported that the Moffat oxidation of (25) using either 
- 20 - 
orthophosphoric acid or pyridinium trifluoroacetate as 
catalyst gave a mixture containing approximately 50% of 
the desired product which could not be further purified by 
silica gel chromatography. An improved method for this 
oxidation was suggested, involving the use of dimethyl 
suiphoxide and acetic anhydride. Using these conditions 
benzyl 6-oxopenicillanate (24) was obtained, in 92% yield, 
as a crystalline solid. 
A comparison of some oxidising methods for the 
conversion of 6 a -hydroxypenicillanates to 6-oxo 
penicillanates was carried out by S. Chandrasekaran 
et a1 34 after which they concluded that the preparation of 
6oxopenicillanates was not as straightforward as earlier 
reports led one to believe. Benzyl 6-oxopenicillanate (24) 
was synthesised in approximately 80% yield using the 
Moffat oxidation with dichloroacetic acid as the catalyst 
and in order to repeat the DMSO/acetic anhydride 
conditions described by Vanderhaege 33 , they found it 
necessary to distil the acetic anhydride from either 
aluminium chloride or calcium carbide. The oxidation was 
also attempted using N-chlorosuccinimide-dimethyl 
sulphide35 , Jones reagent 36 and silver carbonate on 
Celite37 , all of which were unsuccessful. t-Butyl 7-oxo 
cephalosporanate (76) was also synthesised from the 
corresponding 7a -hydroxycephalosporanate using dimethyl 
sulphoxide-DCCI, though the reaction was not as clean as 
for the penicillins. 
- 21 
An alternative route to 6-oxopenicillanic acid and 
7-oxocephalosporanic acid derivatives, involving totally 
different methodology from previous syntheses, was 
introduced by D. Hagiwara et al in 198238.  They reacted 
both benzyl 60-aminopenicillanate and benzyl 70-amino-
cephalosporanate with trifluoromethanesuiphonic anhydride. 
This gave the corresponding bis(trifluoromethyl)sulphonate 
derivatives, which were then converted to the imines by 
treatment with either DBU or triethylamine. The imines 
were finally hydrolysed with dilute HC1 to give the 6-
oxopenicillanate and 7-oxocephalosporanate derivatives in 




7N jX  
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Scheme 1.14 	Synthesis of benzyl 6-oxopenicillanate 
using trifluoromethanesuiphonic anhydride. 
- 22 - 
Some penicillins with a carbon-carbon double bond at 
the 6 position have have been reported to have 
0-lactamase inhibitory properties. D. G. Brenner 
synthesised 6-(methoxymethylene)penjcjllanic acid (34'39, 
from benzyl 6-oxopenicillanate (24), and found the Z_ 
isomer to be a potent 0-lactamase inhibitor which behaved 





The above compound could not be synthesised by a direct 
Wittig reaction between benzyl 6-oxopenicillanate and the 
ylide generated from methoxymethyltriphenyiphosphonjum 
bromide, as the reaction was too slow at low temperatures, 
and increasing the temperature resulted in the loss of 0-
lactam functionality. A method previously employed by 
Magnus and Roy 40 involving the use of silicon stabilised 
anions was found to be successful. This involves the 
reaction of (methoxy(trimethylsilyl)methyl)lithjum, 
generated from (methoxymethyl)trimethylsilane and 
butyllithium, with a ketone to form stable/3-silylalcohol 
adducts. Treatment with - will give methyl 
vinyl ethers in high yield. Brenner reported that this 
reaction had an added advantage in the case of penicillins 
- 23 - 
in that the C-3 ester group could be removed at the 
intermediate stage prior to formation of the enol ether. 
Problems were encountered with the final stage due to 
desilylation competing with the desired elimination 
reaction. To promote the elimination the alcohol at C-6 
was made into a better leaving group by acetylation 
(Scheme 1.15). 
0 ):]NN S 
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SiMe 3 
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Y. L. 	Chen et a141 prepared a series of 6- 
(heterocyclyl)metiiyiene penam suiphones (35) and reported 





They carried out a Swern oxidation 42 on allyl 
6c -hydroxypenicj]janate to give allyl 6-oxopenicillanate 
which was used without purification. The product of the 
Wittig reaction was oxidised to the suiphone using 2 
equivalents of rn-chloroperbenzojc acid, final removal of 
the allyl group gave the required compounds. 
- 25 - 
1.4 Solid phase peptide synthesis 
1.4.1 	Introduction. 
Since the introduction of solid phase methodology by 
R. B. Merrifield in 1963 43  9 it has developed into by far 
the simplest and most efficient means of chemically 
synthesising both peptides and oligonucleotides. 
Merrifield later received the Nobel prize for this work 44 . 
	
The solution phase synthesis of peptides 	is a 
complicated and laborious task. Each protection, coupling 
and deprotection step, of which there may be many, will 
contribute to a significant loss of product, resulting in 
a poor yield of the target compound. Combined with 
-----i 	- 	problems 	 -t 	decreasing .-1..1-4 1 I-.. 	 4.1 pUL.LL .LLd ..LU1I 	 LIU LILI ¼J.L(JUJ..LJ. 	JL L.LL 
growing peptide, it is clear that conventional methodology 
is not ideal for this area of chemistry. 
In solid phase peptide synthesis (SPPs) the first amino 
acid is attached to an insoluble support, a synthetic 
polymer called a 'resin'. Successive activation, coupling 
and deprotection steps eventually lead to the target 
peptide bound to the resin (scheme 1.16). The amino acid 
to be attached to the resin must be protected at the Na - 
position. Once bound to the resin the N -protection can 
be removed. The nature of the protecting group must be 
such that its removal does not affect the amino acid-resin 
linkage or any other side chain protection that may be 
present. 
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R' 
L—NH-- CH— c(o)— OH 
activate 
L —NH- -CI-i—C(o)— A 	+ 	 x —frPLYMEiJ 
couple 
R' 




I 	 I 	couple 
L—NH—CH -.-- —C(0)A 
R" 	 R' 
I I  
L— NH —CH —C(0)NH—CH —c(o) —0 —IPOLYMER1 
deprotect, couple etc. 
H2N—peptide 	+ 	ILPOLYMER1 
Scheme 1.16 Solid phase peptide synthesis. 
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A major advantage of solid phase techniques is that 
when attached to the resin, the peptide is insoluble in 
all solvents. This means that excess reactants and 
reagents may be removed by simple filtration techniques. 
Once the required peptide has been synthesised, all 
side chain protecting groups must be removed and the 
product must be cleaved from the resin. Ideally these 
steps should be carried out simultaneously. 
The repetitive nature of this cycle has led to the 
automation of SPPS. Peptides may be assembled at the rate 
of one amino acid residue every four hours, a vast 
improvement over solution phase techniques. 
1.4.2 The polymer support 
For a polymer to be of use as an insoluble support 
in SPPS it must comply with the following basic rules: 
The size of the polymer particles must allow easy 
manipulation and rapid filtration. 
The polymer must be sufficiently inert so as not to 
change during the synthesis. 
The polymer must swell in appropriate solvents to 
allow the penetration of reagents. 
SWO 
The resin initially developed by Merrifield (36) 43  was 
prepared by the chloromethylation of a cross-linked 
copolymer (37) obtained from 2% divinylbenzene in styrene. 
This gave a chloromethylated resin to which the first 
amino acid could be attached by using the triethylaminonium 
salt (38) (Scheme 1.17). 
CH3 -0-CH2 -Cl 	+ 
CH3OH 	+ 
R' 
LNFI - CH - CO2Et 3HN 
(38) 
\1, 
0_4EEMER J  
(37) 
Cl - CH2 	—fOLYMER 
(36) 
L-NH-H-CO2 -CH2 	 LYMER 
Scheme 1.17 Use of the chioromethylated resin. 
The Na - protecting group initially used by Merrifield 
was benzyloxycarbonyl (Z) 45 which required the rather 
harsh deprotection conditions of HBr in acetic acid. When 
subjected to these conditions a small amount of the 
growing peptide would be cleaved from the resin. This 
created a significant problem during the synthesis of 
large peptides, which was overcome to some extent with the 
introduction of the t-butyloxycarbonyl 46 group. 
- 29 - 
Many alterations have been made to the original resin, 
usually with the aim of increasing or decreasing the 
stability of the peptide-resin bond. It was thought that 
increasing the electron withdrawing effect on the benzylic 
position, by nitrating or brominating the aromatic nucleus 
of the copolymer, would result in a more stable peptide-
resin bond43 . This was found to be true, however the 
peptide-resin link in the nitrated example was resistant 
to acidolysis with HBr and HF, and the brominated example 
suffered from reduced swelling properties. 
Other modifications were carried out to the copolymer 
itself. Reducing the divinylbenzene content from 2% to 1% 
resulted in a resin with improved swelling characteristics 
in both DCM and DMF 439,47 . This gave improved access to 
the reactive sites of the resin, especially important 
when amino acids with bulky side chains are involved. If 
less than 1% divinylbenzene is used 48 the resulting resin 
is very soft and there are often problems with filtration. 
Merrifield also reported43 that supports with 8% and 16% 
crosslinking were very rigid and did not allow easy 
penetration of reagents. 
A further improvement on the chioromethyl resin has 
been the development of the hydroxymethyl resin (39) 
(Scheme 1.18). 
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Cl - CH —K--LYMER 
(36) 
CH3CO K 
CH3— C(o) 0 —CH2—--1LYMER 
\1/ 
HO - CH2——LYMER 
Scheme 1.18 Synthesis of the hydroxymethyl resin. 
The hydroxymethyl resin allows the use of milder 
coupling reagents e.g. DCCI 49 , hence the alkylation of 
nucleophilic side chain functions, for example in 
histidine and methionine, is avoided. This was often a 
problem when the original resin (36) was used with such 
amino acids. 
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1.4.3 The peptide-resin link 
Even after the introduction of the Boc group as a means 
of Na - protection in SPPS there were still problems with 
peptide-resin benzyl ester bond cleavage during 
deprotection. It has been reported that using 50% TFA in 
DCM for the removal of Boc results in the loss of 
approximately 1% of the peptide from the resin. 
A large improvement came with the introduction of the 
phenylacetamidomethyl (Pam) resin (40) by Merrifield 
et a150 . This involved the inclusion of a 'handle' between 
the peptide and the resin. The Pam resin is synthesised by 
the acylation of the aminomethyl resin (41) with 
-acetoxymethyiacetic acid (42) using DCCI 51 The acetyl 
group is then removed by hydrazinolysis to the 
hydroxymethyl Pam resin (40) (Scheme 1.19). (41) is 
generated by the treatment of the chioromethyl resin (36) 
with potassium phthalamide then hydrazine 52 . 
The electron withdrawing effect of the acetamido group 
in the para position of the phenyl ring to which the 
peptide is attached increases the stability of the 
peptide-resin link, by virtue of deactivating any 
incipient carbocation intermediate during alkyl-oxygen 
fission of the benzyl ester. 
The 'handle' also acts as a spacer, increasing the 
distance between the resin and the peptide. This has the 
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effect of making the reactive sites more accessible to 
reagents. 





cH3c( 0 ) 0 _CH2_(D)_- cH2_ C(0)NH—CH2_r__I LYMER . 
HO—CH2__CH2—C(0)NH—CH2 —Kr—ILYMER 
(40) 
Scheme 1.19 Synthesis of the hydroxymethyl Pam resin (40). 
The main problem with such a resin is that larger 
peptides may not be stable to the cleavage conditions 
required, namely HF. Therefore ideally more acid labile 
peptide-resin linkages are required. An example of such a 
resin is the 2-alkoxybenzylalcohol resin (43) introduced 
by Wang53 . The synthesis of this involves the treatment of 
the chioromethyl resin (36) with 4-hydroxybenzylalcohol 
(44) and sodium methoxide (Scheme 1.20). 
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The -a1koxy substituent enhances the lability of the 
ester linkage by donating electrons. A solution of 50% TFA 
in DCM is sufficient to cleave the final peptide from this 
resin. If acid labile Na - protection is used it must be 
stable to these conditions, alternatively, base labile 
protection can be used e.g. 9-fluorenylmethoxycarbonyl 
(see section 1.4.4). 
H0—CH2——QH + C1 — CH2_ILyMER 




Scheme 1.20 Synthesis of the Wang resin (43). 
The 	2-methoxy-4-alkoxybenzylalcohol 	resin 	(45)55 
(Sasrin resin) has recently been introduced as a resin 
that is even more acid labile than the Wang resin. 
Cleavage conditions of between 0.5-1.0% TFA in DCM are 
successful in removing peptides from this resin. Besides 
the increased acid lability of the peptide-resin linkage, 
the Sasrin resin is reported to behave in a similar manner 
to the Wang resin. 






1.4.4 NC-protecting groups 
The Na_ position of an amino acid is usually protected 
by groups of the urethane type (46), as they may be 
removed under relatively mild condition as well as 




R'— O—C--HN— CH— CO2H 
 
Some of 	the Na - protecting groups used in peptide 
synthesis are discussed below: 
Z protecting group 
Benzyloxycarbonyl (z) (47), the first urethane type 
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Deprotection may be achieved by hydrogenolysis or acid 
catalysed solvolysis using hydrobromic acid. Peptide - 
resin cleavage may occur with successive acidic N - 
deprotections. 
Boc protecting group 
CH3 0 
I 	I' 
CH 3 - C —0— C - 
CH3 
(48) 
ter t.Butyloxycarbonyl (Boc) (48)46  is the most widely 
used acid labile protecting group in SPPS. Boc protected 
amino acids are usually deprotected using 50% TFA in DCM 
(Scheme 1.21). 
CH 3 0 	R 	 CH3 OH 	R 
I 	II TFA 	I 	'to I 











CO2 	+ 	NH2—CH—CO2H 
side reactions 
Scheme 1.21 Removal of the Boc protecting group. 
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The carbonium ion intermediate (49) will lose a proton 
to give but-2-ene, but when sulphur containing amino 
acids (methionine or cysteine) or the aromatic systems of 
tyrosine or tryptophan are present, (49) may become 
involved in unwanted side reactions. The addition of 
cation scavengers such as anisole or dimethyl sulphide 56 
will sometimes prevent these side reactions. 
	
Bpoc protecting group 	 - 
The 2-(4-biphenyl)isopropyloxYcarbOnYl (Bpoc) group 
(50) 57  is considerably more acid labile than Boc and can 
be deprotected using 0.2-0.5% TFA in DCM. Bpoc amino acids 
are not stable as free acids, and must be stored as salts. 
CH3 
(50) 
Fmoc protecting group 
The 9-f luorenylmethoxycarbonyl (Fmoc) group (51), 
introduced by Carpino 58 9 is the main base labile 
protecting group used in peptide synthesis. Its potential 
in this field was first realised by Sheppard 59 . 





Base labile N a- protection is often used in SPPS. 
When used in conjunction with acid labile side chain 
protection and peptide-resin linkage, a fully selective 
system is achieved allowing removal of the N C' - protection 
as the peptide is synthesised, followed by the removal of 
any side chain protection, and cleavage from the resin 
after the synthesis is complete. 
Problems are often encountered when amino acids are 
directly acylated with Fmoc chloroformate (52)60, due to 
the formation of up to 20% of an Fmoc-oligopeptide 
contaminant. The chioroformate reacts with the carboxyl 
function of the amino acid producing a mixed anhydride 
intermediate, which can then react with an amine group on 
another amino acid to give an Fmoc-dipeptide system (53) 
(Scheme 1.22). 
This problem is overcome by using the less reactive 
active ester derivative, N_(9_fluorenylmetho4arbonyloxy) 
succinimide (Fmoc-ONSu) (54)61•  This is a stable, 





CH 2 OC-C1 
- 	(52) 
H2NCHCO 2 H 
000, 
\/ 	0 R  





II 	I 	II 	II 
CH20CNHCHC0C0CH 2 
\tH2NCH(R)CO2H  
- 	0 	R 	R 
/\ 
II I 	II I 
CH2 0C-NHCHC- NHCHCO2H 
Scheme 1.22 Attempted protection of amino acids using 





The removal of Fmoc proceeds via a fl-elimination 
mechanism and is normally brought about by the addition of 
20% piperidine in DMF (Scheme 1.23). The by-products 
include dibenzoful.vene (55) and the tertiary amine (56) 
formed by the addition of piperidine to the double bond. 
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(55) and (56) are both soluble in DMF and therefore 
present no contamination problems. No intermediate 
carbonium ions are produced, so scavengers are not 
required. All by-products are soluble in DMF and can be 
















Deprotection of Fmoc amino acids. 
Bnpeoc protecting group 
Fmoc is expensive; Fmoc amino acids are generally two 
to five times more expensive than their Bóc counterparts. 
The 2,2-bis(4'nitrophenyl)ethoxycarbonyl (Bnpeoc) group 
(57) was introduced by Ramage and Florence 62 , and 









The group is. introduced to amino acids using the active 
ester derivative (58), since the chioroformate (59) 
resulted in the same problems that were encountered with 
Fmoc chloroformate (52) (scheme 1.22). 
The synthesis of Bnpeoc is based on the ring opening of 
styrene oxide using phenyl magnesium bromide. Karash and 
Clapp64 observed that the nature of the product depended 
on the order of addition of the reactants. The expected 
secondary alcohol was obtained by adding the Grignard 
reagent to the oxide, but if this order was reversed then 
the primary alcohol would be obtained in 80% yield. Para 
nitration of the phenyl rings of the acetate gave 2,2-
bis(4'nitrophenyl)ethanol (60) 9 from which the 
chloroformate (59) and active ester derivative (58) could 
be synthesised in high yield (Scheme 1.24). Amino acids 
are then protected using either the method developed by 
Lapatsanis 65 or by Rich66 . 
The deprotection of Bnpeoc proceeds by a similar 
mechanism to that of Fmoc (Scheme 1.23). Either 1,5-
diazabicyclo[4.3.0]non - 3 - ene (DBN) or 1 1 8-diazabicyclo- 
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[5. 4 . 0 ]undec - 7-ene (DBU) can be used as the base for this 
reaction. The low nucleophilicity of these bases reduces 
the possibility of unwanted side reactions. The system is 
often buffered with acetic acid to avoid conditions of 
extreme pH. 
Ph 	 + PhMgBr -> 0 
I AcO 
pyridine 





0 2 N 	
q
"..NO2 
XH2 	cc N1 
(bo) 




(59 	11  
NMM 
HONSu 





Scheme 1.24 	Synthesis of the Bnpeoc protecting group. 
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1.4.5 Side chain protection 
All of the reactive sites of amino acid side chains 
must be protected throughout the synthesis of a peptide, 
in order to prevent any unwanted chemical transformation 
of the side chain. 
When acid labile Na_ protection is used, the side chain 
protection must be more stable than this, so that it is 
not affected during Na_ deprotection. Groups often used in 
this case are derived from the benzyl protecting group. 
When the very acid labile N  - protection, Bpoc (50), 
or base labile Na_ protection are used, the t.butyl 
protecting group is often employed to protect side chain 
functionality. 
1.4.6 Coupling methods 
The standard procedure for the formation of a peptide 
bond involves the activation of the carboxyl group of the 
incoming N U  -protected amino acid towards nucleophilic 
attack by the amine function. To achieve this activation 
it is necessary to replace the hydroxyl group with an 
electron withdrawing group (x) (Scheme 1.25). 
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11 	 11 
Activation 	R — C-OH 	> R—C—X 
0 	 0 R' 
II II 	I Coupling 	R —C— X + H2NR' - R —C— NH + HX 
Scheme 1.25 	Coupling of amino acids. 
Some of the more common methods of peptide bond 
formation are outlined below : 
The acid chloride method 
This uses the chlorine atom as the electron withdrawing 
group M. Protected amino acid chlorides have had limited 
use in peptide synthesis due to problems of racemisation 
(via oxazolidinone formation). Other problems encountered 
when using this method are the presence of unwanted side 
reactions, and the need to use relatively stable 
protecting groups in order for them to survive the 
conversion of a carboxylic acid to an acid chloride. 
Recently thionyl chloride in DCM has been used to form 
several Fmoc protected amino acid chlorides 67 . Less than 
0.1% loss of chirality was reported 68 . 
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The carbodjjmjde method 
This is now the most widely used coupling method in 
peptide synthesis. It was first recognised by Sheehan and 
Hess 49  and was later used by Merrifield43 when he first 
introduced SPPS. Merrifield used N,N'-dicyclohexyl 




R - C - OH 
Scheme 1.26 
















R—C— NH —R' 
(63) 
Peptide bond formation using DCCI. 
The mechanism of this reaction was first studied by 
Khorana 69 and more recently by De Tar et a1 70 . The 
reaction has been shown to proceed rapidly due to the high 
reactivity of the 0-acyl urea intermediate (62). This 
intermediate will however spontaneously rearrange to the 
unreactive N-acyl urea (63), which will result in the loss 
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of the Na_protected amino acid from the coupling reaction. 
Such a rearrangement often occurs in polar aprotic 
solvents such as DMF. If the reaction necessitates the use 
of such solvents, then the minimum volume possible should 
be used. 
Diisopropylcarbodiimide (DId) 71 has emerged as an 
alternative to DCCI. Being a liquid DICI is easier to 
handle than DCCI, which is a waxy solid, and the 
corresponding urea by-product is more soluble. 
The active ester method 
The first synthetic peptide chemistry was carried out 
using amino acid methyl and ethyl esters as activating 
agents 72 . It was later discovered by Schwyzer et a1 73 that 
increasing the electron withdrawing effect of the alcohol 
component of the ester increases the electrophilicity of 
the carbonyl carbon, thereby making it more susceptible to 
nucleophilic attack. Aryl esters, especially the p-nitro 
phenyl active ester (64) introduced by Bodansky 74 , have 





These are prepared by reacting the Na-protected amino 
acid with either -nitrophenyl sulphate or phosphite 75 ,or 
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by condensation with -nitrophenol using DCCI 76 . 
The most successful and widely used active esters today 
are those of 1-hydroxybenzotriazole (HOBt) (65) 77  and 




RC-O-N 	N 	 II 
RCO \) 
0 
(65) 	 (66) 
The azide method 
This was first introduced in 90 by Crtu 79 .12 	ui 	His 
methodology involved the treatment of a methyl ester with 
hydrazine followed by the addition of nitrous acid, to 
convert the resulting hydrazide (67) to the acid azide 
(68) (Scheme 1.27). An improved method is the direct 
conversion of carboxylic acids to acid azides using 
diphenylphosphonyl azide. 
0 	 0 	 HONO 	0 II 
H3 	
H2N NH2 	II 
R-C-0-C ) R-C-NH-NH2 	) R-C-N=N=N 
(67) 	 (68) 
Scheme 1.27 Preparation of acid azides. 
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The main problem with this method is the tendency of 
acid azides to rearrange to isocyanates by the Curtius 
rearrangement. To keep this to a minimum, the reaction 
should be performed at low temperature using a minimum of 
solvent and the acid azide must be prepared immediately 
before it is required. 
The preformed symmetrical anhydride method 
Amino acid symmetrical anhydrides (69) can be prepared 
using carbodiimides such as DCCI (Scheme 1.28). 




R 0 NH 














Scheme 1.28 Preparation of symmetrical anhydrides. 
Boc amino acid symmetrical anhydrides are unstable and 
must be prepared immediately before use. This can lead to 
problems with automated SPPS where often the reagents are 
Elmo 
prepared, loaded into the machine, and depending on the 
position in the sequence, may have to wait some time 
before becoming involved in the synthesis. Fmoc amino acid 
symmetrica1r.i,on the other hand, are stable. 
The mixed anhydride method 
Mixed or unsymmetrical anhydrides (70) have been of 





Ideally the R' group should be electron donating, good 
examples being the mixed anhydrides formed from 
isovaleric 80 and trimethylacetic acid chlorides 81 . As well 
as the electron donating effect, the steric bulk of the R' 
group promotes the reaction at the carbonyl derived from 
the carboxyl. 
The problem with mixed anhydrides is their tendency to 
convert to symmetrical anhydrides 82  and the possibility of 
racemisation. Employing low temperatures during 
preparation of the anhydride will reduce the chance of the 
former and short coupling times will help to prevent the 
latter. 
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Mixed anhydrides of organophosphorus acids have 
recently received a lot of attention. The nature of the R' 
group must be such that there is minimal 
disproportionation to the symmetrical anhydride and also 
such that the reaction takes place at the desired 
carbonyl. Some mixed anhy Irides of organophosphorus acids 
have been found to satisfy these requirements. 
Of particular interest to the present research (see 
chapter 2) are phosphinic-carboxylic mixed anhydrides 
derived from a phosphinic acid. A method of synthesising 
these compounds involves the use of diphenyiphosphinyl 
chloride (Dpp-Cl) (71)83, a readily available reagent that 
was introduced as a means of preparing diphenyiphosphinic 
-carboxylic mixed anhydrides (72) by Ramage et a1 84 2 85 
(Scheme 1.29). Dpp anhydrides have been compared to 
pivalic anhydrides in order to determine their relative 
reactivity 85 . The results of these experiments indicated 
that greater activation had occurred in the Dpp example. 
Dpp mixed anhydrides demonstrate a number of advantages 
over their carboxylic counterparts, though problems are 
occasionally encountered due to the insolubility of the 
diphenylphosphinic acid byproduct ( 73). Dpp-Cl is also 
rather difficult to handle since it is a viscous liquid 
that will readily decompose to (73) in the presence of 
moisture. 
Msm 
R 	 0 	NMM 	 R 0 0 
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In an attempt to overcome the handling problems often 
encountered with DPP-Cl, diphenyiphosphinic anhydride 
(DppoDpp) (74) has recently been prepared by workers in 
this research group 86 . This compound is a white 
crystalline solid which is stable under a dry atmosphere. 
The synthesis of (74) was carried out using the method of 





ethyl diphenyiphosphinate (75) in the absence of solvent 
and in an inert environment at 200 0C (Scheme 1.30). (75) 
was prepared by the method of Kosalapoff and Watson 88 ' 
which involves the addition of sodium ethoxide to a cooled 
solution of Dpp-Cl in benzene. The reaction can be 
31 conveniently monitored using 	P n.m.r., the chemical 
shift of the phosphorus atom is different in the chloride 
(71), anhydride (74) and acid (73). 
Diphenyiphosphinic anhydride was shown to be effective 
as a coupling reagent in both solution and solid phase 
peptide synthesis. The pentapeptide, leucylisoleucyl-
phenylalanylalanylglycine (H-Leu-Ile-Phe-Ala-Gly-OH) was 
prepared using both Dpp0Dpp and DICl/HOBt activation, with 
Fmoc amino acids and p-alkoxybenzylalcohol resin, in order 
to compare the performance of the two coupling 
procedures 85 . Yields of the product in both cases were 
found to be comparable, however with DppoDpp the coupling 
times were found to be significantly shorter and only four 
equivalents of the Fmoc amino acid was required per 
residue compared to six with DICl/HOBt. 
The byproduct of diphenyiphosphinic anhydride mediated 
coupling reactions is also the acid derivative (73). This 
can be conveniently converted back to Dpp-Cl (71) by 
reaction with thionyl chloride, allowing the regeneration 
of the starting material. 









Dpp-C1 1Io o o) 
(74) 




2.1 Chemistry involving 6-oxopenicillin and 7-oxo-
cephalosporin compounds 
2.1.1 Introduction 
As was discussed in the previous chapter, the carbonyl 
group at the 6(7)- position of compounds such as benzyl 
6-oxopenicillanate (24) and t.butyl 7-oxocephalosporanate 
(76) is highly reactive towards a number of addition 
reactions, making these compounds very useful precursors 
for the synthesis of novel $-lactam compounds. 
0 	s 
:II 	 CO C H3 
6O 2CH 2Ph 	 CO 2t-Bu 
(24) 	 (76) 
The present research has studied some of the 
literature methods for the synthesis of compounds of this 
type, and then attempted some chemical transformations, 
with the aim of synthesising novel, potentially 
biologically active compounds. 
2.1.2 The synthesis of benzyl 6-oxopenicillanate (24) 
This research initially undertook the task of 
synthesising benzyl 6-oxopenicillanate (24), in order to 
clarify some of the conflicting reports that appear in the 
literature (see chapter 1). 
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Infrared spectroscopy was found to be a Particularly 
useful technique for monitoring the synthesis of this 
compound, and the related cephalosporin (76). The target 
compound has three carbonyl groups, each with a distinct 
absorption in the carbonyl region of the infrared 
spectrum. The ester carbonyl group has an absorption at 
approximately 1740cm 1 , 	the 0-lactam carbonyl has the 
usual absorption at approximately 	1790cm 1 and the 6-oxo 
carbonyl group has a higher absorption at 1830cm 1 . The 
presence of a peak at 1830cm 1 in the infrared spectrum is 
therefore a good indication that the target compound has 
been synthesised. 
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6a-hydroxypenicil].anate (25) which was synthesised by the 
method of Hauser and Sigg 26 , except that a slight 
variation was adopted for the formation of the benzyl 
ester at the end of the synthesis. 6a-Hydroxypenicillanic 
acid (26) was converted to the potassium salt, by 
neutralising with potassium carbonate, this was followed 
by treatment with benzylbromide to give the target 
compound (25) in quantitative yield (scheme 2.1). The 
compound was obtained as an oil, which was crystallised 
using DCM and petroleum-ether to give the pure (25) as a 
white solid. Tlc indicated that no further purification 
was required. 











The first oxidation method attempted was that of 
Vanderhaege et a1 33 , involving the use of DMSO and acetic 
anhydride. Chandrasekaran et a1 34 had reported some 
difficulty in repeating this reaction, and similar 
problems were encountered during the current research. The 
reaction was Only successful when acetic anhydride that 
had been freshly distilled from AlC13 was used, as was 
suggested by Chandrasekaran. Even then, the benzyl 6-
oxopenicillanate was obtained as a yellow oil in 31% yield 
and all attempts to crystallise the product were 
unsuccessful. A much poorer result than that reported by 
Vanderhaege, who obtained a crys-talline solid in 92% 
yield33 . 
Two further oxidation methods, involving the use of 
pyridinium chlorochromate (Pcc), and freshly prepared 
manganese dioxide, were then attempted. There appeared to 
be no literature reports detailing the use of these 
reagents for this reaction. Both methods proved 
unsuccessful. 
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Attention was then directed towards the Moffat 
oxidation 25 which was the method used by Sheehan and Lo in 
the first synthesis of compounds of this type 24 . Ui 
attempts to repeat their work, using DICI, were 
unsuccessful. The reaction was repeated using 1-ethyl-3-
(3 -dime thy laminopropyl)carbodjjmjde hydrochloride (77), a 
water soluble carbodiimide, that had previously been used 
in the Moffat oxidation by workers in this research group 
with some success 89 . This reagent also proved to be 
incapable of carrying out the required oxidation. 
Me2N(CH2 ) 3N=C=NEt .HC1 
( -7 -7 \ 
I / 
Considerable difficulty was also experienced when 
attempting to repeat the work of Hagiwara et a1 38 (Scheme 
1.14), involving the use of trifluoromethanesulphonic 
anhydride. After the initial attempt at the reaction, the 
crude product consisted mainly of starting material. 
Further triethylamine was added, as it was thought that 
the problem was due to the failure to form the 
bistriflate intermediate. However after workup, very 
little of the target compound was recovered. 
The final method attempted was that of T.Jen et a1 32 
who synthesised benzyl 6-oxopenicillanate (24) from benzyl 
6a-methylthio-60 -aminopenicillanate (31) using mercuric 
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chloride in DMF and water. Indeed (31) was used by workers 
at Beecham Pharmaceuticals as a precursor to 6 a - 
subtituted penicillins 90 , and the named company were able 
to provide a quantity of this compound for the purpose of 
this research. As well as (31), a similar compound, benzyl 
6a -tolylthio 60-aminopenicillanate (78) was also provided 
by the same company. Both (31) and (78) had been shown to 
behave in a similar manner towards substitution reactions 
at the 601-position. 
sl/~aMe 
H2NJ 
CO 2CH2 Ph 
(78) 
Benzyl 6-oxopenicillanate was synthesised in high yield 
from both (31) and (78). The product was obtained as a 
yellow oil in both cases and all attempts to convert it to 
a solid failed. Purification was then attempted using 
silica gel chromatography, however when the collected 
fractions were monitored by silica gel tic, impurities 
were still apparent. This coupled with the fact that the 
silica on the column turned red indicated that the 
compound was unstable to these purification conditions. 
Satisfactory nmr data were obtained from the unpurified 
product, which was used in future reactions without 
further purification. 
IMM 
This work has demonstrated the high sensitivity of 
benzyl 6-oxopenicillanate which leads to considerable 
synthetic and purification problems. As far as the present 
research is concerned, the most convenient method of 
synthesising this compound was by the method of Jen 
et a1 31 . The reason for this being the ready availability 
of the precursors (31) and (78), indeed under normal 
circumstances the lengthy synthesis of these precursors 
would significantly decrease the viability of this route. 
This was therefore adopted as the standard method for the 
synthesis of (24) for the remainder of this research. 
2.1.3 The synthesis of tbuty1 7-oxocephalosporanate (76) 
In parallel - with the work involving penicillins, 
it was decided to study the analogous cephalosporin 
analogues. 
Initially the method of Hagiwara et a1 38 was repeated 
in order to synthesise (76). This involves the use of 
trifluoromethanesulphonic anhydde and triethylamine, and 
is identical to the reaction previously attempted when 
synthesising the penicillin derivative (24) (Scheme 1.14). 
Infrared spectroscopy indicated that the required compound 
had been synthesised and this was purified by silica gel 
wet flash chromatography. Some product was recovered from 
the column in the form of a yellow oil, however the 
percentage recovery from the column was low. The silica 
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changed to a red colour during the course of the 
purification, indicating that some decomposition of the 
product was occurring. The recovered material wag  
crystallised using ethyl acetate and hexane which resulted 
in a yield of only 15% of a yellow solid. Nmr and infrared 
analysis of the product indicated that (76) had converted 
to the dihydroxy analogue (79). There were two singlets in 
the n.m.r spectrum at 6-6.7 and 6.9 ppm, that disappeared 
when D20 was added to the n.m.r sample. It appeared that 
when solid, the hydrated form (79) was more stable. This 
is likely to be due to the electronic effects resulting 
from two adjacent carbonyl groups. Hydrating one of the 
carbonyl functions avoids two adjacent partially 
positively charged carbon atoms. A similar situation is 
found with ninhydrin (80), which has a hydrated carbonyl 
adjacent to two carbonyl groups. Previous literature 
reports of 7-oxocephalosporins have not reported the 
dihydroxy compound (79). We found no evidence of an 









Because of previous success when the method of Jen 
et a1 32 was used to synthesise benzyl 6-oxopenicillanate, 
this method was repeated with the aim of synthesising 
t.butyl 7-oxocephalosporanate (76) (Scheme 2.3). This 
reaction was not mentioned in the above report. t.Butyl 
7a-tolylthio 713-aminocephalosporanate (81), supplied by 
Beecham Pharmaceuticals, was reacted with mercuric 
chloride in the presence of water and DMF and the target 
compound was obtained as a yellow oil in 85% yield. This 
was converted to a solid using ethyl acetate and hexane, 





.LOCOCH3 DMF/H ,__ 	
C H, 
20 0 
CO 2 -Bu 	 CO 2 t-Bu 
(81) 
Scheme 2.3 
t.Butyl 7a ,7f3 -dihydroxycephalosporanate (79) could be 
converted back to t.butyl 7-oxocephalosporanate (76) by 
stirring with activated molecular sieves in DCM. This 
conversion was monitored every 5 minutes using 60 MHz 'H 
nmr spectroscopy, which indicated the disappearance of the 
signals due to the hydrated compound (79), combined with 
the appearance of signals due to (76). The main 
differences in the n.m.r spectra of these two compounds 
are the absence of the hydroxy proton signals in the 
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spectrum of (76) and a difference in the chemical shift of 
the signal due to the proton attached to C-6. 
The dihydroxy compound (79) was then reacted with 1 
equivalent of acetyl chloride in an attempt to acetylate 
one of the hydroxy groups. It was thought that acetylation 
would occur preferably at the 7a -hydroxy group, since 
reaction at this site would involve attack from the least 
hindered side of the molecule. Only starting material was 
recovered from this reaction. It was then decided to 
attempt the reaction using excess acetyl chloride in an 
attempt to acetylate both hydroxyl groups. (79) was 
reacted with 3 equivalents each of acetyl chloride and 
pyridine using DCM as the solvent. The reaction mixture 
was stirred for 15 hours, after which tic showed that two 
major components were present, neither of which had a 
retention time corresponding to that of the starting 
material. Furthermore there was a weak absorption at 
1833cm 1  in the infrared spectrum of the crude product 
indicating that there was some t.butyl 7-
oxocephalosporanate present. The mixture was separated 
using silica gel wet flash chromatography, during which 
the silica turned red. -two compounds were isolated. - 
The most polar of these was not identified, however the 'H 
n.m.r spectrum was consistent with the structure being a 
cephalosporin nucleus with an additional CH 2 group, this 
being repres1ented by an extra AB quartet between 53.88 and 
4.05 ppm. H N.m.r spectroscopy indicated that the other 
product was the target 
compound, t.butyl 701,713-diacetoxycephalosporanate (83). 
The failure to recover the t.butyi 7-oxocephaiosporanate 
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that appeared to be present in the crude mixture was 
probably due to the instability of this compound on 








2.1.4 Reactions with amides 
Whilst working on the synthesis of 6a (7a )-formarnido 
penicillins and cephalosporins workers at Beecham 9 ' had 
discovered that formamide was insufficiently nucleophilic 
to yield the target compounds by a mercury (II) mediated 
substitution with 6a (7a)-methylthio substituted compounds 
e.g. (31). However the addition of trimethylsilyl (TMS) 
groups to the nitrogen atom of the amide increased its 
nucleophilicity, and 6a (7a )-formamido penicillins and 
cephalosporins were formed when N,N-bis(trimethylsilyl)-
formamide (84) was used 92 (scheme 2.4). 













It was decided to investigate the reactions of similar 
amides with 6-oxopenicillins and 7-oxocephalosporins. 
N-Trimethylsilylacetarnide failed to react with benzyl 
6-oxopenicillanate (24). The reaction was monitored by 
infrared spectroscopy, and after 4 hours there was still 
an absorption at 1830cm 1 in the infrared spectrum of the 
reaction mixture, indicating that starting material 
remained. The reaction was left for a further 16 hours. 
Whereas there was an amide carbonyl absorption present in 
the infrared spectrum of the final reaction mixture, this 
was absent in the spectrum of the product after workup. 
This indicated that the amide in the reaction mixture was 
unreacted, and that no reaction had taken place The 
reaction was repeated using bistrimethylsilylacetamide. 
N.m.r, infrared, and mass spectrometry of the product 
indicated that the reaction had worked in this case. The 
product, benzyl 6a-(N-trimethylsilylacetamido)60-trimethyl 
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(85) 
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The two methods that were attempted with the aim of 
removing the TMS groups from (85) involved the use of 
tetrabutyl ammonium fluoride (TBAF) (1 eq.) and methanol 
(1 eq.), and water. Cleavage of the f3-lactam ring 
resulted in both cases 
No reaction was observed between t-butyl 7-oxocephalo-
sporanate (76) and N-methyl(N-trimethylsilyl)-acetamjde. 
This result confirms that the extra nucleophilicity of the 
bis—trimethylsilyl compounds is required for amides to 
react with 6-oxopenicillins and 7-oxocephalosporins. 
The 	final 	reaction 	attempted 	was 	between 
bistrimethylsilylformamide (84) and t-butyl 7-oxo-
cephalosporanate (76) from which two products were 
isolated. The major product was identified as t-butyl 
7,7-bistrimethylsilyloxycephalosporanate, formed by the 
addition of trimethylsilyl groups to the hydroxy groups of 
the hydrated compound (79). The minor product from this 
reaction was the more interesting t.butyl 7a-formamido 70-
hydroxycephalosporanate (86), which was obtained after 
aqueous workup and purification by wet flash silica gel 




N 	 OCOCH3  
CO 2 t-Bu 
(86) 
The nmr spectrum of this compound indicated that two 
rotameric forms were present, due to restricted rotation 
about the C-N bond of the formamido group. Similar 
observations were made by researchers at Beecham 92 , who 
studied similar systems. 
Due to the very small amounts of (86) that had been 
synthesised, the reaction was repeated on several 
occasions, in an attempt to obtain sufficient material to 
investigate the chemistry and biological activity of the 
compound. However (86) was not isolated from any of the 
repeated experiments, indicating the high degree of 
sensitivity of such systems. 
Attempts were then made to react the hydroxy group of 
(86) with phenoxyacetyl chloride with a view of 
synthesising (87) (Scheme 2.7). Infrared spectroscopy 
indicated that the major product of this reaction was 
t.butyl 7-oxocephalosporante (76). 
NHCHO 
HO 11 S 
N 	&OCOCH 3 









2.1.5 Wittig reactions 
Wittig reactions of benzyl 6-oxopenicjllanate have 
Previously been reported by Sheehan and L0 28 . It was 
decided to investigate the reaction of both benzyl 
6-oxopenjcjllanate 	and 	t-butyl 	7-oxocephalosporanate 
with 
phosphonium bromide (88). This reagent was developed by 
workers in this research group as a precursor to a-
ketoacid functionality, and it has been used successfully 
in the synthesis of compounds containing this 
functiona].ity 93 7 94 . Reaction of (88) with an aldehyde or 
an activated ketone will produce an ylidene dioxolanone 
(89). The carbonyl group of (89) is susceptible to attack 
by the hydroxyl anion under mildly basic cond1tio5, which 



















The phosphorane (91) has been synthesised in two ways. 
The first method involved the condensation of glycolic 
acid with cyclohexanone using 2-toluenesuiphonic acid as a 
catalyst to give the dioxolanone derivative (92). This was 
converted to the bromide (93) using N-bromosuccinimide. 
Reaction of the bromide with triphenyiphosphine produced 
the stable phosphonium bromide (88) (Scheme 2.9). Variable 
yields, often as low as 40%, have been reported for the 
synthesis of the dioxolanone using this methodology 89 . An 
alternative synthesis of (92), introduced by Pearson and 
Cheng95 , and later used by researchers in this group89 ' 94 9  
results in consistent yields of approximately 95%. This 
involves the treatment of cyclohexanone with 
trimethylsilyl( trimethylsilyloxy)acetate 	(94) 	using 
trimethylsilyl tr'flate as a catalyst (Scheme 2.10). 
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The phosphorane (91) is unstable, hence the compound 
must be stored in the form of the phosphonium bromide 
(88), which can be converted to the phosphorane in situ, 
using one equivalent of 1 , 4-diazabicyclo[2,2,2]octane. 
The expected dioxolanone penicillin analogue (95) was 
formed when benzyl 6-oxopenicillane and the phosphorane 





On completion of the reaction the solid residue of 
triphenyiphosphonium oxide was removed by filtration, and 
the 	product was purified by wet flash silica gel 
chromatography. The target compound was obtained in a 
S. 
yield in excess of 80°h. The compound was analysed by 1H 
nmr spectroscopy, a characteristic feature of the spectrum 
being a broad signal at 6-1.5 ppm due to the 10 protons on 
the cyclohexane ring. 
It was required to remove the benzyl ester group from 
(95) in order that the biological activity be tested. This 
was accomplished using the standard conditions of 
hydrogenation over a palladium/carbon catalyst with 
tetrahydrofuran as the solvent. After the initial attempt, 
tic showed that starting material remained thus fresh 
catalyst was added and the hydrogenation was repeated. The 
acid (96), which was obtained in quantitative yield, was 
converted to the sodium salt by stirring in one equivalent 
of sodium ethyihexanoate. The antibacterial activity and 
/3-lactamase inhibitory properties of the sodium salt were 
tested at Beecham Pharmaceuticals research laboratories,. 
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When a similar Wittig reaction was attempted on t.butyl 
7-oxocephalosporanate (76), two t.butyl signals were 
present in the 'H n.m.r spectrum of the product. This was 
further analysed by hplc, which also showed two components 
with similar retention times. Wet flash silica gel 
chromatography was used to separate these components. The 
'H n.m.r spectra of the separated components were 
identical, however two t.butyl signals were present in 
each spectrum. It was assumed that the two products that 
had been identified by hplc were the geometrical (E and z) 
isomers at C-7, and that each one was a mixture of -2 
(97) and L-3 (98) isomers of the cephalosporin nucleus. As 
well as the t.butyl signal, there were other features in 
the n.m.r spectrum that indicated the presence of a 
mixture of L-2 and -3 compounds 
The presence of three AB quartets. The AB quartet at 
6-3.26 and 3.55 ppm, due to the C-2 protons, had a 
smaller integral than would be expected if the signal 
represented 2 protons. The other two AB quartets, which 
overlap each other between 6-4.50 and 5.05 ppm, are due 
to slight differences in the chemical shift of the CH 2 
protons adjacent to the acetoxy group in the L1-2 and z-
3 isomers. 
The presence of additional signals, at 6-6.40 and 5.75 
ppm, due to the single protons attached to C-2 and C-4 
in the L-2 isomer. 
It therefore appeared that this reaction had generated 
four products. Two geometrical isomers which, having 
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slightly different retention times, could be separated 
using chromatographic techniques. As would be expected, 'H 
n.m.r spectroscopy could not be used to distinguish 
between these. Each geometrical isomer was present in 
both -2 and J.-3 forms, which would result in the four 
products. The L-2 and -3 isomers had identical retention 
times, making their separation an impossible task, however 










Since the formation of L-2 cephalosporins is generally 
brought about by the addition of base, it was thought that 
the most likely cause of the transformation in this 
instance was the DABCO, that was used to convert the 
phosphonium bromide (88) to the phosphorane (91). However, 
L-2 isomers were still formed when excess phosphonium 
salt (88) was used to ensure that all the DABCO was 
consumed prior to the addition of the cephalosporin (76). 
In order to convert the product totally to the required 
L-3 isomer, the reaction product was converted to the 
sulphoxide (99). It is a known fact that cephalosporin 
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suiphoxides do not exist in the L-2 form, though 	the 
reason for this is not fully 	understood. The Z-2/L-3 
mixture was reacted with one equivalent of 
m.chloroperoxybenzoic acid in dichioromethane for ihour. 
After this period the absorption of the /3-lactam carbonyl 
in the infrared spectrum had shifted from 1770cm' to 
1790cm 1 9 indicating that the conversion had occured. 
This was confirmed by mass spectrometry, n.m.r, and hplc. 
The latter technique showed the product to be one 
component that was more polar than the sulphide (98). The 
suiphoxide (99) was reduced back to the sulphide using 
potass..m iodide and acetyl chloride in acetone. Analysis 




Removal of the t.butyl group of (98) was attempted 
using a solution of DCM/TFA (3:1). However significant 
impurities were observed in the product, and all 
purification attempts were unsuccessful. 
Attempts were then made to convert the dioxolanone 
functionality of (94) and (98) to an a-ketoacid, in order 
to synthesise compounds (101) and (102). The standard 
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methodology for this conversion involves the use of half 
an equivalent of barium hydroxide, which would be expected 
to yield the barium salts of (101) and (102). 
HO YA ç)< 
CO2Bz 
0 




(101) 	 (102) 
These reactions can be conveniently monitored by 
ultraviolet spectroscopy. Removal - of the dioxolanone 
functionality results in a significant change in the 
chromophore of the molecule. 
All attempts to carry out this conversion on the 
penicillin 	(94) were unsuccessful. During the reaction 
-. the maximum absorption in the ultraviolet spectrum 
was observed to have change4 from 269nm to 293nm after one 
hour. After workup and lyophilisation a green coloured 
solid remained. The infrared spectrum of this only had a 
very small 0-lactam carbonyl absorption at 1780cm, 
indicating nearly total loss of this functionality. A 
similar result occured with the cephalosporin (98). 
The dioxolanone derivatives have also been used as 
precursors to tetronic Acids 96  (103). Applying similar 
methodology to the penicillin and cephalosporin 
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dioxolanone compounds (94) and (98) could yield compounds 
such as (104), having a tetronic acid nucleus attached 
directly to a /3-lactam nucleus. Molecules of this type 
would be interesting synthetic targets since they consist 
of two independently biologically active nuclei joined 
together. 
HO 	R 







The reaction was attempted on the cephalosporin 
sulphoxide (99), in order to prevent any L-2 formation. 
The cephalosporin suiphoxide (99) was reacted with methyl 
4-methoxypheny lace tate (105) in the presence of lithium 
diisopropylamide and TMEDA at -78 0 C for 2 hours. During 
the course of the reaction the reaction mixture turned 
dark red. The workup resulted in aqueous and organic 
fractions, both of which were found to have no f3-lactam 
functionality. The 13-lactam nucleus was clearly not stable 
to these reaction conditions. 
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2CH3 0 C6 H4 CH2 CO2 CH3 
(105) 
2.1.6 Further work 
In hindsight, less problems may have been encountered 
had the work detailed in the previous section been 
carried out on monocyclic /3-lactam compounds instead of 
the penicillin and cephalosporin nuclei. This would 
eliminate two of the major problems experienced in the 
current research; i.e formation of the -2 cephalosporin, 
and removal of the ester groups. The resulting systems 
would be simpler, allowing the chemistry of the 
dioxolanone system to be investigated in detail without 
interference from the other functionality of the 
penicillin and cephalosporin nuclei. Time did not permit 
reactions of this type to be attempted during the course 
of this research. 
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2.2 The attachment of penicillins and cephalosporins to 
polymer supports 
2.2.1 Introduction 
The idea of synthesising peptides on insoluble polymer 
supports was first introduced by R. B. Merrifield in 
43 1963. 	Since 	then 	solid 	phase 	methodology 	has 
revolutionised the chemical synthesis of both peptides and 
oligonucleotides, to the extent that there are now 
automated systems capable of synthesising these compounds 
in a fraction of the time required by conventional 
techniques. The application of solid phase synthesis 
towards the preparation of peptides has been discussed in 
the previous chapter. 
The present work investigates the potential for the use 
of solid phase methodology in the modif—ication of the 
nuclei of penicillins and cephalosporins. The structural 
similarity between amino acids and both 6-APA (3) and 7-
ACA (9), i.e. they all have terminal amine and carboxylic 
acid groups, led us to believe that very little adaption 
of the well developed techniques for peptide synthesis 
would be required. 
To date SPPS has only been studied in relatively small 
scale reactions, and the technique involves considerable 
expense (the polymer support alone can cost in excess of 
£200/25g). In view of this, it was considered that solid 
phase methodology could be an efficient technique for the 
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targeting of novel /3-lactam compounds. Enough product 
could be recovered from the resin for initial biological 
studies to be carried out. If these studies gave promising 
results, alternative larger scale syntheses could then be 
sought, since for a compound to be marketed as an 
antibacterial agent it must be synthesised in large 
quantities as cheaply as possible. 
The main advantages of solid phase synthesis over 
solution phase techniques likely to be encountered with 
f3-lactams are 
Excess starting materials, reagents and byproducts 
may be removed by simply washing with an appropriate 
solvent. 
It should reduce losses encountered during the 
isolation and purification of intermediates since 
successive reactions may be carried out in the same 
reaction vessel. 
The automated techniques already developed for 
peptide and oligonucleotide synthesis could be 
adapted and used for the synthesis of modified 
f3-lactams. 
This work has been divided into 5 main sections each of 
which would need to be successful for the methodology to 
be of value. These are outlined below 
The preparation of suitably protected penicillin and 
cephalosporin derivatives. (section 2.2.2) 
The attachment of a 60( 7 /3 ) -protected aminopenicillin 
or aminocephalosporin to a solid support (resin). 
(section 2.2.3) 
The removal of the protecting group to give an 
unprotected penicillin or cephalosporin attached to 
a resin. (section 2.2.4) 
The addition of an alternative group to the free 
amino group of the penicillin or cephalosporin. 
(section 2.2.5) 
Cleavage of the final penicillin or cephalosporin 
from the resin. (section 2.2.6) 
By carrying out the study in this order the important 
aspects of loading the resin and cleaving the product 
would be investigated, while also including a relatively 
simple chemical modification. 
2.2.2 Preparation of 6/3 (7(3 )-protected aminopenicillins 
and cephalosporins 
As discussed in the previous chapter, it is common 
practice in SPPS to use base labile Na_ (transient) 
protection combined with acid labile side chain (semi-
permanent) protection and peptide-resin linkage. It was 
decided to protect the 60 (70 )-amino function of the 
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penicillin or cephalosporin with a base labile group in 
order that acid labile resins may be used. 
The most common base labile protecting group in use 
today is the 9-fluorenylmethoxycarbonyl (Fmoc) group (51). 
The one serious drawback to Fmoc methodology is its cost 
and with this in mind alternative protecting groups have 
been sought. One such example is the 2,2 -bis- 
(4'nitrophenyl)ethoxycarbonyl 	(Bnpeoc) 	group 	(57) 
introduced by workers in this research group 62 . 
It was decided to investigate both Fmoc and Bnpeoc 
protection of penicillins and cephalosporins so that a 
comparison of the two could be made. 
Florence 62 	synthesised both 60 - [2,2 -bis(4'nitro- 
phenyl)ethoxycarbonylamino]penjcjllanjc acid (Bnpeoc-APA) 
(106) and 70 - [2,2 -bis( 4 'nitrophenyl)ethoxycarbonylamjno] 
cephalosporanic acid (Bnpeoc-ACA) (107) by reacting either 
6-APA or 7-ACA with the chloroformate derivative of Bnpeoc 
(59) in the presence of 2 equivalents of 10% sodium 
carbonate with DMF as the solvent. He reported that, 
whereas with amino acids the less reactive active ester 
derivative of Bnpeoc (58) was required to prevent 
dipeptide formation, the reduced nucleophilicity of the C-
6(C-7)-amino group of penicillins and cephalosporins 
required the more reactive chloroformate derivative (59) 
for a reaction to take place. 
02N 01, 	1 	
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All attempts to repeat these reactions during the 
current research were unsuccessful. Initial reactions were 
carried out using 6-APA and were monitored by high 
performance liquid chromatography (hplc). The hplc trace 
of the product consisted of 5 peaks of similar intensity. 
The least polar component had a retention time that was 
identical to the retention time of a sample of Bnpeoc 
olefin (108) that had been run under the same conditions. 
is the expected deprotection byproduct of Bnpeoc. 
The presence of this was particularly surprising as 
previous work62 had indicated that Bnpeoc compounds were 
stable under these conditions. 




It was thought that one of the other impurities could 
be a Bnpeoc-APA dimer adduct, analogous to that observed 
when Fmoc chioroformate was used to protect amino acids 
(scheme 1.22) . Florence had shown this to occur when 
Bnpeoc chioroformate was used to protect amino acids, but 
had not reported any such problems during the protection 
of 6-APA. 
A similar result was obtained from the attempted 
synthesis of Bnpeoc-ACA (107) using this methodology. 
Attention was then diverted to the Fmoc protecting 
group (51). The methodology described above was repeated 
using Fmoc chioroformate (52) in an attempt to synthesise 
6 0 - [ 9- fluorenylmethoxycarbonylamino]penicillanic acid 
(Fmoc-APA) (109). This reaction also resulted in an impure 
product. Due to the number of components that were 
present, no attempt was made to isolate the target 
compound from this mixture. Other synthetic routes to 
these compounds, that would result in improved yields 
SMM 
combined with simpler purification 










Meanwhile an alternative method for the preparation of 
Fmoc and Bnpeoc amino acids had been attempted by other 
researchers in this group, with promising results 86 . This 
was a method devised by D. H. Rich 66 for the introduction 
S, lyl 
of his triethoxycarbonyl (Teoc) protecting group to amino 
acids. Fmoc chioroformate (52) was reacted with 6-APA (3) 
using triethylamine as the base and 1,4-dioxane as the 
solvent. Hplc of the crude product from this reaction once 
again showed that significant impurities were present, 
however there was a major component present. It was 
assumed that this was the target compound (109), but 
attempts to isolate it by gel filtration were 
unsuccessful. 
The reaction was repeated using the less reactive 
active ester derivative of Fmoc (54). Comparison of the 
hplc trace of the crude product from this reaction with 
the hplc traces of standard samples indicated the 
presence of the following compounds and other minor 
Offlm 
impurities: 




and one other component that was assumed to be Fmoc-APA 
(109). The major peaks in the hplc trace were the 
unidentified one, and the peak attributed to Fmoc-olefin. 
The size of the peaks is not directly related to the 
quantities of these compounds present, since the 
chromophores differ. Two modifications of the reaction 
were attempted in order to reduce the amount of olefin 
formed. Very little difference was observed when 
acetonitrile was used as the solvent instead of 1,4 
dioxane, and the amount of olefin increased when N-methyl 




Purification of the product was attempted by forming 
the cyclohexylamine (CHA) salt of the crude product. This 
method, initially introduced by Rich 66 , involves reacting 
the impure mixture with one equivalent of cyclohexylamine. 
All carboxylic acids present are converted into water 
soluble cyclohexylamine salts, which allows the removal of 
any organic impurities. The cyclohexylamine salt is 
finally converted back to the carboxylic acid. Hplc 
analysis of the purified product showed that it consisted 
mainly of one component that had the same retention time 
as the unidentified component of the initial reaction 
product. However other impurities were present and 
further purification of this product would have been 
required in order for it to be used in future resin 
coupling experiments. 
The above methodolgy was also repeated with the aim of 
synthesising Bnpeoc-APA (106) and Bnpeoc-ACA (107). The 
penicillin example resulted in very little improvement 
from the previous attempt. Neither chromatography using 
either reverse phase silica or dianion HP20SS resin, or 
gel filtration resulted in the pure compound. Similar 
problems were also experienced with the cephalosporin, 
after which this methodology was abandoned. 
An alternative strategy for the' introduction of Fmoc 
and Bnpeoc to penicillin and cephalosporin nuclei was 
sought in an attempt to try and eliminate the impurities 
encountered in the previous reactions. It was anticipated 
that esters of these compounds would be more stable than 
the free acids and, being considerably less polar, could 
be purified by standard silica gel chromatography 
techniques. Hence both the chloroformate and active ester 
OMM 
derivatives of Fmoc 	and Bnpeoc 	were 	reacted 	with 
esterjfjed APA and ACA. The 0-lactams selected for this 
work, due to their availability, were benzyl 60-amino-
penicillanate (111) and t-butyl 713- aminocephalosporanate 
(112). A method for the preparation of the penicillin 
derivative (111) was supplied by Beecham 
Pharmaceuticals 91.  This involved reacting 6-APA with 
methyl acetoacetate and triethylamine, followed by 
treatment with benzyl bromide. Once the ester had been 
formed the free amine was liberated by treatment with p 
toluenesuiphonic acid. The cephalosporin (112) was 
obtained directly from Beecham Pharmaceuticals. 




CO2Bz 	 CO2t-Bu 
(111) 	 (112) 
Benzyl 6 0 - [ 9- fluorenylmethoxycarbonylamino] penicill-
anate (Fmoc-APA-OBz) (113) was produced in high yield when 
Fmoc chioroformate (52) was reacted with benzyl 60- 
aminopenicillanate (111). Purification of the crude 
reaction product using wet flash silica gel chromatography 
resulted in two compounds. The target compound (113) (71°h 
yield) and also a smaller amount of an impurity which was 
identified by 'H n.m.r as 9-fluorenylmethanol (114). This 
was initially thought to be due to the presence of 
moisture in the reaction mixture, however (114) was still 
formed when activated molecular sieves were added to the 
reaction mixture. 
O H2  
(114) 
This reaction was then repeated using Fmoc-ONSu (54) 
instead of the Fmoc chloroformate (52), however, after a 
reaction time of 7 days, tic monitoring showed that 
significant amounts of starting materials remained. 
Similar 	methodology 	(using 	the 	chioroformate 
derivatives) resulted in high yields of t.butyl 7 0 - [ 2, 
2 -bis-(4' nitrophenyl)ethoxycarbonylamino]cephal.osporanate 
(Bnpeoc-ACA-OtBu) (115), Benzyl 6 13- [ 2 , 2 -bis-(4'nitro-
phenyl)ethoxycarbonylamino]penicillanate (Bnpeoc-APA-OBz) 
(116) and t.butyl 7 /3 -[9-fluorenylmethoxycarbonylamino]-
cephalosporanate (Fmoc-ACA-OtBu) (117). 
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The next step was to convert the esters (113), (115), 
(116) and (117) to the corresponding carboxylic acid 
derivatives. The t-butyl group was successfully removed 
from the cephalosporins by stirring the ester in TFA for 
15 minutes. The TFA was removed by evaporation under 
vacuum to yield the corresponding free acid (107) or (118) 
in quantitative yield. Standard methodology was also 
employed for the removal of the benzyl ester from the Fmoc 
penicillin derivative (113); this involved hydrogenation 
over a palladium/carbon catalyst with THF as the solvent. 
The hydrogenation reaction was left overnight after which 
it was checked by tic. This indicated that some ester 
remained, so fresh catalyst was added and after a further 
period of hydrogenation, the reaction was then found to 
have gone to completion. The tic plates were developed by 
spraying with a solution of 4,4',dimethylamino)phenyi 
carbinol (0.5 g) in acetone (500 ml) (Mary's reagent). The 
presence of a carboxylic acid on a tic plate is indicated 
by an immediate deep blue coloration after the plate is 
sprayed with this solution. The solvent system used during 
these experiments (ethyl acetate/hexane 1:1) was 
insufficiently polar for the acids to run up the tic 
plate, hence a successful reaction was indicated by the 






It was envisaged that hydrogenation of the Bnpeoc 
penicillin derivative (116) would also hydrogenate the 
nitro groups of the protecting group. Because of this the 
method of Olah et a1 99 , involving the use of 
trimethylsilyl chloride and sodium iodide, was attempted 
in order to remove the benzyl group from this compound. 
Even though tic of the reaction mixture indicated that 
some acid was formed (Mary's reagent), hplc showed that 
the product was not pure. Considering the problems that 
had previously been experienced while attempting to purify 
this compound, no purification attempts were carried out 
and all future penicillin work involved the use of the 
Fmoc protected compound (113). 
Since the compounds prepared by this method were 
considerably purer than those prepared by the direct 
method described earlier, this was adopted as the 
preferred method for the synthesis of (106), (107) and 
(118) throughout the remainder of this research. 
2.2.3 	Loading penicillins and cephalosporins onto a 
polymer support 
Much work has been carried out over the years to modify 
the original chloromethyl resin (36), developed by 
Merrifield 43 , with the aim of changing the lability of the 
peptide-resin bond and hence altering the cleavage 
conditions. The lability is mainly affected by the linking 
agent between the molecule and the polymer chain. Some of 
the resins available to the peptide chemist have been 
discussed in the previous chapter. 
In order to cleave an acid sensitive /3-lactam molecule 
from a resin, a labile coupling is essential. The resin 
chosen for this study was the p.alkoxybenzylalcohol resin 
(43) introduced by Wang55 . Electron donation from the 
.alkoxy substituent enhances the acid lability of the 
ester linkage towards alkyl-oxygen fission. Standard 
conditions for the cleavage of peptides from this resin 
are 50°h TFA in DCM. The Wang resin used in this research 
had a functionality of 0.79 mmol/g, i.e. if all the 
reactive sites of the resin were occupied, then there 
would be 0.79 mmol of substituent per gram of resin. 
The coupling method chosen for this work involved the 
formation of a mixed carboxylic-phosphinic anhydride using 
diphenylphosphinic anhydride (74). This compound has been 
shown to be a very effective agent for the coupling of 
amino acids, and the methodology devised for this 
purpose 86 has been used in the course of the current 
research. It involves adding the mixed anhydride to the 
swelled resin in the presence of N-methyl morpholine and a 
catalytic amount of DMAP. 
All reactions involving resin samples were agitated by 
placing the reaction vessel in an ultrasonic bath. This 
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being much preferable than stirring the reaction mixture, 
as some of the resin would adhere to the sides of the 
reaction vessel above the reactants. 
Qualitative monitoring of these reactions was achieved 
by KBr disc infrared spectroscopy of the product resin; a 
carbonyl absorption at 1790 cm indicating the presence 
of a f3-lactam carbonyl group. Two further absorptions in 
the infrared spectrum of interest, specifically relevent 
to Bnpeoc protected compounds, are the nitro group 
stretching frequencies of 1350 and 1520 cm. The 
coupling reactions were quantitatively monitored by one of 
two methods: 
(i) Deprotection of a small amount of the resin, followed 
by ultraviolet spectroscopy of the resulting solution. 
This procedure was developed in this research group as a 
method for monitoring the synthesis of peptides 97 . A known 
amount of the resin was deprotected to give either the 
Bnpeoc olefin (108) or the Fmoc olefin (110) and the 
ultraviolet absorbance of the resulting solution was 
measured at a chosen wavelength. This was compared with a 
previously measured standard in order that the amount of 
olefin present be ascertained. BASIC computer programs 
for use on an Apple II microcomputer are available to 
calculate the results and present the information in the 
form of a printout97 . This test is very sensitive to 
sample mass and had to be repeated to ensure that a 
reliable result was obtained. 
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(ii) Determination of the percentage nitrogen in the 
product resin by CHN analysis, and comparing this value to 
the theoretical maximum if the resin was 100% loaded. 
Quantitative analysis of the product resin after the 
initial coupling reaction indicated a coupling of 
approximately 10%, i.e. /3-lactam molecules occupied 10% of 
the resins reactive sites. This result is considerably 
lower than that which would be expected for amino acids, 
and is likely to be due to increased steric hindrance 
caused by the bulkier penicillin and cephalosporin nuclei. 
Experiments indicated that maximum possible coupling was 
obtained after repeating the coupling reaction three 
times, after which couplings of approximately 40% were 
obtained. Initially each loading reaction involved the use 
of 2 equivalents of penicillin or cephalosporin, 
resulting in a total of 6 equivalents of /3-lactam to 
achieve a coupling of only approximately 0.3 mmol/g of 
resin. In later experiments the amount of 13-lactam was 
reduced to 1.5 equivalents for the first two loading 
reactions and 1 equivalent for the final reaction. This 
resulted in no apparent reduction in the final loading of 
the resin. Clearly this still involves excessive use of 
starting material, and to be of commercial use cheap 
methods of regenerating the -1actam would need to be 
devised. 
Bnpeoc-ACA (107), Fmoc-ACA (118) and Fmoc-APA (109) all 
gave similar results in these coupling reactions. 
Chemically no differences were observed between the Fmoc 
and the Bnpeoc protected couplings. However the presence 
of the nitro absorptions in the infrared spectrum of the 
Bnpeoc example did provide an early indication of the 
success of the reaction. 
2.2.4 The deprotection of Fmoc and Bnpeoc 
The deprotection of both Fmoc and Bripeoc, which 
proceeds via a f3-elimination mechanism, has been discussed 
in the previous chapter. The olefin by-products (110) and 
(108) have strong ultraviolet absorptions, hence 
ultraviolet spectroscopy can be conveniently used to 
monitor these reactions. 
Test deprotection reactions were carried out on the 
protected penicillin and cephalosporin ester derivatives 
(113), (115) and (117) in an attempt to optimise 
conditions before using the resin samples. 
The 	standard 	conditions 	for the deprotection of 
Bnpeoc amino acids involves the use of 1,8 diazabicyclo-
[ 5 . 4 .0]undec -7-ene (DBU) / acetic acid. When these 
conditions were used with Bnpeoc-ACA-OtBu (115), 
opening of the f3-iactam ring resulted. This was shown by 
the absence of a /3-lactam carbonyl absorption in the 
infrared spectrum of the product. However full 
deprotection occurred in 30 minutes, with no apparent loss 
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of f3-lactam functionality, when piperidine (1 equivalent) 
was added to a solution of (115) in DMF. This was 
indicated by the presence of a ninhydrin positive spot on 
a tic plate. The absence of absorptions at 1520 and 1350 
cm' in the infrared spectrum of the product also 
indicated that the deprotection was complete. The /3-lactam 
functionality of (115) was also found to be intact after 
stirring in solutions of 20% and 50% piperidine in DMF 
for 10 minutes. 
The deprotection reaction was then attempted on the 
resin sample. In this case very little deprotection had 
occurred after 1 hour when 2 equivalents of piperidine in 
DMF were used. When the concentration of piperidine was 
increased to a 20% solution in DtIF, full deprotection was 
achieved in 5 minutes. 
These reactions were monitored either by infrared 
spectroscopy or by the Kaiser test 98 . For the Bnpeoc 
deprotection, the absence of the nitro group absorptions 
at 1350 and 1520 cm' in the infrared spectrum indicated a 
successful deprotection. Infrared spectroscopy also 
provided information regarding the 0-lactam functionality. 
The Kaiser test is used to confirm the presence of free 
amine functionality, and involves the addition of equal 
volumes of three solutions to a sample of the resin, which 
is then heated for 10 minutes. The solutions used in the 
Kaiser test are 
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Solution 1 : 76°h w/w phenol in ethanol 
Solution 2 : 0.002M potassium cyanide in pyridine 
Solution 3 : 0.28M ninhydrin in ethanol. 
A positive test is indicated by a purple colouration. 
When 20% piperidine in DMF was used to deprotect Fmoc-
APA-OBz (113), infrared spectroscopy indicated that f3-
lactam ring opening had occurred after a reaction time of 
1 hour. A preferable method for the removal of Fmoc from 
this compound was found to be the use of DBU in DCM. 
Complete deprotection was achieved when (113) was stirred 
in DCM with 1.2 equivalents of DBU for 10 minutes. 
Furthermore the 0-lactam was still intact after 1 hour. 
These conditions were also successful in cleaving Fmoc 
from the sample that was attached to the resin, with no 
apparent loss of f3-lactam functionality. 
2.2.5 The coupling of a group to the amino functionality 
of a penicillin or cephalosporin nucleus attached to a 
resin 
It was decided to carry out a simple reaction at the 
site of the free amine of the penicillin and cephalosporin 
nuclei while they were attached to the resin. Groups were 
chosen that would yield common, well characterised, 
compounds, so that once cleaved there would be no problems 
in identifying the products and consequently assessing the 
effectiveness of the methodology. In the case of the 




the amine at the 7-position. The aim of this was to 
synthesise (119), which would yield 70-(2-thiopheneacetyl) 
arninocephalosporanic acid (cephalothin) (10) as the 
cleaved product. The phenoxyacetyl group was added to the 
penicillin example, with the view of synthesising (120) 
and hence 6 3 -phenoxyacetylaminopenicillanic acid 
(penicillin V) (2). 
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The coupling reactions were carried out using the 
respective acid chlorides in the presence of DCM and 
pyridine. The reactions were monitored using the Kaiser 
test, with a positive test indicating that further 
coupling was required. The coupling reactions were 
generally carried out twice, using 2 equivalents of the 
WIVAM 
acid' chloride each time, in order that a negative Kaiser 
test be obtained. 
2.2.6 Cleaving the final products from the resin 
The standard method for the cleavage of peptides from 
the Wang resin involves the use of a 50°h mixture of 
trifluoroacetic acid (TFA) in DCM. Because of the 
sensitivity of 0-lactam systems to acidic conditions the 
amount of TFA was reduced to 10°!.. The reactions were all 
carried out in an ultrasonic bath for 10 minutes. After 
this time, the resin was filtered and washed with DCM and 
toluene. The filtrate was then evaporated under vacuum to 
yield the crude product in the form of a yellow oil. 
The hplc trace of the product obtained when the 
cephalosporin sample (119) was subjected to these 
conditions showed that two major components were present 
(figure 2.1). This hplc trace was compared to a trace of a 
previously characterised sample of cephalothin which had 
been run under the same conditions. This sample was 
synthesised by coupling 7-ACA with 2-thiopheneacetyl 
chloride using DCCI. One of the peaks in the hplc trace of 
the sample that had been cleaved from the resin was found 
to have an identical retention time to the characterised 
sample. Preparative hplc was then used to purify the 
product and pure cephalothin was obtained. The other 
component was not characterised, however the similarity in 
IMIM 
retention time to the product peak suggested that it could 
be the i-2 cephalosporin analogue of cephalothin (121). 
This transformation is usually brought about in basic 
media, and it was assumed that the basic conditions used 
for the removal of the Bnpeoc and Fmoc were responsible in 
this case. Indeed when a sample of cephalothin was 
subjected to 20°L piperidine in DMF for 15 minutes, nearly 
complete conversion of the cephalothin to a slightly more 
polar compound (hplc) occurred. The transformation to -2 
analogues can be prevented by using cephalosporin 
suiphoxide derivatives in all reactions involving basic 
conditions, or alternatively the L1-21L1-3 mixture can be 
converted to the sulphoxide. This will convert all L-2 to 
-3 (see section 2.27) 
CHIC 
N 	 Oft 0): N
COH 
(121) 
The same conditions were used to cleave 63-phenoxy-
acetylamino penicillanic acid (penicillin V) (3) from the 
resin. The hplc trace of the product in this case 
indicated that the compound was unstable (figure 2.2). 
This was confirmed when a sample of previously 
characterised penicillin V w as found to decompose under 
similar conditions. It was clear that the less acid stable 
penicillin compounds could not be subjected to 10% TFA in 
DCM. Only slight improvement resulted when the penicillin 
V was subjected to 1% TFA in DCM, however these conditions 
would not cleave the product from the Wang resin. 
2.2.7 Formation of cephalosporin suiphoxide 
Initially alternative deprotection conditions were 
attempted to see if the formation of the L-2 adduct could 
be avoided. The use of piperidine in dimethylsulphide 
instead of DMF resulted in no improvement. A solution of 
2% piperidine in DMF removed Bnpeoc from the resin sample 
in 30 minutes. However an equal mixture of two isomers 
resulted when this resin sample was treated as before 
(hplc). 
Finally the resin was added to solutions of 5%, 10% and 
20% morpholine in DMF. It was hoped that morpholine, being 
a weaker base than pyridine, would not encourage the 
formation of the L-2 adduct. These reactions were 
considerably slower than when pyridine was used. The 5% 
example gave a negative Kaiser test after 4 hours 
indicating that no deprotection had occurred. The other 
two examples resulted in some deprotection but the 
products were a mixture of isomers (hplc). 
It was therefore concluded that in order to prevent the 
formation of a z-2 cephalosporin during the deprotection 
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of Bnpeoc or Fmoc, the cephalosporin must be converted to 
the suiphoxide. It is a known fact that cephalosporin 
suiphoxides do not rearrange to the L-2 analogues. 
Two different methods were attempted. Fmoc-ACA-OtBu 
(117) was oxidised to the suiphoxide (122) using 1.2 
equivalents of rn.chloroperoxybenzoic acid. Following 
removal of the t.butylester as before, the suiphoxide 
(123) was loaded onto the resin using the methodology 
described earlier. This resulted in a loading of only 25%, 
significantly lower than that obtained with the sulphide 
(118). The frequency of the infrared 0-lactam carbonyl 
absorption of the resulting resin was at 1805 cm -1 , i.e. 
had increased slightly, as would be expected for a 
suiphoxide. 
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Due to the apparent decrease in the loading of the 
resin, it was decided to attempt the conversion to the 
suiphoxide after the cephalosporin had been coupled to the 
resin, deprotected, and reacted with the 2-thiopheneacety]. 
chloride. A sample of the resin (119) was swelled in DCM 
and mcpba (1.2 equivalents) was added. After this reaction 
some of the resin was cleaved and hplc indicated that the 
conversion had occurred. The product consisted of a single 
component that was more polar than either cephalothin or 
the L-2 compound. The remainder of the resin was reacted 
with phosphorous trichloride in order to reduce the 
suiphoxide back to the sulphide. The hplc trace of this 
product after cleavage from the resin consisted of one 
major peak that had an identical retention time to the 
sample previously characterised. This confirms that the 
extra peak observed was due to the Z-2 analogue, and that 
this problem can be avoided by oxidation and reduction 
steps prior to the removal of the product from the resin. 
2.2.8 Use of the 'Sasrin' resin (45) 
During the course of this research, the 'Sasrin' resin 
(45) was introduced as a highly acid labile resin; 
'Sasrin' stands for 'super acid sensitive resin'. Having 
had problems in cleaving penicillin deriv Ltives from the 
Wang resin, it was considered worthwhile to repeat the 
work using the Sasrin resin. 
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The slightly modified linking agent of the Sasrin resin 
causes a more acid labile peptide-resin bond, which allows 
the use of 0.5 or 1°h TFA in DCM to cleave products. 
A sample of the Sasrin resin, (obtained from Bachem), 
was loaded with Fmoc-APA (113) using the methodology that 
had already been proved successful with the Wang resin. As 
before, the loading reaction was repeated three times, 
after which the resin was only 23% loaded. This lower 
coupling could be due to the increased steric hindrance 
caused by the bulkier linking agent of the Sasrin resin. 
The Fmoc protection was removed using DBU (1.2 
equivalents), and phenoxyacetyl choride was coupled to the 
free amino group. 
Both 0.5% and 1% TFA in 0CM were then used to cleave 
the resulting penicillin V (3) from the resin. The 
reactions were sonicated for periods ranging from 15 to 45 
minutes. The reaction mixture was observed to change 
colour after approximately 5 minutes and, after recovery, 
the resin was a violet colour; an observation that had 
been reported on the product information sheet supplied by 
the manufacturers. Hplc traces of the products obtained 
from these experiments indicated only a slight improvement 
from the previous experiments with the Wang resin, 
The stability of penicillin V was then tested in other 
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weakly acidic solutions. Stirring penicillin V in 10% 2M 
HC1/1,4-dioxane and 10% 0.5M HC1/1,4-dioxane resulted in 
some decomposition, however improved stability was 
observed in a solution of trichloroacetic acid (5 
equivalents) and DCM. A sample of the resin was then 
subjected to these conditions. Trichioroacetic acid (5 
eq.) was added to a sample of the resin that had been 
swelled in DCM. The reaction was left in an ultrasonic 
bath for 15 minutes, after which filtration and 
evaporation of the filtrate yielded the crude product. 
Hplc showed that the major component of the product had a 
retention time identical to that of some previously 
characterised penicillin V, other minor impurities were 
also present (figure 2.2). The product was purified by 
preparative hplc and pure penicillin V (3) resulted. 
2.2.9 	Conclusions 
This research has demonstrated that 13-lactam compounds 
will behave in a similar manner to peptides, and may be 
coupled to insoluble polymer supports. The increased bulk 
of the 3 -lactam molecules, however, leads to a lower 
percentage of the resin's active sites being coupled. 
The synthesis of suitably protected penicillin and 
cephalosporin analogues proved to be a more complex task 
than an earlier report 57 had suggested, however the use of 
penicillin or cephalosporin ester derivatives allowed the 
protection of the 63 (7/3 )-amino functionality in high 
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yield. No significant differences were noted between the 
Fmoc and Bnpeoc protection strategies, however infrared 
spectroscopy provided a good indication of the success of 
the protection and deprotection reactions in the case of 
Bnpeoc. 
Care must be taken when using basic conditions to 
deprotect cephalosporin derivatives in order to prevent 
the formation of z-2 analogues. This problem may be 
avoided by formation of the cephalosporin suiphoxide. 
During the course of this research, the most serious 
problems were encountered when cleaving the final product 
from the resin. Ideally, alternative cleavage conditions 
are required, to which the sensitive penicillin and 
cephalosporin nuclei will be more stable. This will 
probably involve further modification of the linking agent 
between the 0-lactam and the resin. One possible solution 
could be the use of 2-(4-hydroxymethylphenyl)-2-
trimethylsilyipropanoic acid group (124). This is a 
fluoride-labile handle that was introduced by workers in 
this research group, and proved to be successful in the 





After cleaving the penicillin and cephalosporin from 
the resin, purification was still required. This 
considerably reduces any advantage likely to be gained 
from the use of this methodology for short syntheses. 
However during longer, more complicated, syntheses 
avoiding the necessity to purify each intermediate could 
lead to a considerable time saving. 
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Melting points were recorded in open capillary tubes on 
an electrically heated Buchi 510 melting point apparatus 
and are uncorrected. Thin layer chromatography (tic) was 
carried out on commercially available plastic sheets 
coated with silica gel 60 Gf-254 (Merck) in the solvent 
systems quoted in the text. Visualisation of the compounds 
was achieved by a suitable combination of the following 
methods: UV absorption at 254 nm, potassium permanganate, 
bromophenol blue, 4,4'-bis(dimethylamirio)phenylcarbjnol 
(Mary's reagent), and ninhydrin sprays. Wet flash 
chromatography was performed using Merck silica gel 60. 
High performance liquid chromatography (hplc) was carried 
out either using a Waters system consisting of 2 x 600A 
pumps, a U6K injector, a 680 automatic gradient 
controller, a model 441 ultraviolet detector, and a 308 
computing integrator, or an Applied Biosystems system 
consisting of 2 x 1406A solvent delivery systems, a 1480A 
injector/mixer, and a 1783A detector/controller. 
Analytical separations were performed using the columns 
and gradients of water/acetonitrile (+ 0.05% TFA) that are 
listed below, with a flow rate of 1 ml/min. The elution of 
samples was monitored by ultraviolet absorption at 254 nm: 
system 1 Spherisorb C18, 80/20 to 0/100 (28 minutes) 
system 2 Spherisorb C18, 50/50 to 0/100 (16 minutes) 
system 3 Spherisorb C8, 50/50 to 0/100 (28 minutes) 
system 4 Spherisorb C18, 50/50 to 0/100 (28 minutes) 
system 5 Spherisorb C8, 90/10 to 40/60 (25 minutes) 
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Infrared spectra were recorded on a Perkin Elmer 781 
double beam spectrophotometer in the solvent indicated, or 
by the KBr disc technique. Polystyrene (1603 cm) was 
employed as the standard. Ultraviolet spectra were 
recorded on a Pye-Unicam SP8-400 spectrophotometer, in the 
solvent indicated. High and low resolution fast atom 
bombardment (FAB) spectra were measured on a Kratos MS 
50TC machine. Proton n.m.r were recorded on a Jeol FX-60 
(60 MHz), a Brucker WP80 (80 MHz), a Brucker WP200 (200 
MHz), or a Brucker WM 250 (250 MHz) machine in the solvent 
indicated , using tetramethylsilane (TMS) as the external 
standard (= 0.000 ppm). Carbon-13 n.m.r spectra were 
recorded on a Brucker WP200 machine operating at 50.3 MHz. 
Elemental analysis was carried out on a Carlo Erba 
elemental analyser (model 1106). 
All solvents were distilled before use, and the 
following were dried, using the reagents listed, when 
required: benzene (sodium wire), chloroform (phosphorous 
pentoxide), dichloromethane (calcium hydride), diethyl 
ether (sodium wire), toluene (sodium wire), and 
tetrahydrofuran (sodium). N,N-dimethylformamide (hplc 
grade) was commercially supplied by Applied Biosystems, 
Rathbu..rd-, or Aldrich. This was stored over 4A molecular 
sieves and was used without distillation. Petroleum ether 
refers to the fraction with boiling point between 40 0C and 
60°C. 
5t,1: 
601-I{ydroxypenicillanic acid (26) 
The compound was prepared by the general method of 
Hauser and Sigg 26 
6-aminopenicillanic acid (3) (1.08 g, 5.00 mmol) was 
dissolved in 1M p.toluenesulphonic acid (13.5 ml) and was 
cooled to 0°C. To this stirred solution was added a 
solution of sodium nitrite (0.5 g, 7,25 mmol) in water (6 
ml) over a period of 10 minutes. The reaction was left 
stirring for 5 minutes. The product was then extracted 
into ether (3 x 50 ml). The organic layer was washed with 
water (2 x 25 ml) and dried over Na 2 SO4 . Removal of the 
solvent in vacuo gave the product as a pale green foam 
(0.82 g, 76°h): 6H(80MHZ, CD3COCD3) 9.55 (1H,s,acid H), 
5.18 (1H, d ,JtL Hz, 5-H), 4.9 (1H 2 b, OH), 4.75 (1H, d, J 
ftHz, 6-H), 4.42 (1H, s, 3-H), 1.60 (3H, s, CR3 ), 1.55 (3H, 
s, CR3); max  (THF) 1790 ( /3-lactam C=0), 1750 (C=O) cm. 
Benzyl 6a -hydroxypenicillanate (25) 
(26) (1.736 g, 8.00 mmol) was dissolved in a mixture of 
acetone (5 ml) and water (5ml). This was neutralised using 
1M potassium carbonate. The neutralised solution was 
lyophilised which left the potassium salt as a brown 
solid. The potassium salt (1.785 g, 7 mmol) was dissolved 
in dime thy lacetamide (5 ml). A solution of benzyl bromide 
(2.90 g, 1.40 mmol) in dime thy lace tamide (5 ml) was then 
added and the reaction mixture was stirred at room 
temperature for 1.5 hours. The solvent was then removed 
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in vacuo and ethyl acetate (50 ml) was added. The 
resulting solution was washed with water (1 x 50 ml), 
saturated NaHCO 3 (1 x 50 ml) and water (1 x 50 ml). The 
organic phase was then dried over Na2SO4 and the solvent 
removed in vacuo to give the crude product as a yellow 
oil. This was recrystallised from DCM and petroleum ether 
to afford the title compound (1.89 g, 88%) as a white, 
crystalline solid: M.P. 158-160 0 C (lit. 26 157-1600 C); 5H 
(80 MHz, CDC13) 7.38 (5H, s, aromatic H), 5.25 (1H, bd, 
5-H), 5.30 (2H, s, benzyl CH2), 4.82 (1H, bd, 6-H), 4.50 
(1H, s, 3-H), 3.32 (1H, bd, OH), 1.52 (3H, s, CH3 )
1 
 1.48 
(3H, s, CH3); V. max (CH2C12) 1775 (j3 -lactam c=o), 1742 
(ester C=O), 1200, 1178 cm -1 . 
Benzyl 6-oxopenicillanate (24) 
A. Oxidation of benzyl 6a-hydroxypenicillanate (25) 
(i) Using DMSO and acetic anhydride 
The method of Vanderhaege et a1 33 was repeated. 
Benzyl 6cY-hydroxypenicillanate (0.338 g, 1.1 mmol) was 
dissolved in Dt4SO (2m1). To this was added acetic 
anhydride (0.6 ml) that had been freshly distilled from 
A1C1 3 . The reaction mixture was stirred at room 
temperature for 48 hours, after which it was poured into a 
mixture of ice-water (5 ml) and KHCO 3 (5 ml). The 
suspension was extracted with benzene (3 x 10 ml) and the 
combined organic phase was washed with water (5 x 20 ml) 
and dried (Na2SO4). The solvent was removed in vacuo, 
which left the target compound as a yellow oil (0.104 g, 
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317.). All attempts to recrystallise the product failed: 
max (CH2 c1 2 ) 1830 (6-oxo c=o), 1790 ( 0 -lactam C0), 
1742 (ester C=0), 1415, 1200, 1180, 1160, 1110 cm'. 
Using pyridiniun chlorochromate 
Pyridinium chlorochromate (0.053 g, 0.244 mmol) was 
dissolved in DCM (5 ml). To this solution was added benzyl 
6 a -hydroxypenicillanate (25) (0.050 g, 0.16 mmol) that 
had been dissolved in DCM (2 ml). The resulting solution 
was stirred for 12 hours. Ether (20 ml) was then added and 
the solid residue that was formed was removed by 
filtration through celite. The filtrate, which was green 
coloured, was evaporated in vacuo. Infrared spectroscopy 
of the residue indicated that starting material had been 
recovered: Vmax (CH2C12) 1775 ( f3-lactam C=0), 1745 (ester 
C0), 1200, 1178 cm. 
Using manganese dioxide 
Manganese dioxide was freshly prepared for this 
reaction: A solution of manganese sulphate (22.2 g, 0.147 
mol) in water (30 ml), and a solution of 40% NaOH (23.4 
ml) were added simultaneously over 0.25 hour to a solution 
of potassium permanganate (19.2 g, 0.121 mol) in water 
(120 ml). A brown solid was precipitated soon after the 
start of the reaction. After 1 hour the solid was 
collected using a centrifuge and washed with water until 
the washings became colourless. The solid was finally 
dried in an oven at 120 0C, and the target compound was 
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obtained as a brown powder (8.31 g, 65%). 
Freshly prepared manganese dioxide (0.13 g, 1.6 mmol) 
was added to acetonitrile (imi). To this was added benzyl 
6a-hydroxypenicillanate (25) (0,05 g, 0.16 mmol) that had 
also been dissolved in acetonitrile (1 ml). The reaction 
was stirred for 6 hours. The solid residue was then 
removed by filtering the reaction mixture through celite. 
Finally the solvent was removed in vacuo. Infrared 
spectroscopy indicated that starting material (25) had 
been recovered: Tmax  1775 ( f3 -lactam C=O), 1742 (ester 
C=O), 1200, 1178 cm. 
(iv) Moffat oxidation using diisopropylcarbodiimide 
The general methodology of Sheehan and Lo 24 was 
repeated, with some modifications that were introduced by 
Vanderhaege et a1 33 . 
Benzyl 6 a -hydroxypenicillanate (0.050 g, 0.16 mmol) 
was dissolved in dimethyl sulphoxide (1 ml). To this was 
added anhydrous orthophosphoric acid (0.008 g, 0.08 mmol) 
and diisopropylcarbodiimide (0.061 g, 0.48 mmol). The 
reaction was stirred at room temperature for 2.5 hours. 
The excess carbodi-imide was then destroyed using oxalic 
acid dihydrate (0.5 g) in dimethyl suiphoxide (5 ml), 
after which the mixture was poured into ice-water (100 
ml). The precipitated diisopropyl urea was removed by 
filtration and the filtrate was extracted with ethyl 
acetate (3 x 50 ml). The organic layer was washed with 
water (2 x 50 ml) and dried (Na 2 SO4 ) and the solvent 
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removed in vacuo. Tic (EtOAc/hexane 1:1) indicated that 
mainly starting material remained. 
(v) Moffat oxidation using 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide hydrochloride (77) 
A solution of benzyl 6a-hydroxypenicillanate (25) 
(0.05 g, 0.16 mmol) and dry dime thy lsuiphoxide (1 ml) in 
toluene (1 ml) was treated with (77) (0.705 g, 0.37 
mmol) that had been dissolved in pyridine (0.044 g, 0.56 
mmol) and toluene (0.5 ml). Dichioroacetic acid (0.010 g, 
0.08 mmol) in toluene (0.5 ml) was added and the reaction 
mixture was stirred under nitrogen at room temperature for 
24 hours. The reaction mixture was then washed with citric 
acid (2 x 20 ml), saturated NaHCO3 (1 x 20 ml) and brine 
(1 x 20 ml). The organic phase was dried (Na 2 SO4 ) and the 
solvent removed in vacuo. Infrared spectroscopy indicated 
that mainly starting material had been recovered:x max 
(CH2C12) 1775 ( f3-lactam C0), 1745 (ester C=O), 1200, 
1172 cm. 
B. From benzyl 6 0-aminopenicillanate using trifluoro-
methanesulphonic anhydride 
The methodology of Hagiwara et a1 38 was repeated. 
To a solution of (25) (0.910 g, 2.90 mmol) in DCM (10 
ml) at -78 0C was added trifluoromethanesulphonic anhydride 
(2.51 g, 	8.9 mmol) 	and triethylamine 	(0.899 g, 8.9 	mmol). 
This was allowed to warm to room temperature with stirring 
over 2 hours. The reaction was then added to ethyl acetate 
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(50 ml) and washed with ice water (3 x 30 ml). The organic 
layer was dried (Na 2 SO4 ) and the solvent removed in vacuo 
to leave the residue as a brown oil (1.62 g, 2.8 mmol). 
DBU (0.693 g, 4.2 mmol) was then added and the resulting 
mixture was stirred at -78 0C for 1 hour. This was then 
added to 0.5M HC1 (50 ml) and ethyl acetate (50 ml). The 
organic layer was washed with brine (1 x 50 ml) and dried 
(Na2SO4). Removal of the solvent in vacuo left a brown 
oil. Tlc (EtOAc/hexane 1:1) and infrared spectroscopy 
showed this was mainly starting material: R f 0.65; max 
(CH2C12) 1775 ( f3-lactam c=o), 1745 (ester C=O) 1200, 1172 
cm. 
C. From benzyl 6a-methylthio 60-aminopenicillanate (31) 
The general methodology of Jen et a1 32 was repeated. 
A stirred solution of (31) (1.40 g, 4.00 mmol) in DMF 
(60 ml) and water (20 ml) at -20 0C (CC14/acetone bath) was 
treated with mercuric chloride (1.20 g, 4.40 mmol). After 
15 minutes the reaction mixture was warmed up to 0 °C and 
was stirred at this temperature for a further 30 minutes. 
Ether (100 ml) was then added. The precipitate was removed 
by filtration through celite and the filtrate was washed 
with water (2 x 100 ml). The organic phase was dried 
(Na 2 SO4 ) the solvent was removed in vacuo to give the 
title compound as a yellow oil (0.854 g, 70%): 'max 
(CH2C1 2 ) 2965, 1833 (6-oxo C0), 1790 ( j3-lactam C=0), 
1740 (ester C=0), 1375, 1240, 1200, 1095 cm;6H(200 MHz, 
CDC13) 7.37 (5H, s, aromatic H), 5.80 (1H, s, 5-H), 5.25 
-114- 
(2H, s, benzyl CH 2 ), 4.82 (1H, s, 3-H), 1.50 (3H, s, CH3 ), 
1.45 (3H, s, CH 3 ). 
D.From benzyl 6a-toiylthio 613-aminopenicillanate (78) 
The method described above was repeated using (78) 
instead of (31). The reaction between (78) (1.188 g, 3.00 
mmoi) and mercuric chloride (0.90 g, 3.30 mmol) resulted 
in the target compound (24) (0.549 g, 60%). 
t.butyl 7a,70 -dihydroxycephalosporanate (79) (Attempted 
preparation of t.butyl 7-oxocephalosporanate (76)) 
A. From t.butyl 70-aminocephalosporanate using trifluoro-
methanesuiphonic anhydride. 
A solution of t.butyl 713-aminocephalosporanate (0.79 g, 
2.5 mmol) in DCM (10 ml) was cooled to -65 0 C. 
Triethylamine (0.725 ml, 5.00 mmol) and trifluoromethane-
sulphonic anhydride (0.858 ml, 5.00 mmol) were added. The 
reaction mixture was stirred for 2 hours, allowing the 
temperature to reach -10 0C over this period. Tic 
(EtOAc/hexane 3:7) showed that all starting material had 
been consumed: R f (starting material) 0.05, R f (reaction 
mixture) 0, 0.35 9 0.56. The solution was re-cooled to 
-60 0C and triethylamine (0.367 ml, 2.5 mmol) was added, 
and the resulting reaction mixture was allowed to warm up 
to -30 0C. The solution was then poured into ethyl acetate 
(20 ml) and 111 I-IC1 (20 ml). The organic phase was 
separated, washed with brine (2 x 20 ml) and dried 
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(MgSO4 ). The solvent was then removed in vacuo to give a 
yellow oil (0.449 g, 55%). Purification was attempted 
using silica gel chromatography, during which some 
decomposition of the product seemed to occur. Some product 
containing fractions were recovered, and the solvent was 
removed in vacuo. Recrystallisation of the residue using 
ethyl acetate and hexane resulted in a pale yellow solid 
(0.111 g, 15 °!.): m.p. 130-132°C; 'umax (KBr disc) 3020 (OH), 
3140 (OH), 1770 
( 3-lactam Co), 1710 (ester C=0), 1700 
(ester c=o), 1360, 1260, 1150, 1115, 1030, 810 cm-; oH 
(200 MHz, CD3COCD3) 6.88 (1H, s, OH), 6.74 (1H, s, OH), 
4.97 and 4.70 (2H, ABq, 3-CH 2 ), 4.89 (1H, s, 6-H), 3.53 
and 3.40 (2H, ABq, 2-H), 2.05 (3H, s, OCH3), 1.53 (9H, s, 
t.butyl H). 
B. From t.butyl 7a-tolylthio 73-aminocephalosporanate (81) 
A solution of (81) (6.75 g, 15 mmol) in DMF (75 ml) and 
water (15 ml) was cooled down to -5 0C (ice/NaC1 bath), and 
mercuric chloride (3.255 g, 15 mmol) was added. After 30 
minutes, more DMF (30 ml) was added and the reaction 
mixture was filtered through celite to remove the solid 
residue. The solvent was then removed in vacuo which left 
a yellow oil (4.399 g, 85%). This was then recrystallised 
using ethyl acetate and hexane, and the title compound 
(3.778 g, 73%) was obtained as a pale yellow solid: m.p. 
130-132 °C; A max  (DMF) 268, 247 nm; Vmax  (KBr disc) 3460 
(OH), 3290 (on), 1773 
( 
j3 -lactam co), 1715 (ester C=O), 
1700 (ester C=O), 1360, 1260, 1150, 1120, 1030, 815 cm-1. 9 
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6H( 200 MHz, CD 3COCD 3 ) 6.85 (1H, s, OH), 6.70 (1H, s, OH) 
4.95 and 4.72 (2H, ABq, 3-CH 2 ), 4.87 (1H, s, 6-H) 3.67 and 
3.40 (2H, ABq, 2-H), 2.05 (3H, s, OCH3 ), 1.53 (9H, s, 
t.butyl H); 6C(50 MHz, CD3COCD3) 169.5, 163.9, 160.0 
(3 x C=O), 127.0 (C-7), 121.2 and 103.5 (C=C), 82.0 
(t.butyl quaternary C), 65.5 (C-6), 62.0 (C-2), 26.5 (3 x 
t.butyl CH3 ) 25.2 (3-CH2) 9  19.2 (OCH3 ); m/z (FAB) 328 
(MH), 311, 292, 202, 156. 
Conversion of (79) to t.butyl 7-oxocephalosporanate (76) 
(79) (0.10 g, 0.29 mmol) was dissolved in CD 3COCD 3 
(5 ml):
* 
 (60 MHz) 6.40 (1H, b, OH), 6.24 (1H, s, OH), 
4.60 and 4.30 (2H, ABq, 3-CH 2 ), 4.48 (111, s, 6-H), 3.10 
(211 9 d, 2-H), 1.62 (3H, s, OCH3), 1.80 (9H, s, t.butyl H). 
Activated molecular sieves (4A) (0.10 g) were then 
added to this and the solution was left to stand at room 
temperature for 2 minutes: 11 (60 MHz) 6.38 (1.5H, b, 2 x 
OH), 5.32 (0.5H, s, 6-H(76)), 4.50 (0.5H, s, 6-11(79)), 
4.70 and 4.30 (2H, 2 x ABq, 3-CH2), 3.40 (1H, d, 2-H(76)), 
3.15 (1H 9 d, 2-H(79)), 1.70 (3H, s, OCH3), 1.20 and 1.22 
(911, 2 x s, t.butyl H). 
Fresh activated molecular sieves were added and the 
solution was left to stand for a further 5 minutes. The 'H 
n.m.r spectrum (60 MHz) indicated that the solution was 
still a mixture, but more conversion to (76) had occurred. 
Fresh activated molecular sieves (O.lOg) were added and 
the solution was left for 1 hour. The 'H n.m.r spectrum 
(60MHz) of this indicated that the conversion was 
-117- 
complete: vmax (CH 2C1 2 ) 1833 (7-oxo C0), 1790 (f3-lactam 
C0), 1745 (ester C=0), 1730 (ester c=o), 1344, 1230, 
1158, 1045 cm'; H(200 MHz, CD3COCD 3 ) 5.30 (1H, s, 6-H), 
5.10 and 4.85 (2H, ABq, J 13.5 Hz, 3-CH2), 3.64 and 3.43 
(2H, ABq, J 18.7 Hz, 2-H), 2.12 (3H, s, OCH3), 1.55 (9H 9 
S, t.butyl H). 
* 'H irr cttMca' .\%4s 	c'ccc 	cAre ,t.% ocw..rt . 
woe, 	 o.iU.Q. A o TM S for flAiLs. (1c Pot  t%4.+ 
Attempted preparation of t.butyl 7 a -acetoxy 713-hydroxy-
cephalosporana te 
Acetyl chloride (0.026 ml, 0.37 mmol) and pyridine 
(0.029 ml, 0.37 mmol) were added to a solution of t.butyl 
7cr ,70-dihydroxycephalosporanate (79) (0.127 g, 0.37 mmcl) 
in DCM (15 ml). The reaction mixture was stirred under 
argon for -1 hour, after which it was added to ethyl 
acetate (30 ml) and dilute HC1 (30 ml). The organic phase 
was separated and washed with water (2 x 50 ml), saturated 
NaHCO3 (1 x 50 ml), and brine (1 x 50 ml). The organic 
phase was finally dried (MgSO4) and the solvent removed 
in vacuo. Tic (ethyl acetate/hexane 1:1) indicated that 
starting material remained: R f (79) 0.26, R f (roi-eci 
tt9) 0.26. 
-118- 
Preparation of t.butyl 7a ,70 -diacetoxycephalosporanate 
(83) 
Acetyl chloride (0.085 ml, 1.2 mmol) and pyridine 
(0.097 ml, 1.2 mmol) were added to a solution of t.butyl 
7cy,70-dihydroxycephalosporanate (79) (0.138 g, 0.4 mmol) 
in DCM (lOml). The reaction mixture was stirred at room 
temperature for 15 hours, after which tic (EtOAc/ hexane 
1:1) indicated that all starting material had been 
consumed: Rf (79) 0.26, Rf (reaction mixture) 0, 0.36, 
0.50, 0.54. The reaction mixture was then added to ethyl 
acetate (30 ml) and dilute HC1 (30 ml). The organic phase 
was washed with water (2 x 50 ml) and brine (2 x 50 ml) 
and dried (MgSO4), after which the solvent was removed 
in vacuo. Infrared spectroscopy indicated that some 
t.butyl 7-oxocephalosporanate was present: )r max (12c1 2 ) 
1833, 1790 9 1740 9 1170, 1220, 1160 9 1120 cm 1 . Wet flash 
silica gel chromatography (EtOAc/hexane 1:1) afforded two 
products. N.m.r indicated that the least polar (R f 0.54) 
product was the title compound (83) (0.015 g, 9%): 6 H( 200 
MHz, CDC13) 5.10 (1H, s, 6-H), 5.05 and 4.82 (2H, ABq, J 
12 Hz, 3-CH2 ), 3.55 and 3.34 (2H, ABq, J 17.8 Hz, 2-H), 
2.40 (3H, s, 7-COCH3), 2.24 (3H, s, 7-COCH3 ), 2.10 (3H, s, 
3-COCH3 )
9 
 1.59 (9H, s, t.butyl H). 
oS( 	ecorec 	 -- 
-joç- 	fof 	 : OH( 200 MHz, CDC1 3 ) 
5.05 (1H, s, 6-H), 5.07 and 4.83 (2H, ABq, J 13.3 Hz, 3-
4.05 and 3.88 (2H, ABq, J 17.1 MHz, ?-H), 3.58 and 
3.42 (2H, ABq, J 18.5 Hz, 2-H) 1 2.10 (3H, s-, COCH 3 ). 
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Attempted preparation of benzyl 6a -acetamido 6f3 - 
trimethylsilyloxypenicillanate 
Benzyl 6-oxopenicillanate (0.148 g 0.485 mmol) was 
dissolved in DCM (10 ml) and N-trimethylsilylacetamide 
(0.64 g, 0.485 ml) was added. The reaction mixture was 
stirred under nitrogen for 30 minutes, after which the 
progress of the reaction was checked using infrared 
spectroscopy: umax  (CH2C1 2 ) 3415 (amide NH), 2860, 1833 
(6-oxo c=o), 1790 (-lactam Co), 1745 (ester co), 1670 
(amide C0), 1420, 1200, 890 cm. The reaction was also 
checked after 3 and 4 hours and a similar infrared 
spectrum was obtained. Additional N-trimethylsilyl-
acetamide (0.636 g, 0.485 mmol) was added 4 hours after 
the reaction was commenced, and the reaction mixture was 
stirred under the same conditions for a further 18 hours. 
After this time, infrared spectroscopy showed that the 6-
oxo carbonyl group was no longer present, and that there 
was a strong amide carbonyl absorbance.: rmax (after 22 
hours) (CH2C12) 3520, 3410, 2960, 1790 ( 0 -lactam c=o), 
1740 (ester c0), 1670 (amide co) 1595 2 1375, 1200, 1185, 
850 cm'. The reaction mixture was then added to ethyl 
acetate (50 ml), and washed with dilute HC1 (2 x 30 ml), 
water (1 x 30 ml) and brine (1 x 30 ml). The organic phase 
was then dried (Na2SO4) and the solvent removed in vacuo, 
which left an oily residue: it max  1790 ( 0 -lactam C=0), 
1740 (ester c=o), 1200, 1185, 850 cm'. The absence of an 
-120- 
amide carbonyl absorbance in this spectrum indicated that 
the reaction had failed. 
Benzyl 6a -(N-trimethylsilylacetamido)6f3-trimethylsjlyl 
oxypenicillanate (85) 
To a solution of benzyl 6-oxopenicillanate (24) (0.358 
g, 1.17 mmol) in DCM (15 ml), was added bistrimethylsilyl-
acetamide (0.238 g, 1.17 mmol). The reaction mixture was 
stirred at room temperature for 1 hour, after which infra-
spectroscopy indicated that all of (24) had been consumed. 
Removal of the solvent in vacuo gave the title compound 
(0.512 g, 887.) as an oil: Vmax (CH2C1 2 ) 3420 9 2960, 1780 
(f3 -lactam C=O), 1740 (ester C0), 1660 (amide c=o), 1420, 
1305, 1180, 845 cm; 5H(80 MHz, CD 2C1 2 ) 7.38 (5H, s, 
aromatic H), 5.58 (1H, s, 5-H), 5.19 (2H, s, benzyl CR2), 
4.44 (1H, s, 3-H), 1.98 (3-H, s, amide CH3), 1.55 (3H, s, 
CH3) 9  1.40 (3H, s, CR3), 0.22 and 0.10(18H, 2 x s, TMS-H); 
m/z (FAB) 510 (MH), 483, 437, 409, 250, 132. 
Attempted removal of trimethylsilyl groups from (85) 
A. Using TBAF and methanol 
A solution of (85) (0.031 g, 0.06 mmol) in dry THF 
(15 ml) was cooled down to -78 0C. Methanol (0.0024 ml, 
0.06 mmol) and TBAF (0.0189 g, 0.06 mmol) in THF (2 ml) 
were added. The reaction mixture was stirred at this 
temperature for 3 hours, after which ethyl acetate (15 ml) 
was added. The resulting solution was washed with water 
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(3 x 15 ml) and the organic phase was dried (Na 2 SO4 ). 
Finally the solvent was removed in vacuo, which left a 
yellow oil. The infrared spectrum of this showed that the 
3 -lactam ring had cleaved. 
B. Using water 
A sample of (85) was shaken with water. The infrared 
spectrum of the product showed that 0-lactam ring cleavage 
had occurred. 
Attempted 	preparation of t.butyl 7a-N-methylacetamido 
70- trimethylsilyloxycephalosporanate 
N-methyl N-trimethylsilylacetamide (0.55 g, 0.38 mmol) 
was added to a solution of t.butyl 7-oxocephalosporanate 
(0.119 g, 0.38 mmol) in chloroform (25 ml). The reaction 
mixture was stirred under argon for 4 hours. During this 
time the progress of the reaction was monitored every 30 
minutes using infrared spectroscopy, which showed that no 
reaction was taking place: TUmax  (CHC1 3 ) 3450 9 1833 (7-oxo 
C=O), 1790 ( f3-lactam c=o), 1745 (ester c=o), 1730 (ester 
c=o), 1660 (amide c0), 1344, 1230, 1158, 1045 cm'. 
Reaction of t.butyl 701,70-dihydroxycephalosporanate with 
bistrimethylsilylforinamide (84) 
Bistrimethylsilylformamide (0.043 g, 0.19 mmol) was 
added to a solution of (76) (0.062 g, 0.19 mmol) in DCM (5 
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ml), and the resulting reaction mixture was stirred at 
room temperature for 2.5 hours. The infrared spectrum of 
the crude product showed that all of the starting 
material had reacted:Vmax (CH2 C1 2 ) 3400, 2990, 1790 (fl 
lactam C=O), 1745 (ester C=0), 1730 (ester C=0), 1670, 
1610 cm'. 
The reaction mixture was then added to ethyl acetate 
(25 ml) and washed with water (2 x 20 ml). The organic 
phase was dried (Na 2SO4) and the solvent removed in vacuo. 
Tic (EtOAc/hexane 1:1) indicated that the product 
consisted of three components: R f 0.89, 0.36, 0.05. 
Purification of this mixture was afforded by wet flash 
silica gel chromatography using the same solvent system. 
Some of the product decomposed on the silica, and the 
silica turned red. Two compounds were isolated: 
7a ,7 13 -bistrimethylsilyloxycephalosporanate (0.026 g, 
29°h): R f (EtOAc /hexane 1:1) 0.89; V max (CH2C12) 2990, 
1785 ( 0-lactam C=O), 1740 (ester C0); oH  (250MHz CDC1 3 ) 
5.00 and 4.75 (2H 9 ABq, J 13.0 Hz, 3-CH 2 ), 4.67 (1H, s, 
6-H), 3.48 and 3.25 (2H 9 ABq, J 18.0 Hz, 2-H), 2.09 (3H 9 
s, COCH3 ), 1.57 (9H, s, t.butyl-H), 0.26 and 0.27( 18H, 2 
x 5, TMS-H). 
7a-formamido 70-hydroxycephalosporanate (86) (0.006 g, 
8%) was crystallised using ether/petether and obtained as 
a white solid: R f (EtOAc/hexane 1:1) 0.36; max  3410 9 1765 
(13-lactam C=O), 1740 (ester C=O), 1670 (amide C0), 1610 
CM-1; 6H( 250 MHz, CD3COCD3) (major rotamer only) 8.43 (1H, 
b, NH), 8.30 (lii, s, CHO), 6.72 (1H, s, OH), 5.09 (1H, s, 
-123- 
6-H), 5.01 and 4.74 (2H, ABq, J 12.9 Hz, 3-CH 2 ), 3.40 and 
3.70 (2H, ABq, J 18.1 Hz, 2-H), 2.05 (3H, s, COCH 3 ), 1.55 
(9H, s, t.butyl-H). 
Benzyl 	6- [ 2 ' - cyclohexanespiro - l' ,3'-dioxolan-4'-one-5'- 
ylidene] penicillanate (95) 
The phosphonium bromide (88) (1.67 g, 3.36 mmol) was 
dissolved in toluene (30 ml), and 1,4-diazabicyclo[2,2,2] -
octane (0.337 g, 3.36 mmol) was added. The reaction 
mixture was stirred at 60 0C for 10 minutes. During this 
period the reaction mixture turned yellow. Benzyl 6-
oxopenicillanate (24) (1.025 g, 3.36 mmol) was then added. 
The reaction mixture was stirred at the same temperature 
for a further 15 minutes and then allowed to cool down to 
room temperature over 30 minutes. The progress of the 
reaction was then checked by tic (EtOAc/hexane 1:1), which 
showed that all of (24) had been consumed: R f (24) 0.26; 
Rf (reaction mixture) 0, 0.09, 0.48. The solid triphenyl-
phosphine oxide residue was removed by filtration and the 
solvent was removed in vacuo. This left a red coloured oil 
which was purified using wet flash silica gel 
chromatography (EtOAc/hexane 1:1). This resulted in a 
yellow oil (1.205 g, 81%). All attempts to recrystallise 
the product failed: Rf (EtOAc/hexane 1:1) 0.48; -max 
(CH2C12) 2960, 1795 (dioxolanone C=O), 1770 ( 0-lactam 
C=0), 1740 (ester C=0), 1175, 1140, 930 cm; Amax  (Me0F) 
274 nm, 6H(200 MHz, CDC13) 7.30 (5H, s, aromatic H), 5.94 
-124- 
(1H, s, 5-H), 5.12 (2H, s, benzyl CH2), 4.49 (1H, s, 3-H), 
1.65 (10H, bdm, cyclohexane H), 1.50 and 1.33 (6H, 2s, 
methyl H); m/z (FAB) 444 (MH), 400, 354, 250, 114; hrms, 
found 444.14808, C23H26N06S requires 444.14807 (< 1 ppm). 
Sodium 6_[2tcyclohexanespiro_1* ,3'-dioxolan-4'-one-5'-
ylidene] penicillanate 
Sodium salt of (96) 
Activated palladium over charcoal (3.00 g) was added to 
a solution of the benzyl ester (3.00 g, 6.77 mmol) in THF 
(50 ml). This was then stirred under an atmosphere of 
hydrogen for 15 hours after which the progress of the 
reaction was checked by tic (EtOAc/hexane 1:1). This 
indicated that no starting material remained: R f (starting 
material) 0.48; Rf (reaction mixture) 0 (baseline). The 
catalyst was removed by filtration through celite and the 
solvent removed in vacuo which left a pale yellow foam 
(1.58 g, 4.63 mmol). The residue was dissolved in acetone 
(75 ml) and a solution of sodium ethyihexanoate (0.845 g, 
5.09 mmol) in methylisobutylketone (75 ml) was added. The 
resulting mixture was stirred for 30 minutes at room 
temperature, after which it was added to ethyl acetate (50 
ml) and water (50 ml). The aqueous phase was lyophilised 
which left an off-white solid (1.668 g, 65%):\rmax (KBr 
disc) 1795 (dioxolanone C=0), 1770 
( f3-lactam C=0), 1615, 
1270 9 1200, 930 cm; A max  (H20) 270 nm; oH (200 MHz, 
D20) 6.00 (1H, s, 5-H), 4.29 (1H, s, 3-H), 1.55 and 1.49 
(-,2s, M et )N~ t H), loo- 2  
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cyclohexane H); rn/s (-veFAB) 352 (M+), 332 9 310 9 291, 255 9 
210, 107; hrms, found 352.08550, C16H18N06S requires 
352.08547 (< 1 ppm). 
Attempted preparation of benzyl 6j3-(1'-one-2'-carboxyl) 
penicillanate barium salt (101) 
0.0579M Barium hydroxide (1.95 ml, 0.113 mmol) was 
added to a solution of (95) (0.10 g, 0.226 mmol) in DMF 
(10 ml). The reaction mixture immediately went dark 
yellow. The reaction mixture was stirred for 1 hour at 
room temperature, after which it was added to ethyl 
acetate (20 ml) and water (20 ml). The organic phase was 
removed, washed with water (1 x 20 ml), and the combined 
aqueous phases were lyophilised. A solid remained that was 
analysed by infrared spectroscopy. This indicated that 
there was no f3-lactam C0 present: Vmax (KBr disc) 3450, 
2990, 1740, 1330 9 1150, 1010 cm- 1. 
Attempted preparation of t.butyl 7-[2'-cyclohexanespiro-
1' ,3'dioxolan-4'-one-5'-ylidene] cephalosporanate (98) 
The phosphonium bromide (88) (4.70 g, 9.47 mmol) was 
dissolved in toluene (50 ml) and 1,4-diazabicyclo[2,2, 2 ] -
octane (1.06 g, 9.47 mmol) was added. This mixture was 
stirred at 60 0C for 10 minutes, which was followed by the 
addition of t.butyl 7-oxocephalosporanate (76) (3.09 g, 
9.47 mmol) in toluene (50 ml). The reaction mixture was 
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stirred at 60 0C for 10 minutes and then allowed to cool 
down to room temperature over a further 20 minutes. After 
this, tic (EtOAc/hexane 1:1) indicated that all starting 
material had been consumed: Rf (76) 0.29; Rf (reaction 
mixture) 0, 0.33, 0.38. The triphenyiphosphine oxide 
residue was removed by filtration through celite and the 
solvent was removed in vacuo which gave the crude product 
(3.57 g, 87%) as a brown oil. This was purified using wet 
flash silica gel chromatography (EtOAc/Hexane 3:2). Some 
of the column fractions contained material that was only 
one spot on tic: Rf (EtOAc/hexane 1:1) 0.38, and others 
contained a mixture of products: Rf (EtOAc/hexane 1:1) 
0.38, 0.33. The similar fractions were bulked together and 
the solvent was removed in vacuo. The pure product (A) 
(1.98 g, 45%) and the mixture (B) (1.27 g, 29%) were both 
obtained as yellow foams. 
max 1800 1 1770 ( j3-lactam C0), 1740 (ester c=o), 
1370, 1225, 1150, 1090 cm -1 ; A max  (CH3CN) 275 nm; 
MHz, CDC13) (intensities not given for signals that are 
different in the Z-2 and L-3 isomers) 6.40 (s, 2-H z-2), 
5.75 (s, 4-H Z-2), 5.32 (s, 6-H i-2), 5.00 (s, 6-H, z-3), 
5.12-4.48 (2H 7 2ABq, 3-CH2 L-2 and z-3) 3.60 and 3.27 
(ABq, 2-H A-3), 2.05 (3H, s, COCH3), 1.90 (10H, bd, 
cyclohexane H), 1.55 and 1.48 (9H, 2s, t.butyl H i-2 and 
L-3); hplc Rt (system 1) 25.1 minutes. 
rmax 1800, 1770 ( f3-lactam c0), 1740 (ester C=O), 
1370, 1225, 1150 9 1090 cm; 	max  (CH3CN) 275 nm; 
MHz, CDC13) (intensities not given for signals that are 
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affected by the mixture of isomers) 6.40 (bd, 2-H z-2), 
5.71 (s, 4-H i-2) 5.36, 5.22 and 4.94 (3s 6-H i.-2 and 
L-3), 5.10-4.45 (2ABq, 3-CH 2 z-2 and -3), 3.58 and 3.25 
(ABq, 2-H D-3), 2.05 (3H 9 s, COCH3) 9  1.80 (10H 9 bd, 
cyclohexyl H), 1.50 and 1.47 (9H, 2s, t.butyl H -2 and 
A-3); hplc Rt (system 1) 24.8, 25.1 minutes. 
t.Butyl 	7- [ 2 ' - cyclohexanespiro - l' ,3 t dioxolan-4'-one-5'- 
ylidene]cephalosporanate suiphoxide (99) 
To a solution consisting of a mixture of -2 and L-3 
sulphides (97) and (98) (see above) (1.00 g, 2.15 mmol) in 
1,4-dioxane (30 ml) and pH 7 buffer (10 ml) was added 
rn.chloroperoxybenzoic acid (0.445 g, 2.15 mmol). The 
reaction mixture was stirred at room temperature for 1 
hour, after which it was added to chloroform (30 ml) and 
water (30 ml). The organic phase was seDarated. washed 
with water (2 x 50 ml) and brine (1 x 50 ml), and dried 
(Na 2 SO4 ). Removal of the solvent in vacuo gave the crude 
product (0.807 g, 78%), which was purified by dry flash 
silica gel chromatography (EtOAc/hexane 3:2). This 
resulted in the title compound (0.724 g, 70%): Rf 
(EtOAc/hexane 1:1) 0.10; 'max  (CH2C1 2 ) 2960, 1785 9 1735, 
1368, 1220, 1150 cm'; A max (CH3CN) 275 nm; 6H( 200 MHz, 
CDC1 3 ) 5.10 (111, s, 6-H), 5.22 and 4.63 (2H, ABq, J 13.5 
Hz, 3-CH2 ), 3.80 and 3.24 (2H, ABq, J 18.4 Hz, 2-H), 2.02 
(3H, s, COCH3 ), 2.00-1.60 (10H, bd, cyclohexyl-H), 1.52 
(9H, s, t.butyl-H); 6c(50 MHz, CDC1 3 ) 170.2, 160.5 9 159.0, 
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155.0 (4 x c=o), 	135.5, 128.5, 117.5 9 108.5 9 112.5 (4 C=C 
and cyclohexyl quaternary C), 84.0 (t.butyi quaternary C), 
67.2 (c-6) 9 63.5 (3-cH2 ), 46.2 (c-2), 36.0 9 35.5 1 23.5 9  
22.5 (cyclohexyl CH 2 ), 27.5 (t.butyl-CH 3 ), 20.5 (acetyl-
CH3 ); hpic Rt (system 1) 22.7 minutes; m/z (FAB) 482 
(MH), 458, 426, 366, 240, 156; hrms, found 482.14849, 
C22H28N09S requires 482.14846 (< 1 ppm). 
t.butyi 	7- [ 21-cyciohexanespiro - l' ,3'-dioxolan-4'-one-5'- 
ylidene] cephalosporanate (98) 
Potassium iodide (0.249 g, 1.5 mmol) and acetyl 
chloride (0.064 ml, 0.9 mmol) were added to a solution of 
the suiphoxide (99) (0.145 g, 0.3 mmoi) in acetone (20 
ml). The reaction mixture was stirred at 0 °C, under argon 
for 45 minutes, after which tic (EtOAc/hexane 7:3) showed 
that no suiphoxide remained: R f (suiphoxide) 0.37; R f 
(reaction mixture) 0, 0.65. Ethyl acetate (30 ml) was then 
added and the reaction mixture was washed with 2% sodium 
metabisuiphite in brine (2 x 50 ml), brine (1 x 50 ml), 
saturated NaHCO 3 (1 x 50 ml), and brine (1 x 50 ml). The 
organic phase was dried (Na 2 SO4 ) and the solvent removed 
in vacuo, which left a yellow oil (0.418 g, 60%). This was 
purified using wet flash silica gel chromatography 
(EtOAc/hexane 1:3). This resulted in the title compound 
(0.391 g, 56%) as a yellow solid: m.p. 108-110 0C (Dec); 
R f (EtOAc/hexane 1:1) 0.38; Vmax (CH2C1 2 ) 1775, 1740 9 
1370 7 1225, 1150, 1090, 1045 cm-1 ; A max (CH3CN) 275 nm; 
-129- 
6(200 MHz, CDC1 3 ) 5.40 (1H, s, 	6-H), 5.01 and 4.74 (2H, 
ABq, J 13.0 Hz, 3-CH 2 ), 3.56 and 3.27 (2H, ABq, J 18.3 Hz, 
2-H), 2.75 (3H, s, COCH3 ), 2.00-1.50 (10H, bd, cyclohexyl-
H), 1.55 (9H, s, t..butyl-H); 6c( 50 MHz, CDC1 3 ) 170.5, 
160.2, 160.1 and 156.1 (4 C0), 135.4, 129.0, 120.2, 117.0 
and 116.6 (4 C=C and cyclohexyl quaternary C), 83.7 
(t.butyl quaternary C), 63.1 (3-CH2), 54.8 (C-2), 36.3, 
35.9 1 23.6 2 22.5 and 22.0 (cyclohexyl-CH2 ), 27.6 
(t.butyl-CH3), 20.6 (acetyl-CH 3 ); m/z (FAB) 466 (MH), 
433 2 406, 350 9 283, 252; hrms, found 466.15354, C22H28 N08 S 
requires 466.15355 (< lppm). 
Attempted preparation of 7- [ 2 ' - cyclohexanespiro - l' ,3 1 -
dioxolan-4'-one-5'-ylidene] cephalosporanic acid 
The t.butyl ester (98) (0.20 g, 0.43 mmol) was 
dissolved in DCM (6 ml) and trifluoroacetic acid (2 ml). 
The reaction mixture was stirred at room temperature for 
15 minutes, after which the progress of the reaction was 
checked by hplc: Rt (system 2) (98) 16.7 minutes; Rt 
(system 2) (reaction mixture) 4.1, 6.4, 10.1, 12.2 
minutes. This indicated that significant impurities were 
present. All attempts to purify the mixture failed. 
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Attempted preparation of t.butyl 7-(1'-one-2'-carboxyl) 
cephalosporanate barium salt (102) 
A solution of barium hydroxide (0.034 g, 0.107 mmol) in 
water (10 ml) was added to (98) (0.100 g, 0.215 mmol) that 
had been dissolved in methanol (1 ml). On addition of the 
barium hydroxide, a precipitate appeared. More methanol (4 
ml) was added until the precipitate redissolved. The 
reaction mixture was stirred at room temperature for 1 
hour, after which tic showed that no starting I  material 
remained. The reaction was washed with ethyl acetate (2 x 
20 ml), and the aqueous phase was lyophilised. Infrared 
spectroscopy of the solid residue showed that there was 
no 3-1actam carbonyl present: "max  (KBr disc) 3440, 2995, 
1740, 1410, 1210 9 1050 cm 1 . 
Attempted preparation of the 7- substituted cephalosporin 
tetronic acid (104) 
Lithium 	diisopropylamide.THF 	(1.5M 	solution 	in 
cyclohexane) (0.29 ml, 0.435 mmol) was added to THF (3 ml) 
and cooled down to -78 0C. To this solution 	was added 
methyl 4-methoxyphenylacetate (0.069 ml, 	0.435 mmol) 
and tetramethylethylenediamine (0.066 ml, 0.435 mmol). The 
resulting mixture was stirred at -78 0C for 30 minutes. The 
cephalosporin suiphoxide (99) (0.20 g, 0.416 mmoi) in THF 
(2 ml) was then added dropwise. The reaction mixture, 
which immediately turned dark red, was stirred at -78 0C 
for 3 hours, and then allowed to warm up to room 
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temperature over a further 2 hours. Ether (10 ml) and 
water (10 ml) were then added. The aqueous phase was 
extracted with ether (2 x 30 ml), and then acidified to pH 
1.5 using 2M HCl. This was once again extracted with ethyl 
acetate (2 x 50 ml) and the combined organic phases were 
dried (Na2SO4). Removal of the solvent in vacuo left a 
dark coloured oil. Infrared spectroscopy showed that there 
was no 3-lactam C=0 present in the product: 'max (CH2C12) 
1740 9 1612, 1520 9 1150 cm -1 . The ether phase from the 
extraction was then dried (Na 2 SO4 ) and evaporated 
in vacuo. There was no 0-lactam carbonyl absorption in the 
infrared spectrum of this residue: 1max (CH2C12) 1740, 
1615 2 1518, 1230, 1160, 1040 cm -1 . 
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Attempted preparation of 613-[2,2 -bis(4'nitrophenyl)-
ethoxycarbonylamino]penicillanic acid (Bnpeoc-APA) (106) 
direct from 6-aminopenicillanic acid (3) 
A. Using Bnpeoc-chloroformate (59) 
6-Aminopenicillanic acid (0.259 g, 1.20 mmol) was 
dissolved in 10°h aqueous Na 2CO 3 (2.55 ml, 2.40 mmol) and 
DMF (2.5 ml). Water (1 ml) was added, so that a clear 
solution was obtained. This solution was cooled down to 
0°C and Bnpeoc-chloroformate (59) (0.351 g, 1.20 mmol) was 
added. The reaction mixture was stirred at room 
temperature for 30 minutes, after which it was added to 
ether (50 ml) and water (50 ml). This was extracted, and 
the aqueous phase was washed with ether (2 x 50 ml) and 
ethyl acetate (2 x 50 ml). The aqueous phase was then 
acidified to pH 1.5 using 2M citric acid. The expected 
precipitate did not appear at this stage. The aqueous 
phase was extracted with ethyl acetate (3 x 100 ml) and 
the combined organic phases were washed with brine (1 x 
100 ml) and dried (MgSO 4 ). Removal of the solvent in vacuo 
left the crude product. This was shown, by hplc, to 
consist of 5 significant components: Rt (system 3) 6.8, 
10.0 7 14.0, 18.2 7 20.9 minutes. No attempt was made to 
purify this product, since improved methodology was 
sought. 
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B. Using Bnpeoc-ONSu (58) 
The general procedure of Rich 66 was followed. 
Triethylamine (0.271 g, 2.33 mmol) in 1,4-dioxane 
(2 ml) was added to 6-aminopenicillanic acid (3) (0.503 g, 
2.33 mmol) that had been suspended in water (10 ml). When 
the 6-APA had dissolved, Bnpeoc-ONSu (58) (1.00 g, 2.33 
mmol) was added. The reaction mixture was stirred at room 
temperature for 2 hours, after which the Bnpeoc ONSu 
still appeared to be suspended in solution. More 1,4-
dioxane (6 ml) was added, after which the reaction 
mixture was stirred for a further 10 hours. Water (50 ml) 
was added and the reaction mixture was acidified to pH 3 
using saturated potassium hydrogen sulphate. This was 
then extracted into ethyl acetate (3 x 25 ml). The 
combined organic phases were dried (Na 2SO4 ) and the 
solvent was removed in vacuo. This left an oil, which was 
converted into a white solid upon trituration with 
ether/petroleum ether. Hplc showed that the reaction 
product was impure, with the major components having 
similar retention times as the p'roduct from method A 
(above): Rt (system 3) 6.8, 10.4, 14.0, 18.5, 21.0 
minutes. Three purification techniques; chromatography 
using both reverse phase silica gel and dianion HP20SS 
resin (supplied by Beecham Pharmaceuticals), and gel 
filtration, were attempted on the reaction product, but 
the title compound was not isolated in a pure form. 
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Attempted preparation of 60 -[9-fluorenylmethoxycarbonyl-
amino]penicillanic acid (Fmoc-APA) (109) direct from 6-
aminopenicillanic acid (3) 
Using Fmoc-chloroformate (52) 
6-Aminopenicillanic acid (0.10 g, 0.463 mmol) was 
dissolved in 10% sodium carbonate (1.00 ml, 0.926 mmol) 
and acetone (2 ml). Fmoc-chloroformate (52) (0.120 g, 
0.463 mmol) was added to this. The reaction mixture was 
stirred for 24 hours, after which it was acidified to pH 3 
using 2M potassium hydrogens uiphate, and added to ether 
(20 ml) and water (20 ml). The organic phase was separated 
and the aqueous layer washed with ether (1 x 20 ml) and 
ethyl acetate (1 x 20 ml). The combined organic phases 
were then washed with brine (1 x 30 ml), dried (Na2SO4) 
and the solvent removed in vacuo. A yellow oily residue 
remained, which hplc showed to be impure: Rt (system 3) 
6.2, 7.8 (strong), 10.2 (strong), 18.2, 20.8 (strong). 
Using Fmoc-chloroformate (52) 
The general procedure of Rich 66 was followed. 
Triethylamine (0.701 g, 6.94 mmol) in 1,4-dioxane (10 
ml) was added to 6-aminopenicillanic acid (1.00 g, 4.63 
mmol) that had been suspended in water (10 ml). When the 
6-APA had dissolved, Fmoc-Cl (52) (1.795 g, 4.63 mmol) was 
added. The reaction mixture was stirred at room 
temperature for 10 hours, after which it was acidified to 
pH 3 using 2M potassium hydrogensulphate. Ethyl acetate 
(50 ml) and water (50 ml) were then added and the organic 
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phase was separated. The aqueous phase was washed with 
ethyl acetate (2 x 50 ml) and the combined organic phases 
were dried (Na 2 SO4 ). Removal of the solvent in vacuo left 
a white solid. Hplc of this showed that impurities were 
present: Rt (system 3) 7.9, 10.3, 16.1, 18.1, 21.0 
minutes. The peak at 10.3 minutes was considerably larger 
than the rest. Purification was attempted using gel 
filtration, but even though the gel filtration trace 
indicated that some separation had been achieved, hplc of 
the recovered material indicated that very little 
improvement had resulted. 
C. Using Fmoc-ONSu (54) 
The procedure described above, (B), was repeated using 
the active ester derivative of Fmoc (54) instead of Fmoc-
chioroformate (52). 6-aminopenicillanic acid (0.20 g, 
0.962 mmol) was reacted with Fmoc-ONSu (0.312 g, 0.962 
mmol) and triethylamine (0.140 g, 1.443 mmol), in water (3 
ml) and 1,4-dioxane (3 ml). Following workup, a white 
solid was obtained. This was analysed by hplc: Rt (system 
3) 6.0, 9.0, 10.1, 15.8, 18.0 minutes. Previous studies 
had indicated that, under similar hplc conditions, Fmoc-
olefin (110) had a retention time of 18.0 minutes, Fmoc-
ONSu a had retention time of 15.9 minutes, N-
hydroxysuccinimide had a retention time of 8.9 minutes and 
that the triethylamine salt of 6-APA had a retention time 
of 6.0 minutes. 
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Using Fmoc-ONSu (54) 
The reaction described above, (C), was repeated using 
acetonitrile as the solvent instead of 1,4-dioxane. Hplc 
of the crude reaction product indicated that less Fmoc-
olefin was produced in this case. However significant 
amounts were still present. 
Using Fmoc-ONSu (54) 
The reaction described above, (D), was repeated using 
N-methylmorpholine as the base instead of triethylarnine. 
Hplc of the crude reaction product indicated that the 
amount of olefin produced had increased compared to the 
reaction with triethylamine. 
Attempted purification of Fmoc-APA (109) by formation of 
the cyclohexylamine salt 
Cyclohexylamine (0.40 g, 4.04 mmol) was added to a 
solution of the crude reaction product (109) (1.76 g, 4.04 
mmol), that had been prepared by method C above, in ethyl 
acetate (15 ml). A white precipitate appeared within a few 
minutes. The reaction mixture was stirred at room 
temperature for 1.5 hours. The precipitate was then 
removed by filtration and washed thoroughly with ethyl 
acetate, which on drying, left a white solid (1.062 g) 
The solid formed above was suspended in ethyl acetate 
(10 ml), and citric acid (10 ml) was added. The reaction 
mixture was stirred at room temperature for 2 hours, then 
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allowed to stand for 5 minutes before removing the organic 
phase. This was washed with citric acid (1 x 20 ml), 
water (1 x 20 ml) and brine (1 x 20 ml), and dried 
(Na 2SO4). Removal of the solvent invacuo left a white 
solid (0.454 g) which was recrystallised using 
ether/petroleum ether. Hplc showed that the product 
consisted of one major constituent and four minor 
constituents: Rt (system 3) 6.0, 8.8, 10.0 (major), 11.9, 
15.8. Infrared spectroscopy indicated that a/3-lactam C=O 
group was present: "max  (KBr disc) 3420, 1790 (0-lactam 
C=O), 1730, 1520 9 1240, 1180 cm'. 
Attempted preparation of 73 -[2,2 -bis(4'nitrophenyl) 
ethoxycarbonylaminocephalosporanic acid (Bnpeoc-ACA) (107) 
direct from 7-aminocephalosporanic acid (9) 
A. Using Bnpeoc-chloroformate (59) 
7-Aminocephalosporanic acid (0.10 g, 0.37 mmol) was 
dissolved in 107 aqueous sodium carbonate (0.7 ml, 0.74 
mmol) and acetonitrile (10 ml). The solution was cooled 
down to 0 °C, and Bnpeoc-chloroformate (0.150 g, 0.42 mmol) 
in acetonitrile (2 ml) was added. The reaction mixture was 
stirred at 0 °C for 30 minutes and then allowed to warm up 
to room temperature over a further 30 minutes. The 
reaction mixture was then washed with ethyl acetate and 
the resulting aqueous phase was lyophilised with the 
intent of recovering the sodium salt of the title 
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compound. 'H N.m.r of the recovered solid indicated that 
the reaction had not worked. 
B. Using Bnpeoc-ONSu 
To a solution of Bnpeoc-ONSu (0.167 g, 0.4 mmol) in 
acetonitrile (8 ml), a solution of 7-aminocephalosporanic 
acid (0.10 g, 0.367 mmol) in water (4 ml) and 
triethylamine (0.073 g, 0.55 mmol) was added dropwise over 
15 minutes. The reaction mixture was then stirred at room 
temperature and the progress of the reaction was followed 
by hplc: Rt (system 3) Bnpe-olefin (108) 16.5 minutes, 
Bnpeoc-ONSu 113.5 minutes, N-hydroxysuccinimide 3.3 
minutes, 7-ACA in H20/Et3N 3.1 minutes; Rt (system 3) 
Reaction mixture, after 30 minutes 3.1, 3.3, 9.4 (small), 
10.2 (small), 12.2, 13.4 minutes, after 2 hours 3.0, 3.3. 
9.5 (small), 10.3 (small), 12.3, 13.4 minutes, after 6 
hours 3.1 (small), 3.3, 9.3, 9.8, 10.1, 12.1 (major), 13.1 
(small) minutes. In view of the purification problems 
experienced with the penicillin reactions, no attempt was 
made to isolate the product from this reaction. 
Benzyl 60 -[2,2 -bis(4'nitrophenyl)ethoxycarboriylamino] 
penicillanate (Bnpeoc-APA-OBz) (116) 
Bnpeoc-chloroformate (1.60 g, 5.10 mmol) and pyridine 
(0.40 g, 5.10 mmol) were added to a solution of benzyl 
60 -aminopenicillanate (1.40 g, 4.60 mmol) in DCM (50 ml) 
at 0°C. The reaction mixture was stirred at this 
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temperature for 15 minutes and allowed to warm up to room 
temperature over a further 30 minutes. Tic after this 
showed that all of the starting material had been 
consumed: Rf (EtOAc/hexane 1:1) (benzyl 6j3 -amino- 
penicillanate) 0.20, (reaction mixture) 0.35, 0.46 
(major), 0.70. The reaction mixture was then added to 
ethyl acetate (100 ml) and 0.5M HC1 (100 ml). The organic 
phase was separated and washed with saturated NaHCO 3 (1 x 
100 ml) and brine (1 x 100 ml). After drying (Na2SO 4 ), the 
solvent was removed in vacuo which left a yellow oil. This 
was purified using wet flash silica gel chromatography 
(EtOAc/hexane 1:1). Removal of the solvent in vacuo, from 
the fractions containing material with R f 0.46, left a 
white solid (2.567g, 907.): m.p. 73-75°C; 'umax  (CH2C12) 
3420, 1790 (13 -lactam C=0), 1740 (ester C0), 1520 (Bnpeoc 
NO2), 1350 (Bnpeoc NO2), 1240, 1050 cm -1 ; 6 H(80 MHz, 
CDC13) 8.17 (4H, d, JAB  8.7 Hz, Bnpeoc aromatic H), 7.27 
(4H, d, JAB  8.7 Hz, Bnpeoc aromatic H), 7.34 (5H, s, 
benzyl aromatic H), 5.38 (2H, b, NH and 5-H), 5.27 (2H, 
s, benzyl CH2), 4.65 (3H, m, Bnpeoc CH and CH 2 ), 4.40 (1H 9 
s, 3-H), 1.55 (3H, s, CH3), 1.38 (3H, s, CH3); m/z (FAB) 
621 (MH), 575, 502, 486, 350; hrms, C30H29N409S requires 
621.64054, found 621.64057 (< 1 ppm). 
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Attempted preparation of 6 0-[2,2 -(4'nitrophenyi)ethoxy-
carbonylaminopenicillanic acid (Bnpeoc-APA) (106) from the 
benzyl ester (Bnpeoc-APA-OBz) (116) 
The method of Oiah et a1 99 was attempted. 
Trimethyisilyl chloride (0.05 ml, 0.378 mmoi) was added 
to a solution of Bnpeoc-APA-OBz (116) (0.117 g, 0.189 
mmoi) and sodium iodide (0.056 g, 0.378 mmoi) in 
acetonitrile (10 ml). The reaction mixture was stirred at 
room temperature, and the progress was monitored by tic. 
After 45 minutes only a small amount of material 
corresponding to the starting material remained, and there 
was a strong polar component that turned blue when sprayed 
with Mary's reagent: Rf (MeOH/CHC1 3 1:9) (starting 
material) 0.60; (reaction mixture) 0.15 (+ve Mary's 
reagent), 0.37, 0.67 (weak). Water (20 ml) was then added 
and the product was extracted into ether (2 x 30 ml). The 
organic phase was washed with water (1 x 30 ml) and 
saturated sodium thiosuiphate (1 x 30 ml) and then dried 
(Na 2 SO4 ), Removal of the solvent in vacuo left a white 
solid which was analysed by hplc: Rt (system 3) 12.1, 
14.5 9 16.4 1 20.4 (weak), 21.6 (weak), 23.5 (weak) 
minutes. No attempts were made to purify this mixture in 
view of the problems that were experienced in earlier 
experiments. 
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Benzyl 60 -[9-fluorenylmethoxycarbonylamino]penicillanate 
(Fmoc-APA-OBz) (113) 
A similar procedure to that described above for the 
synthesis of Bnpeoc-APA-OBz (116) was followed, using 
Fmoc-chloroformate instead of the Bnpeoc chioroformate. 
Benzyl 6 0 -aminopenicillanate (1.021 g, 3.02 mmol) was 
reacted with pyridine (0.24 ml, 3.02 mmol) and Fmoc-
chioroformate (0.861 g, 3.02 mmol) in DCM (30 ml). After 
workup, a yellow oil was obtained. This was purified using 
wet flash silica gel chromatography (EtOAc/hexane 1:3) and 
two compounds were isolated. 
A. title compound (1.242 g, 71%): Rf (EtOAc/hexane 1:1) 
0.59; Vmax  (CH2C12) 3420, 1790 (0-lactam C0), 1733 (ester 
CO 3 urethane C=O), 1510, 1220, 1180 cm' ; max (MeOH) 265 
nm; 6H(200 MHz, CDC13) 7.80-7.25 (13H, m, Fmoc aromatic H 
and benzyl aromatic H), 5.52 (3H, b, NH, 5-H and 6-H), 
5.20 (2H, s, benzyl CH2), 4.47 (1H, s, 3-H), 4.43 (2H, d, 
AB 6.3 Hz, Fmoc CH2 ), 4.22 (1H, t,JAB 7.1 Hz, Fmoc CH), 
1.64 (3H, s, CH 3 ), 1.43 (3H, s, CH3); 6c(50MHz, CDC13) 
173.5 and 167.3 (0-lactam CO 3 ester Co), 154.8 (urethane 
Co), 143.4 and 141.1 (Fmoc quaternary aromatic C's), 
134.6 (Benzyl quaternary C), 128.5-119.9 (Fmoc aromatic 
CH's and benzyl aromatic CH's), 70.4, 68.0 and 60.5 (C-3, 
C-S and C-6), 67.6 and 67.3 (Fmoc CH2, benzyl CH2), 64.7 
(C-2), 46.9 (Fmoc CH), 31.7 and 26.8 (2 x CH 3 ); m/z (FAB) 
529 (MH), 551 (MNa), 410, 351, 291; hrms, C30H29N205S 
requires 529.17970, found 529.17968 (< 1 ppm); hplc, R  
(system 1) 25.0 minutes. 
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B. 9-fluorenylmethanol: m.p 99-100 0C (ref 1-°0 100-101 0C); 
R f (EtOAc/hexane 1:1) 0.40; oH (80MHz, CDC13) 7.83-7.21 
(8H, m, Fmoc aromatic H), 4.50 (2H, s, CH2), 1.60 (1H, s, 
CH). 
Attempted synthesis of benzyl 60 -[9-fluorenylmethoxy-
carbonylamino]penicillanate (Fmoc-APA-OBz) (113) using 
Fmoc-0NSu (54) 
Benzyl 6 0 -aminopenicillanate (0.217 g, 0.71 mmoi), 
Fmoc-ONSu (0.183 g, 0.71 mmol) and pyridine (0.06 ml, 0.71 
mmol) were stirred in DCM (30 ml) at room temperature. The 
reaction was monitored using tic for 7 days, after which 
much starting material remained and the reaction was 
terminated. 
60 -[9-Fluorenylmethoxycarbonylamino]penicillanic acid 
(Fmoc-APA) (109) 
Fmoc-APA-OBz (113) (1.171 g, 2.29 mmol) in THF (15 ml) 
was hydrogenated in the presence of 107 palladium-
charcoal catalyst (1.171 g) for 12 hours at room 
temperature and pressure. After this the progress of the 
reaction was checked by tic (EtOAc/hexane 1:1) which 
showed that starting material remained: R f 0.59. The spent 
catalyst was removed by filtration through celite and 
fresh catalyst (1.171 g) was added. Following 
hydrogenation for a further 12 hours, tic (EtOAC/hexane 
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1:1) showed that only baseline material remained. The 
reaction mixture was filtered through celite and the 
solvent removed in vacuo, which left the title compound as 
a colourless oil. This was converted to a solid (0.830 g, 
867) using ether/petether: m.p 121-123 0C (Dec); Vmax (KBr 
disc) 3420, 1790 (0-lactam c=o), 1730 (urethane C0), 1695 
(acid C=0), 1510, 1220, 1180 cm 1 ; 6H(200MHz, CD3COCD3) 
8.15-7.55 (8H, m, Fmoc aromatic H), 5.80 (2H, bd, 5-H and 
6-H), 4.73 (1H, s, 3-H), 4.70-4.50 (3H, m, Fmoc CH, CH2), 
1.64 (3H, s, CH3), 1.45 (3H, s, CH 3 ); 6c(50  MHz, CD 3COCD3 ) 
174.2-155.1 (3 C=O), 143.3, 141.1 (Fmoc quaternary 
aromatic C's), 128.8 and 128.0 (CC), 127.6-120.2 (Fmoc 
aromatic C's), 70.5 64.4 and 60.1 (C-3, C-5 and C-6), 67.7 
(Fmoc CH2 ), 46.7 (Fmoc CH), 26.9 and 25.3 (2 x CH3); m/z 
(FAB) 439 (MH), 261, 179; hrms, C 23H23N205S requires 
439.13276, found 439.132762 (<1 ppm); hpic (system 1) Rt 
19.5 minutes. 
t.Butyl 70 -[2,2 -bis(4'nitrophenyi)ethoxycarbonylamino 
cephalosporanate (Bnpeoc-ACA-OtBu) (115) 
Pyridine (0.88 ml, 1.1 mmol) and Bnpeoc-chloroformate 
(0.351 g, 1.0 mmol) were added to a solution of t.butyl 
7 f3-aminocephalosporanate (112) (0.328 g, 1.0 mmoi) in DCM 
(20 ml) at 0°C. The reaction mixture was stirred for I 
hour at this temperature, after which tic (EtOAc/hexane 
1:1) indicated that all starting material had been 
consumed: Rf (112) 0.15; Rf (reaction mixture) 0.33 
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(major). The reaction mixture was added to ethyl acetate 
(30 ml) and 0.5M HC1 (30 ml). The organic phase was 
separated and washed with water (1 x 50 ml), saturated 
NaHCO3 (1 x 50 ml) and brine (1 x 50 ml). Drying of the 
organic phase (Na2SO4) followed by removal of the solvent 
in vacuo gave a yellow oil which was purified by wet flash 
silica gel chromatography to give the title compound as a 
colourless oil (0.558 g, 79%): \Tmax (CH2C1 2 ) 3425 9 1790 
( 0 -lactam C=o), 1730 (2 ester CO 3 urethane C=0), 1520 
(NO2), 1350 (NO2), 1225 9 1155, 1050 cm'; H( 200 MHz, 
CDC13) 8.20 (4H, d, JAB  8.7 Hz, Bnpeoc aromatic H), 7.40 
(4H 9 d, JAB  8.7 Hz, Bnpeoc aromatic H), 5.52 (2H 9 b, 7-H 
and NH), 5.05 and 4.79 (2H, ABq, J 13.2 Hz, 3-CH2), 4.92 
(1H 9 d, JAB  4.4 Hz, 6-H), 4.74-4.60 (3H, m, Bnpeoc CH, 
3.56 and 3.34 (2H 9 ABq, J 18.4 Hz, 2-H), 2.06 (3H, 
s, acetyl CH3 ), 1.50 (9H, s, t.butyl H); 6c(50 MHz, CDC1 3 ) 
170.0-154.7 (4 x c=o), 146.5 (Bnpeoc quaternary aromatic 
C's), 128.8 and 123.4 (Bnpeoc aromatic CH's), 126.4 and 
123.6 (c=C), 83.0 (t.butyl quaternary C), 65.9 62.5 and 
59.8 (Bnpeoc CH21  C-2 and 3-CH2), 60.5 and 56.9 (C-6 and 
C-7) 9 48.9 (Bnpeoc CH), 27.1 (t.butyl-CH 3 ), 20.1 (acetyl-
CH3); hplc Rt  (system 4) 14.0 minutes. 
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7 13 - [2,2 -(4'Nitrophenyl)ethoxycarbonyiamino-
cephalosporanic acid (Bnpeoc-ACA) (107) 
Trifluoroacetic acid (1.5 ml) was added to Bnpeoc-ACA-
OtBu (115) (0.205 g, 0.32 mmol). The resulting solution 
was stirred at room temperature for 30 minutes, after 
which tic (EtOAc/hexane 1:1) showed that all starting 
material had been consumed. Toluene (5 ml) was added and 
the solvent was removed in vacuo. This resulted in the 
title compound as a pale yellow solid (0.184 g, 987o):\r max 
(KBr disc) 3420, 1790 ( f3-lactam C0), 1740 (ester C=O, 
urethane co), 1520 (NO2), 1350 (NO 2 ), 1220 cm; 6H( 200 
MHz, CDC13) 8.16 (4H, d, JAB  8.6 Hz, Bnpeoc aromatic H), 
7.40 (4H 9 d, JAB  8.6 Hz, Bnpeoc aromatic H), 6.61 (1H, b, 
OH), 5.84 (1H 2 d, JAB  9.7 Hz, NH) 5.54 (1H, bm, 7-H), 4.96 
(1H 2 d, JAB  4.3 Hz, 6-H), 5.11 and 4.92 (2H 9 ABq, J 13.9 
Hz, 3-CH2 ), 4.85-4.60 (3H, m, Bnpeoc CH2, CH), 3.59 and 
3.37 2H, ABq, J 18.6 Hz, 2-H), 2.06 (3H, s, acetyl-CH3); 
6( 50 MHz, CDC13) 171.0-155.1 (4 x Co), 147.0 and 146.6 
(Bnpeoc quaternary aromatic C's), 129.1 and 123.9 (Bnpeoc 
aromatic CH's), 127.6 and 124.9 (CC), 66.6 and 63.0 
(Bnpeoc CH2 and 3-CH2), 60.7 and 57.3 (C-6 and C-7), 49.4 
(Bnpeoc CH), 26.1 (C-2), 20.5 (acetyl-CH3); m/z (FAB) 587 
(MH), 609 (MNa), 528; hrms, C 2 5H23N40 1 1S requires 
587.10839, found 587.10838 (< 1 ppm); hpic (system 1) Rt 
20.3 minutes. 
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t.Butyl 70 -[9-fluorenylmethoxycarbonylamino 
cephalosporanate (Fmoc-ACA-OtBu) (117) 
The procedure described above for the synthesis of 
Bnpeoc-ACA-OtBu (115) was repeated using Fmoc-
chioroformate instead of Bnpeoc-chloroformate. t.Butyl 7 - 
aminocephalosporanate (1.00 g, 3.05 mmol) was reacted with 
Fmoc-chloroformate (0.80 g, 3.35 rnmol) in the presence of 
pyridine (0.27 ml, 3.35 mmol) with DCM (20 ml) as the 
solvent. Purification of the crude product by wet flash 
silica gel chromatography left a colourless oil which was 
triturated from ether/petether to give the title compound 
as a white solid (1.342 g, 80°h): m.p. 103-104 0C (dec); R f 
(EtOAc/hexane 1:1) 0.67; Vmax (CH2C12) 3420 9 1790 ( 0 
lactam c0), 1730 (2 ester CO 3 urethane c0), 1510 9 1223, 
1155 cm;max (MeOH) 264 nm; H(20OMHz,  CDC13) 7.79-7.25 
(8H 9 m, Fmoc aromatic H), 5.70-5.52 (2H, m, 7-H and NH), 
5.09 and 4.82 (2H, ABq, J 13.2 Hz, 3-CH2), 5.00 (1H 9 d, 
AB 4.6 Hz, 6-H), 4.42 (2H 9 d, JAB  6.4 Hz, Fmoc CH 2 ), 4.24 
(1H9 t ,  -TAB 6.7 Hz, Fmoc CH), 3.59 and 3.38 (2H 9 ABq, J 
18.5 Hz, 2-H), 2.10 (3H, s, acetyl CH3), 1.54 (9H, s, 
t.butyl CH3); 6C( 50  MHz, CDC13) 170.4-155.4 (4 x 
143.3 and 141.0 (Fmoc quaternary aromatic C's), 127.6 
126.9 124.9 and 119.8 (Fmoc aromatic CH's), 127.3 and 
123.6 (C=C), 83.6 (t.butyl quaternary C), 67.6 and 62.9 
(Fmoc CH2 and 3-CH2), 61.0 and 57.4 (C-6 and C-7), 46.7 
(Fmoc CH), 27.6 (t.butyl-CH3), 26.2 (C-2), 20.6 (acetyl-
CH3 ); m/z 551 (MH), 494, 450, 435, 407, 257, 166; hrms, 
C29H31N 207S requires 551.18518, found 551.18519 (< 1 ppm); 
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hplc (system 1) 26.0 minutes. 
7 0 - [ 9- Fluorenylmethoxycarbonylamino]cephalosporanic acid 
(Fmoc-ACA) (118) 
Trjfluoroacetjc acid (10 ml) was added to Fmoc-ACA-OtBu 
(117) (0.424 g, 0.77 mmol) and the resulting solution was 
stirred at room temperature for 30 minutes. Toluene (10 
ml) was added and the solvent was removed in vacuo which 
left the title compound as a yellow oil. Trituration using 
ether/petroleum ether resulted in a pale yellow powder 
(0.332 g, 87%): Vmax  (KBr disc) 3300, 1790 (0-lactam C=0), 
1730 (ester C=0, urethane co), 1690 (acid C0), 1530, 
1330, 1235 9 1050 cm-1 ; A max (MeOH) 265 nm; H( 200 MHz, 
CD 3SOCD 3 ) 8.63 (1H, d, J AB  8.6 Hz, NH), 7.94-7.29 (8H, m, 
Fmoc aromatic H's), 5.56 (1H, q, J 4.6 Hz, 7-H), 5.12 (1H, 
d, JAB  4.8 Hz, 6-H), 5.01 and 4.70 (2H 9 ABq, J 12.8 Hz, 3-
CH2 ) 2 4.40-4.25 (3H, m, Fmoc CH, CH2), 3.68 and 3.48 (2H, 
ABq, J 18.1 Hz, 2-H), 2.02 (3H, s, acetyl -CH3);ôc( 50MHz, 
CD3SOCD3) 170.4-156.1 (4 x C0), 143.8 and 140.9 (Fmoc 
quaternary aromatic C's), 127.9 127.3 125.5 and 120.3 
(Fmoc aromatic CH's), 126.6 and 123.4 (Cc), 66.6 and 62.9 
(Fmoc CH2 and 3-CH2), 61.3 and 57.9 (C-6 and c-7), 46.7 
(Fmoc CH), 25.8 (C-2), 20.7 (acetyl-CH3); m/z (FAB) 495 
(MH), 435; hrms, C 25H23N 207S requires 495.12258, found 
494.12259 (< 1 ppm); hplc (system 4) Rt 4.0 minutes. 
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t.Butyl 7 13 -aminocephalosporanate 
Removal of Bnpeoc from Bnpeoc-ACA-OtBu (115) 
Using DBU and acetic acid 
Acetic acid (0.009 ml, 0.158 mmol) and DBU (0.023 ml, 
0.158 mmol) were added to a solution of Bnpeoc-ACA-OtBu 
(115) (0.050 g, 0.078 mmol) in DMF (5 ml). The reaction 
mixture was stirred at room temperature for 30 minutes and 
the solvent was removed in vacuo. Infrared spectroscopy 
showed that the f3-lactam ring had cleaved:vmax (CH2C1 2 ) 
2950 9 1710, 1675 7 1645, 1520 (NO 2 ), 1350 (NO 2 ) cm. 
Using piperidine 
Piperidine (0.007 ml, 0.078 mmol) was added to a 
solution of Bnpeoc-ACA-OtBu (115) (0.050 g, 0.078 mmol) in 
DMF 5 ml. The reaction was stirred for 30 minutes after 
which tic (EtOAc/hexane 1:1) indicated that no starting 
material remained: Rf (115) 0.33; Rf (reaction mixture) 
0,24, 0.58. The more polar component of the reaction 
mixture went purple when sprayed with ninhydrin, 
indicating the presence of a free amine group. The solvent 
was removed from the reaction mixture in vacuo, and 
infrared spectroscopy identified the presence of a 13-
lactam C=0 group in the residue: "max  3420, 1790 (13-lactam 
C=O), 1740 9 1675, 1520, 1350, 1230 cm. 
A similar result was obtained when solutions of 207 and 
50% piperidine in DMF were used. 
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Benzyl 613-aminopenicillanate 
Removal of Fmoc from Fmoc-APA-QBz (113) 
Using 20%piperidine/DMF 
Fmoc-APA-OBz (113) 	(0.020 g, 0.037 mmoi) was stirred 
in 207 piperidirie/DMF for 15 minutes. The'solvent was then 
removed in vacuo and the infrared spectrum of the residue 
showed a considerable decrease in the strength of the 3 - 
lactam C=0 group absorption. Additional 20% piperidine/DMF 
(5 ml) was added to the residue and the deprotection was 
stirred for a further 45 minutes, after which the solvent 
was removed in vacuo. There was no /3-lactam C0 absorption 
in the infrared spectrum of the residue recovered after 
this period: V max  3320 9 1730 7 1670 (s) (DMF c=o), 1495 9 
1380, 1090 cm. 
Using DBU 
DBU (0.004 ml, 0.023 mmol) was added to a solution of 
Fmoc-APA-OBz (113) (0.010g, 0.019 mmol) in DCM (3 ml). The 
reaction mixture was stirred at room temperature for 10 
minutes after which tic (EtOAc/hexane 1:1) showed that no 
starting maeria1 remained: Rf (113) 0.59; Rf (reaction 
mixture) 0, 0.14 2 0.70. The component with R f 0.14 turned 
purple when the tic plate was sprayed with ninhydrin, 
indicating the presence of a free amine group. The 
stability of the fi-lactam system under these conditions 
was then further tested by adding additional DBU (0.010 
ml, 0.057 mmoi) and running an infrared spectum of the 
reaction mixture after a further 20 minutes and after a 
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total time of 1 hour: Vmax  (CH2C1 2 ) (after 1 hour) 2915, 
1780 (0-lactam C=0), 1740, 1610, 1312, 1185, 960 cm'. 
The attachment of 70 -[2,2 -(4'nitrophenyl)ethoxycarbonyl 
amino]cephalosporanic acid (107) onto the p-benzyloxy-
benzylalcohol resin 
(preparation of Bnpeoc ACA-(O-CH2C6H4-OR)) 
N-methylmorpholine (0.093 ml, 0.85 mmol) was added to a 
solution of Bnpeoc-ACA (107) (0.500 g, 0.85 mmol) in DCM 
(5 ml). This was stirred for 1 minute after which 
diphenyiphosphinic anhydride (0.355 g, 0.85 mmol) was 
added. The resulting solution was stirred at room 
temperature for 10 minutes and then added to 
benzyloxybenzylalcohol resin (Bachem, 0.79 mmol/g) (0.717 
g, 0.57 minol) which had been swelled in DMA (5 ml) in the 
presence of DMAP (0.004 g, 0.03 mmol). NMM (0.093 ml, 0.85 
mmol) was added and the reaction mixture was agitated for 
three hours in an ultrasonic bath at room temperature. The 
resin was filtered, washed with DMA (3 x 30 ml) and DCM (3 
x 30 ml), and dried. Infrared spectroscopy showed that 
some coupling had taken place: Vmax  ([(Br disc) 3300, 2920, 
1790 (w) ( 0 -lactam C0), 1750 (ester C=O), 1605 7 1510, 
1350 (w) (NO2), 1240, 1030 cm'. The coupling yield was 
found to be 20°h (0.158 mmol/g) (Calculated from °IN of the 
resin, obtained from CHN analysis). 
The resin was swelled in DMA (5 ml) in the presence of 
DMAP (0.004 g, 0.03 mmol) and a solution of Bnpeoc-ACA 
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(107) (0.441 mg, 0.75 mmol), N-methylmorpholine (0.083 ml, 
0.75 mmol), and diphenyiphosphinic anhydride (0.315 mg, 
0.75 mmol), prepared as described above, was added. 
Following the addition of N-methylmorpholine (0.83 mmol, 
0.75 mmol), the reaction mixture was agitated in an 
ultrasonic bath for 3 hours at room temperature. The 
resin was then filtered, washed with DMA (3 x 30 ml) and 
DCM (3 x 30 ml), and dried. The infrared spectrum of the 
resin had a stronger 3 -lactam C0 absorption indicating 
that further coupling had taken place. The coupling yield 
after this reaction was 42% (calculated from %N of the 
resin). 
The coupling reaction was repeated once more using 
Bnpeoc-ACA (107) (0.200 g, 0.34 mmol), N-me thy lmorpholine 
(0.037 ml, 0.34 mmol) and diphenyiphosphinic anhydride 
(0.142 g, 0.34 mmol). The infrared spectrum of the resin 
after this reaction had a strongj3-lactam C0 absorption: 
max (KBr disc) 3300, 2920, 1790 (0-lactam c=o), 1740 
(ester C=O), 1600 9 1510, 1350 (NO2), 1230, 1030 cm'. A 
coupling yield of 47% (0.37 mmol/g) was calculated from 
the %N of the final resin: %N 1.44%, %N for 100% loaded 
resin 3.06%. 
Removal of Bnpeoc from Bnpeoc-ACA-(O-CH2C6H4-OR) 
(preparation of 7-ACA-(O-CH 2C6H4-OR)) 
A. Using 1% and 2% piperidine in DMF 
A sample of the loaded resin (0.500 g) was added to a 
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solution of 	1% piperidine in DMF (10 ml). The reaction 
mixture was agitated in an ultrasonic bath for 5 minutes 
at room temperature. The resin was filtered, washed with 
DMF (3 x 30 ml) and DCM (3 x 30 ml), and dried. The dried 
resin was analysed by infrared spectroscopy: 'max  (KBr 
disc) 3225, 2920, 1790 (f-lactam C0), 1740, 1600, 1510, 
1350 (NO2), 1220 7 1030 cm'. The presence of the 
absorbance at 1350 cm indicated that full deprotection 
had not occured. A further quantity of 1% piperidine in 
DMF (10 ml). The reaction mixture was agitated under the 
same conditions for 10 minutes after which the resin was 
washed and dried as before. A qualitative Kaiser test of 
the final resin indicated that the deprotection had not 
ocurred. A solution of 2% piperidine in DMF (10 ml) was 
then added to the resin. This was agitated under the same 
conditions for 1 hour and the resin recovered as before. 
The infrared spectrum of the resin after this showed a 
significant decrease in the strength of the f3-lactam C=O 
absorbance: max  (KBr disc) 3025, 2920, 1790 (w), 1740, 
1605 7 1510, 1450, 1220, 1030 cm. 
B. Using 20% piperidine in DMF 
A sample of the loaded resin (0.100 g) was added to a 
solution of 20% piperidine in DMF (5 ml). The reaction 
mixture was agitated in an ultrasonic bath for 5 minutes 
at room temperature. The resin was filtered, washed with 
DMF (3 x 30 ml) and DCM (3 x 30 ml), and dried. The final 
resin gave a positive qualitative Kaiser test and infrared 
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spectroscopy indicated that the j3-lactam ring was still 
intact: 7max (KBr disc) 3025, 2920, 1790 ($-lactam C=0), 
1740 2 1605, 1510, 1450, 1220, 1025 cm. 
C. Using 5%, 10% and 20% morpholine in DMF 
The loaded resin (0.100 g) was added to a solution of 
5% morpholine in DMF (10 ml). The reaction mixture was 
agitated in an ultrasonic bath for 1 hour at room 
temperature, after which the resin was filtered, washed 
with DMF (2 x 30 ml) and DCM (3 x 30 ml), and dried. The 
final resin gave a negative qualitative Kaiser test, 
indicating that the deprotection had not taken place. A 
solution of 10% morpholine in DMF (is ml) was then added 
to the same resin sample and the reaction mixture was 
left, under the same conditions as above, for a further 2 
hours. The resin was recovered by filtration, and washed 
and dried as before. There was still an absorbance at 1350 
cm-1 in the infrared spectrum of the resin, indicating 
that Bnpeoc was still present: Vmax (KBr disc) 3020, 2920, 
1790 9 1740 9 1605 2 1510, 1450, 1350 (NO2 ),1215, 1030 cm. 
Finally a solution of 20% morpholine in DMF (15 ml) was 
added to the same resin sample, and the reaction mixture 
was agitated under the same conditions as before for a 
further 2 hours. The intensity of the 13-lactam C0 at 1790 
cm - in the infrared spectrum of the resin had decreased 
significantly after this. Indicating that, as well as 
removing the protecting group, some 0-lactam ring opening 
was taking place: 'rmax (KBr disc) 3020, 2920, 1790 (w), 
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1740 9 1605 9 1510 9 1450 9 1215 9 1030 cm. 
Coupling of 2-thiopheneacetyichioride and 7-ACA-(0-CH2C6H 4 
-OR) 
(preparation of cephalothin-(O-CH2C6H4-OR) (119)) 
DC1 (20 ml) was added to the deprotected resin (xx) 
(0.37 mmol/g) (0.218 g, 0.08 mmol). To this was added 2-
thiopheneacety1chloride (0.025 ml, 0.161 mmol) and 
pyridine (0.02 ml, 0.161 mmol). The reaction mixture was 
agitated in an ultrasonic bath for 4 hours at room 
temperature. The resin was then filtered and washed with 
DCM (3 x 50 ml). The reaction was repeated, using the same 
quantities of solvents and reagents, to ensure that 
complete coupling had taken place. The final dried resin 
gave a negative qualitative Kaiser test and the infrared 
spectrum had an additional C0 absorption at 1690 cm: 
Vmax (KBr disc) 3030, 2920 2 1790 (0-lactarn C=O), 1740, 
1690 2 1605 2 1510, 1450 2 1230, 1030 cm. 
Cleaving 70-(2-thiopheneacetyl)aminocephalosporanic acid 
(cephalothin) (10) from the Wang resin 
To the loaded resin (0.570 g, 0.189 mmol) was added a 
solution of 10% TFA in DCM (15 ml). The reaction mixture 
was agitated in an ultrasonic bath for 15 minutes at room 
temperature, after which the resin was removed by 
filtration and washed with 0CM (3 x 30 ml) and toluene (3 
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x 30 ml). The combined filtrates were evaporated in vacuo 
which left the crude product as a yellow oil. This was 
converted into a white powder (0.045 g, 61%) by 
trituration using ether. Hplc of the crude product 
indicated that two main components were present, one of 
which corresponded to a standard sample of cephalothin 
which was run under the same conditions: Rt (reaction 
mixture) (system 1) 13.4, 14.0 (major); Rt (10) (system 1) 
14.0 minutes. The close proximity of the peaks at 14.0 and 
13.4 minutes suggested that they could be due to L-2 and 
-3 cephalosporin analogues. The mixture was purified using 
preparative hplc, and a sample consisting of a single peak 
(Rt (system 1) 14.0 minutes) was obtained: 	Lmax (CHC1 3 ) 
1780 9 1740, 1680 9 1503, 1140, 1020 cm -1 
 ; 
	
6 H( 2 00MHz, 
CD3COCD3) 8.07 (1H, b, NH), 7.30-6.95 (3H, m, Thiophene 
ring H's), 5.88 (1H, ABq, J 4.7 Hz, 7-H), 5.15 (1H, d, JAB 
4.7 Hz, 6-H), 5.10 and 4.82 (2H, ABq, J 13.8 Hz, 3-CH2 ), 
3.90 (2H, s, thiophene-CH2), 3.72 and 3.53 (2H, ABq, J 
18.4 Hz, 2-H); m/z (FAB) 397 (MH), 337, 293, 274. 
7 /3-(2-Thiopheneacetyl)aminocephalosporanic acid (10) 
N,N-Dicyclohexylcarbodiimide (0.412 g, 2.0 mmol) was 
added to a mixture 2-thiopheneacetic acid (0.284 g, 2 
mmol) and hydroxybenzotriazole (0.306 g, 2.26 mmol) in DCM 
(40 ml). The resulting solution was stirred at room 
temperature for 5 hours. The solid residue was removed by 
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filtration, and the filtrate was added to a solution of 
7-aminocephalosporanic acid (0.545 g, 2.0 mmol) and 
triethylamine (1.40 ml, 10.0 mmol) in DCM (10 ml). This 
was stirred at room temperature for 3 hours, after which 
the solvent was removed in vacuo. Water (50 ml) was added 
to the residue and the solution was acidified to pH2 with 
10% citric acid. The product was then extracted with ethyl 
acetate (2 x 50 ml). The combined organic phases were 
washed with water (2 x 50 ml) and dried (Na 2SO4 ). Removal 
of the solvent in vacuo left a yellow residue which was 
converted into a pale brown powder (0.610 g, 77%) by 
trituration with ether: vmax (CH2C1 2 ) 3680, 1790 (0-lactam 
c0), 1740, 1690, 1510, 1210, 1140 cm; 	H( 200 MHz, 
CD3COCD3) 	7.33-6.95 (3H, m, thiophene ring H'S), 5.84 
(1H, d, JAB  4.9 Hz, 7-H), 5.13 (1H, d, J AB  4.8 Hz, 6-H), 
5.10 and 4,83 (2H 9 ABq, J 13.1 Hz, 3-CH2), 3.90 (2H, s, 
thiophene-CH2), 3.72 and 3.53 (2H, ABq, J 18.2 Hz, 2-H); 
m/z (FAB) 397 (MH), 337, 225; hplc (system 1) Rt 14.0 
minutes. 
Investigating the stability 	of 713-(2-thiophenacetyl)- 
aminocephalosporanic acid (10) in 20% piperidine/DMF 
70 -(2-Thiopheneacetyl)aminocephalosporanic acid (0.050 
g) was stirred in 20% piperidine/DMF (10 ml) for 15 
minutes at room temperature. The solvent was then removed 
in vacuo, and the residue was analysed by hplc. This was 
compared to hplc traces of the starting material, and of a 
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sample of the product that had been cleaved from the 
resin, that had been obtained under the same conditions: 
Rt (10) (system 5) 21.4 minutes; Rt (product from resin) 
(system 5) 20.7, 21.4 minutes; Rt (reaction residue) 
(system 5) 20.7 minutes. 
t.Butyl 7 0 - [ 9 - fluorenylmethoxycarbonylamino] 
cephalosporanate 1-oxide (121) 
Fmoc-ACA-OtBu (117) (4.000 g, 7.27 mmoi) and rn.chloro-
peroxybenzoic acid (1.880 g, 10.90 mmol) were stirred in 
DCM (100 ml) for 10 minutes at room temperature. After 
this time, tic indicated that no starting material 
remained: Rf (EtOAc/hexane 1:1) (reaction mixture) 0.10, 
0.34; R f (117) 0.67. The solvent was then removed in 
vacuo, and ethyl acetate (50 ml) was added to the residue. 
This solution was washed with saturated NaHCO3 (2 x 50 
ml), the organic phase was dried (Na 2 SO4 ), and the solvent 
removed in vacuo. Purification of the crude product was 
carried out by dry flash silica gel chromatography to give 
the title compound (2.75 g, 66.8%): Rf (EtOAc/hexane 1:1) 
0.34; Vmax  3400, 1805 (A.-lactam Co), 1735 (2 ester CO 3 
urethane c=o), 1510 9 1223, 1048 cm;)max (tleOH) 265 nm; 
6H( 200MHZ2 CDC13) 7.75-7.25 (8H, m, Fmoc aromatic H's), 
6.22(1H, bd, 6-H), 5.78 (1H, bm, 7-H), 5.32 and 5.73 (2H, 
ABq, J 13.7 Hz, 3-CH2), 4.50-4.15 (3H, m, Fmoc CH, CH 2 ), 
3.77 and 3.20 (2H 9. ABq, J 18.6 Hz, 2-H), 2.05 (3H, s, 
acetyl CH3 ); MHz, CDC13) 170.3-155.4 (4 x C=0), 
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143.3 and 141.0 (Fmoc quaternary aromatic C's), 127.6-
119.8 (Fmoc aromatic CH's), 118.3 (c=c), 84.1 (t.butyl 
quaternary C), 67.9 and 63.1 (3-CR 2 and Fmoc CH 2 ), 66.7 
and 61.3 (C-6 and C-7), 46.6 (Fmoc CH), 45.7 (C-2), 27.6 
(t.butyl-CH3), 20.5 (acetyl-CH3); hplc (system 1) Rt 24.0 
minutes. 
7 0 _[9_Fluorenylmethoxycarbonylamino]cephalosPOranic acid 
1-oxide (122) 
7 3 _[9_Fluorenylmethoxycarbonylamino]cephalosporanate 
1-oxide (121) (2.10 g, 3.71 mmol) was stirred in TFA (15 
ml) for 10 minutes at room temperature. Toluene (10 ml) 
was added to the reaction mixture and the solvent was 
removed in vacuo. The title compound was isolated as a 
solid (1.88 g, 99 °h) after triturating with ether/petroleum 
ether: Vmax  3400, 1805 ( 0lactam C=0), 1735, 1690, 1530, 
1225, 1040 cm-1;A max (MeOH) 265 nm; 6H(200 MHz, CD3SOCD3) 
8.94-7.60 (8H, m, Fmoc aromatic H's), 5.76 (1H 9 bq, 7-H), 
4.97 (1H 9 b, 6-H), 5.26 and 4.70 (2H, ABq, J 13.1 Hz, 3-
CH2 ), 4.35 (3H, m, Fmoc CH, CR2), 3.98 and 3.65 (2H, ABq, 
J 18.8 Hz, 2-H), 2.05 (3H, s, acetyl-CH3); 6C(50 MHz, 
CD3SOCD3) 170.3-155.7 (4 c0), 143.8 and 140.9 (Fmoc 
aromatic quaternary C's), 127.9 127.3 125.6 125.5 and 
120.3 (Fmoc aromatic CH's), 126.0 and 119.1 (CC), 66.9 
and 63.2 (Fmoc CH2 and 3-CH2), 66.5 and 60.7 (C-6 and C-
7), 46.6 (C-2), 45.5 (Fmoc CH), 20.8 (acetyl CR3); hplc 
(system 1) Rt  18.1 minutes. 
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The attachment of 70 - [9 - f luorenylmethoxycarbonylamino] 
cephalosporanic acid 1-oxide (122) onto the p-benzyloxy-
benzylalcohol resin 
(preparation of Fmoc-ACA(i-oxide)-(Q-CH2C6H4-OR)) 
7 0 - [ 9-Fluorenylmethoxycarbonylamino]cephalosporanjc 
acid 1-oxide (122) (0.750 g, 1.47 mmol) and N-
methylmorpholine (0.161 ml, 1.47 mmol) were added to DMF 
(5 ml). This was stirred for 1 minute at room temperature 
after which diphenylphosphinic anhydride (0.614 g, 1.47 
mmol) was added. After stirring this solution for 10 
minutes at room temperature, it was added to the resin 
(Bachem, 0.79 mmol/g) (0.930, 0.74 rnmol) which had been 
swelled in DMF (10 ml) in the presence of DMAP (0.009 g, 
0.07 mmol). N-methylmorpholine (0.161 ml, 1.47 mmol) was 
added and the reaction mixture was agitated for 3 hours in 
an ultrasonic bath at room temperature. The resin was then 
filtered, washed with DMF (3 x 30 ml) and DCM (3 x 30 ml), 
and dried. The coupling yield of the resin was found to be 
9% (liv deprotection study 97). 
The reaction was repeated using the same procedure and 
quantities of reagents as outlined above. This resulted in 
the resin being 16% loaded (liv deprotection study97 ). 
A third reaction was then carried out on the resin 
using only half the amount of reagents that were used 
previously (i.e. 1 equivalent). The final resin was 25% 
loaded (UV deprotection study 97 ) and infrared spectroscopy 
identified the presence of 0 -lactam functionality: 'max 
(KBr disc) 3020, 1804 (0-lactam C=O), 1740, 1605, 1450, 
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1220, 1030 cm-. 
Oxidation 	of 	cephalothin-(O-CH?-C6H4-OR) 	(119) 	to 
cephalothin 1-oxide-(0-CH2-C6H11-OR) followed by reduction 
back to cephalothin-(O-CH ,)-C6H4-OR) (119) 
The loaded resin (0.710 g, 0.258 mmol) was swelled in 
DCM (10 ml), and rn.chloroperoxybenzoic acid (0.058 g, 
0.309 mmol) was added. The reaction mixture was agitated 
in an ultrasonic bath for 3 hours at room temperature, 
after which the resin was filtered, washed with DCM (3 x 
30 ml), and dried. Infrared spectroscopy indicated that 
the conversion had taken place: v max  (KBr disc) 3020, 
2925 9 1803 (0-lactam c=o), 1740, 1680, 1450, 1220, 1030 
cm. A sample of the resin (0.010 g) was cleaved at this 
stage. 10% TF'A in DCM (1 ml) was added to the resin and 
the reaction mixture was agitated in an ultrasonic bath 
for 15 minutes. The resin was removed by filtration and 
washed with toluene (30 ml). The solvent was removed from 
the filtrate in vacuo, and the residue was analysed by 
hplc: Rt (starting material) (system 1) 10.1 (impurity), 
13.2 (4-2) 2 14.0 (A-3); Rt (reaction residue) (system 1) 
9.6 (suiphoxide), 10.1 (impurity). 
The remaining loaded resin (0.665 g, 0.24 mmol) was 
swelled in DCM and phosphorus trichloride (0.043 g, 0.312 
mmol) was added. The reaction mixture was agitated in an 
ultrasonic bath for 1.5 hours at room temperature. The 
resin was then filtered and washed with DCM (3 x 50 ml). 
-161- 
The product was then cleaved from the resin using 10% TFA 
in DCM (15 ml), in a similar manner to that described 
above. Hplc of the residue showed that only a very small 
amount of the -2 adduct was present, and that the major 
peak had the same retention time as a sample of 
cephalothin (10) that had previously been characterised by 
n.m.r: Rt  (10) (system 1 ) 14.0 minutes; Rt (reaction 
residue) (system 1) 10.1 (impurity), 14.0 (cephalothin). 
The attachment of 613- [ 9- fluorenylmethoxycarbonylamino -
penicillanic acid (109) onto the p-benzyloxybenzylalcohol 
resin 
(preparation of Fmoc-APA-(0-CH2-C6H4-OR)) 
N-methylmorpholine (0.17 ml, 1.58 mmol) was added to a 
solution of Fmoc-APA (109) (0.692 g, 1.58 mmol) in DCM (10 
ml). The resulting mixture was stirred for 1 minute, after 
which diphenylphosphinic anhydride (0.660 g, 1.58 mmol) in 
DMF (10 ml) was added. After the reaction mixture had been 
stirred for 10 minutes at room temperature, it was added 
to the benzyloxybenzylalcohol resin (Bachem, 0.79 mmol/g) 
(1.00 g, 0.79 mmol) that had been swelled in DMF (5 ml) in 
the presence of DMAP (0.005 g. 0.04 mmol). N-methyl-
inorpholine (0.17 ml, 1.58 mmol) was added and the reaction 
mixture was agitated in an ultrasonic bath for 3 hours at 
room temperature. The resin was filtered, washed with DMF 
(3 x 30 ml) and DCM (3 x 30 ml), and dried. 
The reaction was then repeated on the same resin, using 
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the same procedure and quantities of reagents. After this, 
a coupling yield of 467 (0.348 mmol/g) was obtained (UV 
deprotection study 97 ). 	This was considered to be 
sufficient for future work. Infrared spectroscopy 
identified the presence of /3-lactam C=0 functionality on 
the resin: vmax (KBr disc) 3020, 2920, 1790 (0-lactam 
c=o), 1740 7 1605 9 1450, 1030 cm'. 
Removal of Fmoc from 60-Fmoc-APA-(O-CH2C6H4-OR) 
(preparation of 6-APA-(0-CH2C6H4-OR)) 
DBU (0.015 ml, 0.083 mmol) was added to the loaded 
resin (0.200 g, 0.069 mmol) that had been swelled in DCM 
(15 ml). The reaction mixture was agitated in an 
ultrasonic bath for 15 minutes at room temperature. The 
resin was then filtered, washed with DCM (3 x 30 ml) and 
dried. The final resin gave a positive qualitative Kaiser 
test, and infrared spectroscopy identified the presence of 
/3-lactam C=0 functionality: 'max  (KBr disc) 3020, 2920, 
1780 ( j3-lactam c=o), 1740, 1605, 1450, 1170, 1030 cm - . 
Coupling of phenylacetyl chloride and 6-APA-(0-CH9CH-0R) 
(preparation of penicillin V-(0-CH2C6H4-OR) (120)) 
The deprotected resin (0.166 g, 0.060 mmol) was swelled 
in DCM (10 ml). To this was added pyridine (0.010 ml, 0.12 
rnmol) and phenoxyacetyl chloride (0.020 ml, 0.12 mmol). 
The reaction mixture was agitated in an ultrasonic bath 
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for 2 hours at room temperature, after which the resin was 
filtered, washed with DCM (3 x 30 ml), and dried. A 
qualitative Kaiser test on the final resin proved 
negative, and infrared spectroscopy indicated the presence 
of an extra C=0 absorption at 1700 cm: Vmax (KBr disc) 
3025, 2930, 1795 ( j3-lactam C0), 1740, 1700, 1605, 1455, 
1170, 1030 cm'. 
Investigating the stability of penicillin V (2) in 
TFA/DCM 
Penicillin V (0.10 g, 0.28 mmol) was stirred in 10% 
TFA/DCM (15 ml) for 10 minutes at room temperature, after 
which toluene (10 ml) was added and the solvent was 
removed in vacuo. The residue was analysed by hplc. The 
hplc traces were compared to traces obtained from 
authentic samples that had been run under the same 
conditions: Rt  (system 1) (2) 15.9 minutes; Rt (system 1) 
(reaction product) 10.0, 12.5, 15.9 (major), 20.8 minutes. 
The stability of penicillin V in 1°h TFA/DCM was also 
investigated. Penicillin V (0.10 g, 0.28 mmol) was stirred 
in 1% TFA/DCtI for 15 minutes at room temperature. Toluene 
(10 ml) was added and the solvent was removed in vacuo. 
The residue was analysed using the same hplc system as in 
the previous experiment: Rt (system 1) (reaction product) 
10.0, 12.5, 15.9 (major). 
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Investigating the stability of penicillin V (2) in 
EIC1/1 , 4-dioxane 
Penicillin V (0.100 g, 0.28 mmol) was stirred in a 
solution of 2M hydrochloric acid (0.5 ml) in 1,4-dioxane 
(4.5 ml) for 15 minutes at room temperature. The reaction 
mixture was then added to ethyl acetate (20 ml) and water 
(20 ml). The resulting aqueous phase was washed with ethyl 
acetate (3 x 30 ml). The combined organic phases were 
dried (Na 2 SO4 ) and the solvent was removed in vacuo. The 
residue was analysed by hplc.: Rt (system 1), (reaction 
product) 9.8 (major), 14.5, 15.9 (penicillin V), 20.2. 
The stability of penicillin V in a solution of 0.5M 
hydrochloric acid (0.5 ml) in 1,4-dioxane (4.5 ml) was 
then investigated. Penicillin V (0.050 g, 0.14 mmol) was 
stirred in this solution (5 ml) for 15 minutes at room 
temperature. The product was obtained in a similar manner 
to that described above, and was analysed by hplc: Rt 
(system 1) (reaction product) 12.2, 15.9 (penicillin V), 
21.1 9 24.0. 
Investigating the stability of penicillin V (2) in 
trichioroacetic acid (TCA)/DCM 
Trichioroacetic acid (0.035 g, 0.215 mmol) was added to 
a solution of penicillin V (0.015 g, 0.043 mmol) in DCM (5 
ml). The reaction mixture was agitated in an ultrasonic 
bath for 15 minutes at room temperature after which it was 
added to ethyl acetate (20 ml) and water (20 ml). The 
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organic layer was washed with water (3x 20 ml), dried 
(Na 2 SO4 ), and the solvent was removed in vacuo. The 
residue was analysed by hplc: Rt (system 1) (reaction 
product) 15.9 minutes. 
Attempted cleavage of penicillin V from the Wang resin 
(120) 
The loaded resin (120) (0.010 g, 0.004 mmol) was added 
to 107 TFA/DCM (2 ml), and the reaction was agitated in an 
ultrasonic bath for 10 minutes at room temperature, after 
which the resin was removed by filtration. Toluene (10 ml) 
was added to the filtrate, and the solvent was removed in 
vacuo. Hplc indicated that extensive decomposition of the 
product had occured. Rt (system 1) 11.4, 15.9 (small), 
20.8 1 27.0. 
The reaction was repeated using one equivalent of TFA. 
TFA (0.007 ml, 0.04 mmol) was added to the resin (0.100 g, 
0.04 mmol) that had been swelled in DCM (15 ml). The 
reaction mixture was agitated in an ultasonic bath for 30 
minutes at room temperature after which the resin was 
removed by filtration. Toluene (5 ml) was added to the 
filtrate, and the solvent was removed in vacuo. No residue 
was visible after removal of the solvent, indicating that 
the reaction had not taken place. 
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The attachment of 6 0 - [ 9- fluorenylmethoxycarbonylamino] 
penicillanic acid (109) onto the 2-methoxy-4-alkoxybenzyl 
alcohol resin (Sasrin resin) 
(preparation of Fm0cAPA-(0-CH2-C6H3(OMe)-OR)) 
Fmoc-APA (109) (0.468 g., 1.07 mmol) in DCM (10 ml) and 
N-methylmorpholine (0.12 ml, 1.07 mmol) were added to 
diphenyiphosphinic anhydride (0.447 g, 1.07 mmol) in DMF 
(20 ml). The reaction mixture was stirred for 10 minutes, 
after which it was added to the 2-methoxy-4-
alkoxybenzylalcohol resin (Bachem, 1.07 mmol/g) (0.50 g, 
0.535 mmol) that had been swelled in DMF (10 ml) in the 
presence of DMAP (0.003 g, 0.027 mmol). N-methylmorpholine 
(0.12 ml, 1.07 mmol) was added and the reaction mixture 
was agitated in an ultrasonic bath for 3 hours at room 
temperature. The resin was then filtered and washed with 
DMF (3 x 30 ml) and DCM (3 x 30 ml). 
The reaction was then repeated on the same resin, using 
the same conditions and quantities of reactants as before. 
After this the resin was dried, and was shown to be 237 
loaded (UV deprotection study97): 'max  (KBr disc) 3020, 
2920, 1790 ( j3-lactam co), 1735, 1605, 1450, 1150, 1025 
cm. 
The removal of Fmoc from Fm0cAPA-(O-CH2-C6H3(OMe)-OR) 
(preparation of 6-APA-(0-CH 2 -C6 H3 (OMe)-OR) 
The loaded resin (0.467 g, 0.115 mmol) was swelled in 
DCM (15 ml) and DBU (0.023 ml, 0.138 mmol) was added. The 
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reaction mixture was agitated in an ultrasonic bath for 15 
minutes at room temperature. The resin was then filtered, 
washed with DCM (3 x 30 ml), and dried. The final resin 
gave a positive qualitative Kaiser test: 'max  (KBr disc) 
3020, 2920 9 1785, 1745 9 1450, 1153 9 1025 cm 1 . 
Coupling of phenoxyacetyl chloride and 6-APA-(O-CH2CH 3 -
(OHe)-OR) 
(preparation of penicillin V-(O-CH2C6H3(OMe)-OR) 
Phenoxyacetyl chloride (0.027 ml, 0.20 mmol) and 
pyridine (0.016 ml, 0.20 mmol) were added to the 
deprotected resin (0.410 g, 0.10 mmol) that had been 
swelled in DCM (10 ml). The reaction mixture was agitated 
in an ultrasonic bath for 2 hours at room temperature. The 
resin was then filtered, washed with DCM (3 x 30 ml), and 
dried. 
The reaction was then repeated using the same 
conditions and quantities of reagents, to ensure that full 
coupling had occured. The final resin gave a negative 
qualitative Kaiser test: sJ max (KBr disc) 3025, 2900, 1790 
( f3-lactam c=o), 1740, 1700 9 1605, 1453, 1160, 1030 cm. 
The cleavage of penicillin V from penicillin v-(o-
CH7CH(0Me)-QR) 
Trichloroacetic acid (0.022 g, 0.123 mmol) in DCM (5 
ml) was added to the loaded resin (0.100 g, 0.02 mmol) 
that had been swelled in DCM (5 ml). The reaction mixture 
was agitated in an ultrasonic bath for 15 minutes at room 
temperature. The resin was then removed by filtration, and 
the filtrate was added to ethyl acetate (20 ml) and water 
(20 ml). The organic phase was separated, washed with 
water (2 x 20 ml) and dried (Na2SO4). The solvent was 
removed in vacuo which left the crude product: Hplc, Rt 
(system 1) (reaction product) 11.5, 15.9 9 24.0 minutes; Rt 
(system 1) (penicillin V) 15.9 minutes. The product was 
purified using preparative hplc and pure penicillin V 
(0.021 g , 487) was obtained as a white solid: 6 11 (80MHz, 
CD3COCD) 7.65 (1H, bd, NH), 7.48-6.90 (5H, m, phenoxy 
aromatic H's), 5.77-5.56 (2H, m, 5-H and 6-H), 4.63 (2H, 
s, acetyl CH2), 4.42 (1H, s, 3-H), 1.61 and 1.57 (6H, 2s, 
2 x CH3 ); Rt (system 1) 15.9 minutes. 
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